"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2014/0364821 A1,092-241-397-451-402,2014-12-11,2014,US 201214001513 A,2012-02-27,US 201214001513 A;;US 201161446612 P;;US 2012/0026785 W,2011-02-25,SYSTEM AND METHOD FOR DRAINING FLUIDS,"A system and/or a method of evacuating patient fluid from a subdural space of a patient. The system includes a flexible subdural drain having a plurality of apertures and a port in fluid communication with a valve. A reservoir containing a cleansing fluid is in fluid communication with the valve. An outlet in fluid communication with the valve. In a flush state, the valve is configured to establish fluid communication between the reservoir and the flexible subdural drain for evacuating the cleansing fluid from the reservoir. In a priming state, the valve is configured to close the fluid communication between the reservoir and the flexible subdural drain. In a drain state, the valve is configured to establish fluid communication between the flexible subdural drain and the outlet for evacuating the patient fluid via a siphoning effect through the outlet.",GIBBONS KEVIN;;UNIV NEW YORK STATE RES FOUND,GIBBONS KEVIN,THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (2013-12-24),https://lens.org/092-241-397-451-402,Patent Application,yes,3,13,3,3,0,A61M27/00;;A61M2210/0693;;A61B17/00234;;A61B2217/005;;A61B2217/007;;A61M1/85;;A61M2210/0693;;A61M27/00;;A61B17/00234;;A61B2217/007;;A61B2217/005;;A61M1/743;;A61M1/85;;A61M2202/0464,A61M1/00,604/319,0,0,,,,DISCONTINUED
2,EP,A1,EP 1295021 A1,078-608-295-469-231,2003-03-26,2003,EP 01946665 A,2001-06-22,US 0119982 W;;US 60237100 A,2000-06-23,"METHOD AND APPARATUS FOR PROVIDING SHUTOFF, OVERSPEED PROTECTION, AND DIRECTIONAL CONTROL OF A BYPASS FLOW IN A FUEL DELIVERY SYSTEM",,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,,https://lens.org/078-608-295-469-231,Patent Application,yes,0,1,8,8,0,F02C9/38;;F02C9/38,F02C9/28;;F02C7/232;;F02C9/38,,0,0,,,,EXPIRED
3,DE,T2,DE 60130656 T2,138-227-196-916-142,2008-06-26,2008,DE 60130656 T,2001-06-22,US 60237100 A;;US 0119982 W,2000-06-23,"VERFAHREN UND VORRICHTUNG ZUM HERSTELLEN EINER KRAFTSTOFFVERSORGUNGSANLAGE MIT EINER ABSPERRKLAPPE, EIN HÖCHSTDREHZAHLSCHUTZ UND EIN BYPASSWEGEVENTIL",,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,,https://lens.org/138-227-196-916-142,Granted Patent,no,0,0,8,8,0,F02C9/38;;F02C9/38,F02C7/232;;F02C9/38;;F02C9/28,,0,0,,,,EXPIRED
4,CA,A1,CA 2270161 A1,166-168-346-831-362,1998-06-04,1998,CA 2270161 A,1997-11-24,US 75380096 A;;US 9721932 W,1996-11-29,ACTUATOR WITH FAILFIXED ZERO DRIFT,The present invention provides an actuator controlled by an electro-hydraulic servovalve (12) with a failfixed operation upon the loss of electrical power to the servovalve. A lock valve (69) has apertures therethrough with friction pads (99) therein for locking the actuator in position upon loss of the electrical power.,UNITED TECHNOLOGIES CORP,GIBBONS KEVIN D,,https://lens.org/166-168-346-831-362,Patent Application,no,0,0,8,8,0,F15B15/26;;F15B13/0436;;F15B20/002;;F15B2211/8623;;F15B2211/8752;;F15B15/26,F15B13/043;;F15B15/26;;F15B20/00,,0,0,,,,DISCONTINUED
5,EP,B1,EP 0941408 B1,010-189-504-292-751,2003-07-16,2003,EP 97948593 A,1997-11-24,US 9721932 W;;US 75380096 A,1996-11-29,ACTUATOR WITH FAILFIXED ZERO DRIFT,,UNITED TECHNOLOGIES CORP,GIBBONS KEVIN D,,https://lens.org/010-189-504-292-751,Granted Patent,yes,6,0,8,8,0,F15B15/26;;F15B13/0436;;F15B20/002;;F15B2211/8623;;F15B2211/8752;;F15B15/26,F15B13/043;;F15B15/26;;F15B20/00,,0,0,,,,EXPIRED
6,US,A1,US 2008/0166173 A1,086-561-164-687-76X,2008-07-10,2008,US 64952507 A,2007-01-05,US 64952507 A,2007-01-05,Mobile marking board implement holder,"A one-piece, molded holder is provided for dry-erase markers and other presentation aids. This mobile implement holder provides easy, continuous access and storage of multiple color markers and other presentation/teaching aids while actively presenting or instructing. The light-weight holder provides for hand grip allowing single-handed support while the other hand is used in active teaching. The holder secures marker caps allowing quick removal, use, and replacement of markers while caps remain in place on the holder. Additional holes exist in the holder for storing on a nail near a marking board. A magnet(s) is integrated allowing for mounting to a magnetic white board. A straight edge for drawing straight lines on marking boards and an integral eraser allow for easy access during presentations. Fastener strips allow remote presentation slide advancer, remote electronic computer mouse, laser pointer, and the like to attach to the holder for ease of use during presentations.",GIBBONS KEVIN AUGUSTINE,GIBBONS KEVIN AUGUSTINE,,https://lens.org/086-561-164-687-76X,Patent Application,yes,11,24,1,1,0,B43K23/001;;B43L7/005;;B43L21/00;;B43L21/04;;B43K23/001;;B43L21/00;;B43L21/04;;B43L7/005,B43K23/02,401/131,0,0,,,,DISCONTINUED
7,WO,A3,WO 2012/154280 A3,172-475-837-510-27X,2013-01-24,2013,US 2012/0026785 W,2012-02-27,US 201161446612 P,2011-02-25,SYSTEM AND METHOD FOR DRAINING FLUIDS,"A system and/or a method of evacuating patient fluid from a subdural space of a patient. The system includes a flexible subdural drain having a plurality of apertures and a port in fluid communication with a valve. A reservoir containing a cleansing fluid is in fluid communication with the valve. An outlet in fluid communication with the valve. In a flush state, the valve is configured to establish fluid communication between the reservoir and the flexible subdural drain for evacuating the cleansing fluid from the reservoir. In a priming state, the valve is configured to close the fluid communication between the reservoir and the flexible subdural drain. In a drain state, the valve is configured to establish fluid communication between the flexible subdural drain and the outlet for evacuating the patient fluid via a siphoning effect through the outlet.",UNIV NEW YORK STATE RES FOUND;;GIBBONS KEVIN J,GIBBONS KEVIN J,,https://lens.org/172-475-837-510-27X,Search Report,yes,4,0,3,3,0,A61M27/00;;A61M2210/0693;;A61B17/00234;;A61B2217/005;;A61B2217/007;;A61M1/85;;A61M2210/0693;;A61M27/00;;A61B17/00234;;A61B2217/007;;A61B2217/005;;A61M1/743;;A61M1/85;;A61M2202/0464,A61M27/00;;A61B17/22;;A61J1/10;;A61M1/00;;A61M39/22,,0,0,,,,PENDING
8,WO,A1,WO 2002/001055 A1,192-139-566-142-673,2002-01-03,2002,US 0119982 W,2001-06-22,US 60237100 A,2000-06-23,"METHOD AND APPARATUS FOR PROVIDING SHUTOFF, OVERSPEED PROTECTION, AND DIRECTIONAL CONTROL OF A BYPASS FLOW IN A FUEL DELIVERY SYSTEM","Methods and apparatus are disclosed for providing shutoff, overspeed protection, and directional control of a bypass flow in a fuel delivery system (10) for a combustion engine, such as a gas turbine engine. A valve pack (72) is integrated into a fuel metering unit (12) and provides shutoff and overspeed protection, including verification of the operational integrity of the shutoff and overspeed protection components. A bypass directional control valve (150) is integrated into one embodiment of the fuel metering unit (12) and provides directional control of a bypass flow from an upstream side of a fuel metering valve (20) based upon the position of a metering valve spool (44) in the metering valve (20).",HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,,https://lens.org/192-139-566-142-673,Patent Application,yes,4,20,8,8,0,F02C9/38;;F02C9/38,F02C9/28;;F02C9/38;;F02C7/232,,0,0,,,,PATENTED
9,EP,B1,EP 1295021 B1,166-097-677-130-944,2007-09-26,2007,EP 01946665 A,2001-06-22,US 0119982 W;;US 60237100 A,2000-06-23,"METHOD AND APPARATUS FOR PROVIDING SHUTOFF, OVERSPEED PROTECTION, AND DIRECTIONAL CONTROL OF A BYPASS FLOW IN A FUEL DELIVERY SYSTEM",,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,,https://lens.org/166-097-677-130-944,Granted Patent,yes,3,1,8,8,0,F02C9/38;;F02C9/38,F02C7/232;;F02C9/28;;F02C9/38,,0,0,,,,EXPIRED
10,WO,A2,WO 2012/154280 A2,151-149-826-510-535,2012-11-15,2012,US 2012/0026785 W,2012-02-27,US 201161446612 P,2011-02-25,SYSTEM AND METHOD FOR DRAINING FLUIDS,"A system and/or a method of evacuating patient fluid from a subdural space of a patient. The system includes a flexible subdural drain having a plurality of apertures and a port in fluid communication with a valve. A reservoir containing a cleansing fluid is in fluid communication with the valve. An outlet in fluid communication with the valve. In a flush state, the valve is configured to establish fluid communication between the reservoir and the flexible subdural drain for evacuating the cleansing fluid from the reservoir. In a priming state, the valve is configured to close the fluid communication between the reservoir and the flexible subdural drain. In a drain state, the valve is configured to establish fluid communication between the flexible subdural drain and the outlet for evacuating the patient fluid via a siphoning effect through the outlet.",UNIV NEW YORK STATE RES FOUND;;GIBBONS KEVIN J,GIBBONS KEVIN J,,https://lens.org/151-149-826-510-535,Patent Application,yes,0,0,3,3,0,A61M27/00;;A61M2210/0693;;A61B17/00234;;A61B2217/005;;A61B2217/007;;A61M1/85;;A61M2210/0693;;A61M27/00;;A61B17/00234;;A61B2217/007;;A61B2217/005;;A61M1/743;;A61M1/85;;A61M2202/0464,A61M27/00;;A61B17/22;;A61J1/10;;A61M1/00;;A61M39/22,,0,0,,,,PENDING
11,AU,A,AU 2001/068682 A,126-620-192-394-32X,2002-01-08,2002,AU 2001/068682 A,2001-06-22,US 60237100 A;;US 0119982 W,2000-06-23,"Method and apparatus for providing shutoff, overspeed protection, and directional control of a bypass flow in fuel delivery system",,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,,https://lens.org/126-620-192-394-32X,Patent Application,no,0,0,8,8,0,F02C9/38;;F02C9/38,F02C7/232;;F02C9/28;;F02C9/38,,0,0,,,,PENDING
12,EP,A1,EP 0941408 A1,045-994-162-330-819,1999-09-15,1999,EP 97948593 A,1997-11-24,US 9721932 W;;US 75380096 A,1996-11-29,ACTUATOR WITH FAILFIXED ZERO DRIFT,,UNITED TECHNOLOGIES CORP,GIBBONS KEVIN D,,https://lens.org/045-994-162-330-819,Patent Application,yes,0,0,8,8,0,F15B15/26;;F15B13/0436;;F15B20/002;;F15B2211/8623;;F15B2211/8752;;F15B15/26,F15B13/043;;F15B15/26;;F15B20/00,,0,0,,,,EXPIRED
13,US,A,US 5735122 A,042-502-878-832-694,1998-04-07,1998,US 75380096 A,1996-11-29,US 75380096 A,1996-11-29,Actuator with failfixed zero drift,The present invention provides an actuator controlled by an electro-hydraulic servovalve with a failfixed operation upon the loss of electrical power to the servovalve. A lock valve has apertures therethrough with friction pads therein for locking the actuator in position upon loss of the electrical power.,UNITED TECHNOLOGIES CORP,GIBBONS KEVIN D,UNITED TECHNOLOGIES CORPORATION (1996-11-27),https://lens.org/042-502-878-832-694,Granted Patent,yes,9,27,8,8,0,F15B15/26;;F15B13/0436;;F15B20/002;;F15B2211/8623;;F15B2211/8752;;F15B15/26,F15B13/043;;F15B15/26;;F15B20/00,60/406;;91/44;;91/45;;92/18,0,0,,,,EXPIRED
14,US,B1,US 6401446 B1,063-497-363-773-435,2002-06-11,2002,US 60237100 A,2000-06-23,US 60237100 A,2000-06-23,Valve apparatus for providing shutoff and overspeed protection in a gas turbine fuel system,"
    Methods and apparatus are disclosed for providing shutoff, overspeed protection, and directional control of a bypass flow in a fuel delivery system (  10  ) for a combustion engine, such as a gas turbine engine. A valve pack (  72  ) is integrated into a fuel metering unit (  12  ) and provides shutoff and overspeed protection, including verification of the operational integrity of the shutoff and overspeed protection components. A bypass directional control valve (  150  ) is integrated into one embodiment of the fuel metering unit (  12  ) and provides directional control of a bypass flow from an upstream side of a fuel metering valve (  20  ) based upon the position of a metering valve spool (  44  ) in the metering valve (  20  ). 
",HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,HAMILTON SUNDSTRAND CORPORATION (2000-08-01),https://lens.org/063-497-363-773-435,Granted Patent,yes,6,82,8,8,0,F02C9/38;;F02C9/38,F02C9/28;;F02C9/38;;F02C7/232,60/39.281;;60/734,0,0,,,,EXPIRED
15,DE,D1,DE 60130656 D1,088-112-263-308-752,2007-11-08,2007,DE 60130656 T,2001-06-22,US 60237100 A;;US 0119982 W,2000-06-23,"VERFAHREN UND VORRICHTUNG ZUM HERSTELLEN EINER KRAFTSTOFFVERSORGUNGSANLAGE MIT EINER ABSPERRKLAPPE, EIN HÖCHSTDREHZAHLSCHUTZ UND EIN BYPASSWEGEVENTIL",,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN D,,https://lens.org/088-112-263-308-752,Granted Patent,no,0,0,8,8,0,F02C9/38;;F02C9/38,F02C7/232;;F02C9/38;;F02C9/28,,0,0,,,,EXPIRED
16,WO,A1,WO 1998/023866 A1,021-213-364-137-042,1998-06-04,1998,US 9721932 W,1997-11-24,US 75380096 A,1996-11-29,ACTUATOR WITH FAILFIXED ZERO DRIFT,The present invention provides an actuator controlled by an electro-hydraulic servovalve (12) with a failfixed operation upon the loss of electrical power to the servovalve. A lock valve (69) has apertures therethrough with friction pads (99) therein for locking the actuator in position upon loss of the electrical power.,UNITED TECHNOLOGIES CORP,GIBBONS KEVIN D,,https://lens.org/021-213-364-137-042,Patent Application,yes,6,1,8,8,0,F15B15/26;;F15B13/0436;;F15B20/002;;F15B2211/8623;;F15B2211/8752;;F15B15/26,F15B13/043;;F15B15/26;;F15B20/00,,0,0,,,,PATENTED
17,GB,A,GB 2417058 A,009-016-378-587-995,2006-02-15,2006,GB 0417904 A,2004-08-11,GB 0417904 A,2004-08-11,Water mixing valve,"A water mixing valve for mixing hot water from a combi-boiler with cold water from a cold-water supply, the water mixing valve including a hot-water flow controller defining a hot-water flow path 32 of variable cross-section and a cold-water flow controller defining a cold-water flow path 34 of variable cross-section. A temperature controller 24 simultaneously operates the hot and cold-water flow controllers to provide a user-selectable outlet water temperature. The hot and cold-water flow controllers operate in tandem so that, for a mid-range portion of operation, the total through-flow of water is substantially constant. However, the hot-water flow controller operates at at least one end of the range of operation to vary the total through-flow of water and, hence, extends the temperature range achievable by the water mixing valve.",AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE,,https://lens.org/009-016-378-587-995,Patent Application,no,9,4,3,3,0,F16K3/08;;F16K11/074;;F16K11/074;;G05D23/1393,F16K11/074;;F16K3/08;;G05D23/13,F2V VP16          VV10;;F2V VV10          VV10;;NOT CLASSIFIED    NONE,0,0,,,,ACTIVE
18,FR,B1,FR 2968394 B1,063-934-622-685-003,2015-06-26,2015,FR 1161079 A,2011-12-02,US 96214010 A,2010-12-07,SYTEME DE DETECTION DE POSITION,,HAMILTON SUNDSTRAND CORP,VILLANO WILLIAM;;GIBBONS KEVIN,,https://lens.org/063-934-622-685-003,Granted Patent,no,0,0,3,3,0,G01B7/003;;G01D5/2291;;G01B7/003;;G01D5/2291,G01B21/12,,0,0,,,,ACTIVE
19,GB,A,GB 2457291 A,191-760-195-531-096,2009-08-12,2009,GB 0802419 A,2008-02-08,GB 0802419 A,2008-02-08,MOUNTING BRACKET,"A mounting bracket (10) including at least two pipe fittings, each for connection between a water supply pipe and an outlet, and a mounting member extending between the pipe fittings. The pipe fittings and mounting member are constructed as a single piece integral article. The mounting member is provided with a top wall (26) allowing the mounting member to be mounted to a downwardly facing surface and a rear wall (22) allowing the mounting member to be mounted against a forwardly facing surface. Flanges (32) are provided around the outlets (2) allowing the mounting bracket to be mounted against a rearwardly facing surface.",AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE,,https://lens.org/191-760-195-531-096,Patent Application,no,9,2,2,2,0,E03C1/021;;E03C1/021;;E03C2001/028,E03C1/02,,0,0,,,,DISCONTINUED
20,GB,B,GB 2417058 B,097-841-780-116-552,2008-08-13,2008,GB 0417904 A,2004-08-11,GB 0417904 A,2004-08-11,Water mixing valve,,AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE,,https://lens.org/097-841-780-116-552,Granted Patent,no,9,1,3,3,0,F16K3/08;;F16K11/074;;F16K11/074;;G05D23/1393,F16K11/074;;F16K3/08;;G05D23/13,,0,0,,,,ACTIVE
21,US,B1,US 11329999 B1,130-505-914-308-579,2022-05-10,2022,US 201816192458 A,2018-11-15,US 201816192458 A;;US 201862754602 P,2018-11-02,Determining environment parameter values using rendered emoji analysis,"Techniques are provided for determining environment parameter values based on rendered emoji analysis, A server computer provides a first set of code that, when executed by a browser application at a client computing device, renders a set of emoji at the client computing device, generates a set of rendered graphic data for the set of emoji at the client computing device, and transmits the set of rendered graphic data for each emoji of the set of emoji from the client computing device to the server computer. The server computer receives the rendered graphic data generated at the client computing device, Based on the set of rendered graphic data for the set of emoji generated at the client computing device, the server computer determines a set values for one or more environment parameters of the client computing device.",SHAPE SECURITY INC;;F5 INC,GIBBONS KEVIN;;FICARRA MICHAEL,SHAPE SECURITY INC (2018-11-15),https://lens.org/130-505-914-308-579,Granted Patent,yes,3,1,1,1,0,H04L63/1416;;H04L2463/144;;G06F21/6218;;G06F21/554;;H04L63/1416;;G06T2207/10024;;G06T7/90,G06T7/90,,0,0,,,,ACTIVE
22,GB,A,GB 2457292 A,184-429-098-858-43X,2009-08-12,2009,GB 0802420 A,2008-02-08,GB 0802420 A,2008-02-08,Housing for mounting water pipes,"A water pipe mounting housing 20 is used for installing a water outlet in a wall. The housing has inlet openings for receiving water supply pipes, and pipe mounts are provided adjacent the inlet openings to mount fittings 70 for the respective water supply pipes. The housing 20 allows the supply pipes to be fixed before or after it is attached to the wall, and allows interchangeable cover plates 90, 100, 110 for different taps and mixers.",AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE,,https://lens.org/184-429-098-858-43X,Patent Application,no,5,4,3,3,0,E03C1/021;;E03C1/021,E03C1/02,,0,0,,,,INACTIVE
23,FR,A1,FR 2968394 A1,035-338-267-703-046,2012-06-08,2012,FR 1161079 A,2011-12-02,US 96214010 A,2010-12-07,SYTEME DE DETECTION DE POSITION,"A position detecting system for a differential movement system which moves a first surface (12) and a second surface (14) from a fixed surface (16) includes an actuation system (10) to move the second surface (14) relative to the first surface (12) and to allow the second surface (14) to move with the first surface (12); a sensor (18a, 18b) connected to the actuation system (10) to detect a parameter of the actuation system (10) related to an expected amount of movement of the second surface (14) to determine the expected amount of movement of the second surface (14); and a sensor system (20) connected to the second surface (14) and the fixed surface (16) to detect the amount of actual movement of the second surface (14).",HAMILTON SUNDSTRAND CORP,VILLANO WILLIAM;;GIBBONS KEVIN,,https://lens.org/035-338-267-703-046,Patent Application,no,1,0,3,3,0,G01B7/003;;G01D5/2291;;G01B7/003;;G01D5/2291,G01B21/12,,0,0,,,,ACTIVE
24,GB,B,GB 2457292 B,037-783-885-856-443,2012-03-28,2012,GB 0802420 A,2008-02-08,GB 0802420 A,2008-02-08,Water pipe mounting housing,,AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE,,https://lens.org/037-783-885-856-443,Granted Patent,no,5,0,3,3,0,E03C1/021;;E03C1/021,E03C1/02,,0,0,,,,INACTIVE
25,EP,A3,EP 2390484 A3,006-240-689-043-01X,2013-04-17,2013,EP 11167781 A,2011-05-26,US 78684410 A,2010-05-25,Fuel pumping system for a gas turbine engine,"A fuel supply system (50) for a gas turbine engine (40) has a first pump (26) for delivering fuel to a first use (72) on a gas turbine engine, and a second pump (24) for delivering fuel to a second use on the gas turbine engine. A valve (52) allows flow from the first pump to be delivered to the first use, but also routes some flow from the first pump to supplement fuel flow from the second pump until a pressure downstream of the second pump increases. The valve then allows flow from the second pump to flow to the first use to supplement the flow from the first pump.
",HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,,https://lens.org/006-240-689-043-01X,Search Report,yes,5,0,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/22;;F02C7/232;;F02C7/236;;F02C9/26,,0,0,,,,ACTIVE
26,GB,A,GB 1277024 A,017-707-022-288-33X,1972-06-07,1972,GB 4153868 A,1968-08-30,GB 4153868 A,1968-08-30,IMPROVEMENTS IN OR RELATING TO MOULDS,"1277024 Matched sheet forming moulds BRITISH PETROLEUM CO Ltd 24 July 1969 [30 Aug 1968] 41538/68 Heading B5A A hollow article having an undercut is deep drawn from a heat softened thermoplastic sheet between co-operating male and female mould halves, the female half being provided with retractable projections which co-operate with recesses in the male half. One of the side walls of each recess of the male mould half is itself formed by a retractable projection which co-operates with the corresponding face of the corresponding projection of the female half. In the preferred embodiment, an egg box having projecting locking tabs (such as that described in Specification 1,257,792) is drawn from a heat softened expanded polystyrene sheet between a female mould half 1, mounted upon a bed 2, and a male mould half 16. One side 3 of the female mould, which side is higher than the others, is provided at a point above the general surface of the mould with slots 5 through which are movable projections 6 forming part of L-shaped levers 7 pivotally mounted upon a rod 8. The projections are moved through and retracted from the slots 5 by means of an actuating plate 10 which is suitably slotted to engage the horizontal arms of the levers and which carries at its upper end a striker plate. An upwardly acting biasing spring 15 urges the plate 10 upwardly to normally withdraw the projections through the slots. The corresponding side of the male mould half is provided with recesses 17 adapted to engage projections 6 of the female mould half. Each recess is provided with a slot 18 on which is located a projection 19 carried by an L-shaped lever 20. The levers are actuated by a recessed spring biased actuating plate 23, the lower end of which is provided with a striker plate 26 located within a recess 25 in the leading face of the male mould half. In operation, the mould halves are closed, the sticker plate 26 and that of the actuating plate 10 are engaged by the opposite mould half and the projections are forwarded into co-operation through their slots. Upon withdrawal of the mould halves after moulding the spring biased actuating plates cause the projections to be withdrawn through the slots facilitating the full opening of the mould and the removal of the moulded article. Reference has been directed by the Comptroller to Specification 1,229,218.",BRITISH PETROLEUM CO,GIBBONS JOHN GILBERT;;WESTMAN KEVIN,,https://lens.org/017-707-022-288-33X,Granted Patent,no,0,0,1,1,0,B29C51/34;;B29C51/082;;B29C51/38,B29C51/08;;B29C51/34;;B29C51/38,B5A AT16D         T16D;;B5A A1R14B        A9;;B5A A1R14C1X      A9;;B5A A1R20         A9;;B5A A1R214B       T16D;;B5A A1R314C1D     T16D;;B5A A1R400        T16D;;B5A A1R407        T16D;;B5A A1R419        T16D;;B5A A2A4A         T16D;;B5A A2D2          T16D;;B5A A2E10         T16D;;B5A A2E12A        T16D;;B5A A2E12B        T16D;;B5A A2E3          T16D;;B5A A2E6          T16D;;B5A A2E7A         T16D;;B5A A2E7B         T16D;;B5A A2K2          T16D;;B5A A9            A9;;B5A A9H3          T16D;;B5A A9Q           T16D,0,0,,,,EXPIRED
27,US,B1,US 11741197 B1,042-816-364-603-415,2023-08-29,2023,US 202017066962 A,2020-10-09,US 202017066962 A;;US 201962915183 P,2019-10-15,Obfuscating programs using different instruction set architectures,"Technology related to obfuscating programs using different instruction set architectures is disclosed. In one example, a method includes receiving a program implemented as a set of ordered instructions. Each instruction of the set of ordered instructions has a type specified by a first instruction set architecture (ISA). A subgroup of instructions is selected from the set of ordered instructions. A new instruction type is generated to perform the operations of the subgroup of consecutive instructions. The new instruction type is added to a second ISA. An updated program is generated by replacing the subgroup of instructions with a new instruction of the generated new instruction type. An interpreter for executing programs using the second ISA is generated. In response to a request for the program, the updated program and the interpreter is sent.",SHAPE SECURITY INC,GIBBONS KEVIN;;FICARRA MICHAEL J,SHAPE SECURITY INC (2020-10-06),https://lens.org/042-816-364-603-415,Granted Patent,yes,75,0,1,1,0,G06F21/14;;G06F21/54;;G06F21/14,G06F21/14,,4,1,003-164-258-961-301,10.1109/icastech.2009.5409720,"Currie, M. W. et al., “In the Wire Authentication: Protecting client-side critical data fields in secure network transactions”, IEEE, pp. 232-237, Jan. 14, 2009.;;International Search Report for PCT/US16/41337, dated Oct. 11, 2016.;;International Search Report for PCT/US17/21409, dated May 23, 2017.;;European Search Report for EP Application No. 17764019.0, dated Feb. 4, 2020.",ACTIVE
28,JP,A,JP 2011247259 A,159-416-440-358-133,2011-12-08,2011,JP 2011115366 A,2011-05-24,US 78684410 A,2010-05-25,FUEL PUMPING SYSTEM FOR GAS TURBINE ENGINE,"PROBLEM TO BE SOLVED: To provide a fuel supply system for a gas turbine engine.SOLUTION: The fuel supply system 50 for the gas turbine engine 40 has a first pump 26 for delivering fuel to a first use part on the gas turbine engine 40, and a second pump 24 for delivering fuel to a second use part 28 on the gas turbine engine 40. A valve 52 allows flow from the first pump 26 to be delivered to the first use part, but also routes some flow from the first pump 26 to supplement fuel flow from the second pump 24 until a pressure downstream of the second pump 24 increases. The valve 52 then allows flow from the second pump 24 to flow to the first use part to supplement the flow from the first pump 26.",HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,,https://lens.org/159-416-440-358-133,Patent Application,no,4,2,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C9/48;;F02C9/28,,0,0,,,,ACTIVE
29,US,A1,US 2012/0139531 A1,048-655-122-694-987,2012-06-07,2012,US 96214010 A,2010-12-07,US 96214010 A,2010-12-07,POSITION DETECTING SYSTEM,A position detecting system for a differential movement system which moves a first surface and a second surface from a fixed surface includes an actuation system to move the second surface relative to the first surface and to allow the second surface to move with the first surface; a sensor connected to the actuation system to detect a parameter of the actuation system related to an expected amount of movement of the second surface to determine the expected amount of movement of the second surface; and a sensor system connected to the second surface and the fixed surface to detect the amount of actual movement of the second surface.,VILLANO WILLIAM E;;GIBBONS KEVIN;;HAMILTON SUNDSTRAND CORP,VILLANO WILLIAM E;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2010-12-01),https://lens.org/048-655-122-694-987,Patent Application,yes,8,7,3,3,0,G01B7/003;;G01D5/2291;;G01B7/003;;G01D5/2291,G01B7/30,324/207.18,0,0,,,,DISCONTINUED
30,US,B2,US 11408347 B2,042-585-203-204-573,2022-08-09,2022,US 201916518493 A,2019-07-22,US 201916518493 A,2019-07-22,Fuel systems,"A fuel system can include a total flow line configured to receive a total flow and a primary flow line connected to the total flow line. The primary flow line can be in fluid communication with one or more primary fuel nozzles of a nozzle assembly. The fuel system can include a secondary flow line connected to the total flow line in parallel with the primary flow line, the secondary flow line in fluid communication with a plurality of secondary flow nozzles of the nozzle assembly. The fuel system can include a flow split system configured to control a flow split between a primary flow of the primary flow line and a secondary flow of the secondary flow line.",REUTER CHARLES E;;GIBBONS KEVIN;;HAMILTON SUNDSTRAND CORP,REUTER CHARLES E;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2019-07-22),https://lens.org/042-585-203-204-573,Granted Patent,yes,12,3,5,5,0,F02C7/228;;F02C9/26;;F05D2260/96;;F05D2270/14;;F02C7/228;;F02C9/263;;F02C9/34;;F23R3/34;;F02C9/26;;F05D2260/96;;F05D2270/14,F02C7/228;;F02C9/26;;F02C9/34;;F23R3/34,,1,0,,,"Extended European Search Report dated Jul. 10, 2020, issued during the prosecution of European Patent Application No. EP 19216263.4.",ACTIVE
31,EP,A1,EP 3440542 A1,031-722-080-419-169,2019-02-13,2019,EP 17764019 A,2017-03-08,US 201662306022 P;;US 2017/0021409 W,2016-03-09,APPLYING BYTECODE OBFUSCATION TECHNIQUES TO PROGRAMS WRITTEN IN AN INTERPRETED LANGUAGE,,SHAPE SECURITY INC,FICARRA MICHAEL J;;GIBBONS KEVIN,,https://lens.org/031-722-080-419-169,Patent Application,yes,0,0,6,6,0,H04L2463/144;;G06F9/45529;;G06F9/45504;;G06F21/53;;G06F21/14;;H04L2463/144;;G06F9/455;;G06F21/71;;G06F9/45529;;G06F9/45504;;G06F9/30021;;H04L63/1416,G06F9/45,,0,0,,,,ACTIVE
32,US,A1,US 2013/0255270 A1,178-117-244-467-403,2013-10-03,2013,US 201213431187 A,2012-03-27,US 201213431187 A,2012-03-27,PASSIVE EQUILIZATION FLOW DIVIDER VALVE,A method and system for providing fuel to primary and secondary fuel nozzles in a gas turbine engine fuel system comprises generating a fuel flow and routing primary fuel from the fuel flow to a primary fuel nozzle. Backpressure on the fuel flow is maintained using a valve. The valve is opened at increased fuel flow to route secondary fuel from the fuel flow to a secondary fuel nozzle. The valve is progressively opened under increasing fuel flows to reduce a pressure drop across the valve produced by the secondary fuel.,GIBBONS KEVIN;;DYER GERALD P;;HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,HAMILTON SUNDSTRAND CORPORATION (2012-03-23),https://lens.org/178-117-244-467-403,Patent Application,yes,0,6,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C7/232;;F02C7/228,60/776;;60/747,0,0,,,,ACTIVE
33,EP,A2,EP 2390484 A2,124-565-306-335-167,2011-11-30,2011,EP 11167781 A,2011-05-26,US 78684410 A,2010-05-25,Fuel pumping system for a gas turbine engine,"A fuel supply system (50) for a gas turbine engine (40) has a first pump (26) for delivering fuel to a first use (72) on a gas turbine engine, and a second pump (24) for delivering fuel to a second use on the gas turbine engine. A valve (52) allows flow from the first pump to be delivered to the first use, but also routes some flow from the first pump to supplement fuel flow from the second pump until a pressure downstream of the second pump increases. The valve then allows flow from the second pump to flow to the first use to supplement the flow from the first pump.
",HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,,https://lens.org/124-565-306-335-167,Patent Application,yes,0,0,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/22;;F02C7/232;;F02C7/236;;F02C9/26,,0,0,,,,ACTIVE
34,US,B2,US 11879393 B2,007-672-962-321-355,2024-01-23,2024,US 202217882384 A,2022-08-05,US 202217882384 A;;US 201916518493 A,2019-07-22,Fuel systems,"A fuel system can include a total flow line configured to receive a total flow and a primary flow line connected to the total flow line. The primary flow line can be in fluid communication with one or more primary fuel nozzles of a nozzle assembly. The fuel system can include a secondary flow line connected to the total flow line in parallel with the primary flow line, the secondary flow line in fluid communication with a plurality of secondary flow nozzles of the nozzle assembly. The fuel system can include a flow split system configured to control a flow split between a primary flow of the primary flow line and a secondary flow of the secondary flow line.",HAMILTON SUNDSTRAND CORP,REUTER CHARLES E;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2019-07-22),https://lens.org/007-672-962-321-355,Granted Patent,yes,12,0,5,5,0,F02C7/228;;F02C9/26;;F05D2260/96;;F05D2270/14;;F02C7/228;;F02C9/263;;F02C9/34;;F23R3/34;;F02C9/26;;F05D2260/96;;F05D2270/14,F02C9/26;;F02C7/228;;F02C9/34;;F23R3/34,,1,0,,,"Extended European Search Report dated Jul. 10, 2020, issued during the prosecution of European Patent Application No. EP 19216263.4.",ACTIVE
35,EP,A4,EP 3440542 A4,197-015-805-749-446,2020-02-12,2020,EP 17764019 A,2017-03-08,US 201662306022 P;;US 2017/0021409 W,2016-03-09,APPLYING BYTECODE OBFUSCATION TECHNIQUES TO PROGRAMS WRITTEN IN AN INTERPRETED LANGUAGE,,SHAPE SECURITY INC,FICARRA MICHAEL J;;GIBBONS KEVIN,,https://lens.org/197-015-805-749-446,Search Report,no,1,0,6,6,0,H04L2463/144;;G06F9/45529;;G06F9/45504;;G06F21/53;;G06F21/14;;H04L2463/144;;G06F9/455;;G06F21/71;;G06F9/45529;;G06F9/45504;;G06F9/30021;;H04L63/1416,G06F9/455;;G06F21/71,,0,0,,,,ACTIVE
36,US,A1,US 2011/0289925 A1,003-540-370-128-367,2011-12-01,2011,US 78684410 A,2010-05-25,US 78684410 A,2010-05-25,FUEL PUMPING SYSTEM FOR A GAS TURBINE ENGINE,"A fuel supply system for a gas turbine engine has a first pump for delivering fuel to a first use on a gas turbine engine, and a second pump for delivering fuel to a second use on the gas turbine engine. A valve allows flow from the first pump to be delivered to the first use, but also routes some flow from the first pump to supplement fuel flow from the second pump until a pressure downstream of the second pump increases. The valve then allows flow from the second pump to flow to the first use to supplement the flow from the first pump.",DYER GERALD P;;GIBBONS KEVIN,DYER GERALD P;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2010-05-20),https://lens.org/003-540-370-128-367,Patent Application,yes,6,23,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/22,60/734;;137/565.11,0,0,,,,ACTIVE
37,US,A1,US 2022/0372919 A1,066-731-375-390-96X,2022-11-24,2022,US 202217882384 A,2022-08-05,US 202217882384 A;;US 201916518493 A,2019-07-22,FUEL SYSTEMS,"A fuel system can include a total flow line configured to receive a total flow and a primary flow line connected to the total flow line. The primary flow line can be in fluid communication with one or more primary fuel nozzles of a nozzle assembly. The fuel system can include a secondary flow line connected to the total flow line in parallel with the primary flow line, the secondary flow line in fluid communication with a plurality of secondary flow nozzles of the nozzle assembly. The fuel system can include a flow split system configured to control a flow split between a primary flow of the primary flow line and a secondary flow of the secondary flow line.",HAMILTON SUNDSTRAND CORP,REUTER CHARLES E;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2019-07-22),https://lens.org/066-731-375-390-96X,Patent Application,yes,0,0,5,5,0,F02C7/228;;F02C9/26;;F05D2260/96;;F05D2270/14;;F02C7/228;;F02C9/263;;F02C9/34;;F23R3/34;;F02C9/26;;F05D2260/96;;F05D2270/14,F02C9/26;;F23R3/34,,0,0,,,,ACTIVE
38,WO,A1,WO 2017/156158 A1,081-914-760-577-849,2017-09-14,2017,US 2017/0021409 W,2017-03-08,US 201715453048 A;;US 201662306022 P,2016-03-09,APPLYING BYTECODE OBFUSCATION TECHNIQUES TO PROGRAMS WRITTEN IN AN INTERPRETED LANGUAGE,"In an embodiment, a computer system configured to improve security of client computer interacting with server computers comprises one or more processors; a digital electronic memory storing a set of program instructions which when executed using the one or more processors cause the one or more processors to: process a first set of original instructions that produce a first set of outputs or effects; generate a first set of interpreter instructions that define a first interpreter; generate a first set of alternate instructions from the first set of original instructions, wherein the first set of alternate instructions is functionally equivalent to the first set of original instructions when the first set of alternate instructions is executed by the first interpreter; send, to the first client computer, the first set of alternate instructions and the first set of interpreter instructions.",SHAPE SECURITY INC,FICARRA MICHAEL J;;GIBBONS KEVIN,,https://lens.org/081-914-760-577-849,Patent Application,yes,2,0,6,6,0,H04L2463/144;;G06F9/45529;;G06F9/45504;;G06F21/53;;G06F21/14;;H04L2463/144;;G06F9/455;;G06F21/71;;G06F9/45529;;G06F9/45504;;G06F9/30021;;H04L63/1416,G06F9/45,,1,0,,,See also references of EP 3440542A4,PENDING
39,US,A1,US 2021/0025330 A1,092-508-155-127-423,2021-01-28,2021,US 201916518493 A,2019-07-22,US 201916518493 A,2019-07-22,FUEL SYSTEMS,"A fuel system can include a total flow line configured to receive a total flow and a primary flow line connected to the total flow line. The primary flow line can be in fluid communication with one or more primary fuel nozzles of a nozzle assembly. The fuel system can include a secondary flow line connected to the total flow line in parallel with the primary flow line, the secondary flow line in fluid communication with a plurality of secondary flow nozzles of the nozzle assembly. The fuel system can include a flow split system configured to control a flow split between a primary flow of the primary flow line and a secondary flow of the secondary flow line.",REUTER CHARLES E;;GIBBONS KEVIN;;HAMILTON SUNDSTRAND CORP,REUTER CHARLES E;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2019-07-22),https://lens.org/092-508-155-127-423,Patent Application,yes,0,1,5,5,0,F02C7/228;;F02C9/26;;F05D2260/96;;F05D2270/14;;F02C7/228;;F02C9/263;;F02C9/34;;F23R3/34;;F02C9/26;;F05D2260/96;;F05D2270/14,F02C7/228;;F02C9/26;;F02C9/34;;F23R3/34,,0,0,,,,ACTIVE
40,EP,B1,EP 3440542 B1,169-841-121-823-536,2021-04-28,2021,EP 17764019 A,2017-03-08,US 201662306022 P;;US 2017/0021409 W,2016-03-09,APPLYING BYTECODE OBFUSCATION TECHNIQUES TO PROGRAMS WRITTEN IN AN INTERPRETED LANGUAGE,,SHAPE SECURITY INC,FICARRA MICHAEL J;;GIBBONS KEVIN,,https://lens.org/169-841-121-823-536,Granted Patent,yes,3,0,6,6,0,H04L2463/144;;G06F9/45529;;G06F9/45504;;G06F21/53;;G06F21/14;;H04L2463/144;;G06F9/455;;G06F21/71;;G06F9/45529;;G06F9/45504;;G06F9/30021;;H04L63/1416,G06F21/14;;G06F9/455;;G06F21/53,,0,0,,,,ACTIVE
41,CA,C,CA 2806951 C,045-961-724-794-025,2015-11-17,2015,CA 2806951 A,2013-02-14,US 201213431187 A,2012-03-27,PASSIVE EQUILIZATION FLOW DIVIDER VALVE,A method and system for providing fuel to primary and secondary fuel nozzles in a gas turbine engine fuel system comprises generating a fuel flow and routing primary fuel from the fuel flow to a primary fuel nozzle. Backpressure on the fuel flow is maintained using a valve. The valve is opened at increased fuel flow to route secondary fuel from the fuel flow to a secondary fuel nozzle. The valve is progressively opened under increasing fuel flows to reduce a pressure drop across the valve produced by the secondary fuel.,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,,https://lens.org/045-961-724-794-025,Granted Patent,no,0,0,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C7/232;;F02C7/22;;F23R3/28,,0,0,,,,ACTIVE
42,EP,A1,EP 3770403 A1,070-402-954-175-997,2021-01-27,2021,EP 19216263 A,2019-12-13,US 201916518493 A,2019-07-22,FUEL SYSTEMS,"A fuel system (100) can include a total flow line (101) configured to receive a total flow and a primary flow line (103) connected to the total flow line. The primary flow line can be in fluid communication with one or more primary fuel nozzles of a nozzle assembly. The fuel system can include a secondary flow line (107) connected to the total flow line in parallel with the primary flow line, the secondary flow line in fluid communication with a plurality of secondary flow nozzles of the nozzle assembly. The fuel system can include a flow split system (111) configured to control a flow split between a primary flow of the primary flow line and a secondary flow of the secondary flow line.
",HAMILTON SUNDSTRAND CORP,REUTER CHARLES E;;GIBBONS KEVIN,,https://lens.org/070-402-954-175-997,Patent Application,yes,4,0,5,5,0,F02C7/228;;F02C9/26;;F05D2260/96;;F05D2270/14;;F02C7/228;;F02C9/263;;F02C9/34;;F23R3/34;;F02C9/26;;F05D2260/96;;F05D2270/14,F02C7/228;;F02C9/26,,0,0,,,,PENDING
43,US,B2,US 8590310 B2,014-540-245-718-260,2013-11-26,2013,US 201213431187 A,2012-03-27,US 201213431187 A,2012-03-27,Passive equilization flow divider valve,A method and system for providing fuel to primary and secondary fuel nozzles in a gas turbine engine fuel system comprises generating a fuel flow and routing primary fuel from the fuel flow to a primary fuel nozzle. Backpressure on the fuel flow is maintained using a valve. The valve is opened at increased fuel flow to route secondary fuel from the fuel flow to a secondary fuel nozzle. The valve is progressively opened under increasing fuel flows to reduce a pressure drop across the valve produced by the secondary fuel.,GIBBONS KEVIN;;DYER GERALD P;;HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,HAMILTON SUNDSTRAND CORPORATION (2012-03-23),https://lens.org/014-540-245-718-260,Granted Patent,yes,26,8,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C1/00,60/734,0,0,,,,ACTIVE
44,CA,A1,CA 2736449 A1,039-735-700-676-726,2011-11-25,2011,CA 2736449 A,2011-04-06,US 78684410 A,2010-05-25,FUEL PUMPING SYSTEM FOR A GAS TURBINE ENGINE,"A fuel supply system for a gas turbine engine has a first pump for delivering fuel to a first use on a gas turbine engine, and a second pump for delivering fuel to a second use on the gas turbine engine. A valve allows flow from the first pump to be delivered to the first use, but also routes some flow from the first pump to supplement fuel flow from the second pump until a pressure downstream of the second pump increases. The valve then allows flow from the second pump to flow to the first use to supplement the flow from the first pump.",HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,,https://lens.org/039-735-700-676-726,Patent Application,no,0,0,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/236;;F02C7/232,,0,0,,,,ACTIVE
45,US,A1,US 2017/0264623 A1,065-982-066-131-681,2017-09-14,2017,US 201715453048 A,2017-03-08,US 201715453048 A;;US 201662306022 P,2016-03-09,APPLYING BYTECODE OBFUSCATION TECHNIQUES TO PROGRAMS WRITTEN IN AN INTERPRETED LANGUAGE,"In an embodiment, a computer system configured to improve security of client computer interacting with server computers comprises one or more processors; a digital electronic memory storing a set of program instructions which when executed using the one or more processors cause the one or more processors to: process a first set of original instructions that produce a first set of outputs or effects; generate a first set of interpreter instructions that define a first interpreter; generate a first set of alternate instructions from the first set of original instructions, wherein the first set of alternate instructions is functionally equivalent to the first set of original instructions when the first set of alternate instructions is executed by the first interpreter; send, to the first client computer, the first set of alternate instructions and the first set of interpreter instructions.",SHAPE SECURIY INC,FICARRA MICHAEL J;;GIBBONS KEVIN,SHAPE SECURITY INC (2017-03-07),https://lens.org/065-982-066-131-681,Patent Application,yes,5,26,6,6,0,H04L2463/144;;G06F9/45529;;G06F9/45504;;G06F21/53;;G06F21/14;;H04L2463/144;;G06F9/455;;G06F21/71;;G06F9/45529;;G06F9/45504;;G06F9/30021;;H04L63/1416,H04L29/06;;G06F9/30,,0,0,,,,ACTIVE
46,EP,A2,EP 2644864 A2,139-564-031-848-309,2013-10-02,2013,EP 13155199 A,2013-02-14,US 201213431187 A,2012-03-27,Passive equalization flow divider valve,"A method and system for providing fuel to primary, 30, and secondary, 32, fuel nozzles in a gas turbine engine fuel system, 12, comprises generating a fuel flow and routing primary fuel from the fuel flow to a primary fuel nozzle, 30. Backpressure on the fuel flow is maintained using a valve. The valve is opened at increased fuel flow to route secondary fuel from the fuel flow to a secondary fuel nozzle, 32. The valve is progressively opened under increasing fuel flows to reduce a pressure drop across the valve produced by the secondary fuel.
",HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,HAMILTON SUNDSTRAND CORPORATION (2020-04-15),https://lens.org/139-564-031-848-309,Patent Application,yes,0,3,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C7/232;;F02C9/26,,0,0,,,,ACTIVE
47,EP,B1,EP 2644864 B1,118-467-215-716-013,2020-12-30,2020,EP 13155199 A,2013-02-14,US 201213431187 A,2012-03-27,Passive equalization flow divider valve,,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,HAMILTON SUNDSTRAND CORPORATION (2020-04-15),https://lens.org/118-467-215-716-013,Granted Patent,yes,4,0,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C7/232;;F02C9/26,,0,0,,,,ACTIVE
48,EP,B1,EP 2390484 B1,119-193-070-496-208,2019-05-08,2019,EP 11167781 A,2011-05-26,US 78684410 A,2010-05-25,Fuel pumping system for a gas turbine engine,,HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,,https://lens.org/119-193-070-496-208,Granted Patent,yes,5,0,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/22;;F02C7/232;;F02C7/236;;F02C9/26,,0,0,,,,ACTIVE
49,CA,A1,CA 2806951 A1,190-184-301-217-107,2013-09-27,2013,CA 2806951 A,2013-02-14,US 201213431187 A,2012-03-27,PASSIVE EQUILIZATION FLOW DIVIDER VALVE,A method and system for providing fuel to primary and secondary fuel nozzles in a gas turbine engine fuel system comprises generating a fuel flow and routing primary fuel from the fuel flow to a primary fuel nozzle. Backpressure on the fuel flow is maintained using a valve. The valve is opened at increased fuel flow to route secondary fuel from the fuel flow to a secondary fuel nozzle. The valve is progressively opened under increasing fuel flows to reduce a pressure drop across the valve produced by the secondary fuel.,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,,https://lens.org/190-184-301-217-107,Patent Application,no,0,0,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C7/232;;F02C7/22;;F23R3/28,,0,0,,,,ACTIVE
50,EP,A3,EP 2644864 A3,196-302-292-788-17X,2016-11-09,2016,EP 13155199 A,2013-02-14,US 201213431187 A,2012-03-27,Passive equilization flow divider valve,"A method and system for providing fuel to primary, 30, and secondary, 32, fuel nozzles in a gas turbine engine fuel system, 12, comprises generating a fuel flow and routing primary fuel from the fuel flow to a primary fuel nozzle, 30. Backpressure on the fuel flow is maintained using a valve. The valve is opened at increased fuel flow to route secondary fuel from the fuel flow to a secondary fuel nozzle, 32. The valve is progressively opened under increasing fuel flows to reduce a pressure drop across the valve produced by the secondary fuel.
",HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;DYER GERALD P,HAMILTON SUNDSTRAND CORPORATION (2020-04-15),https://lens.org/196-302-292-788-17X,Search Report,yes,4,0,7,7,0,F02C7/232;;F02C9/263;;F02C7/232;;F02C9/263,F02C7/232;;F02C9/26,,0,0,,,,ACTIVE
51,US,B2,US 10834101 B2,049-087-471-577-715,2020-11-10,2020,US 201715453048 A,2017-03-08,US 201715453048 A;;US 201662306022 P,2016-03-09,Applying bytecode obfuscation techniques to programs written in an interpreted language,"In an embodiment, a computer system configured to improve security of client computer interacting with server computers comprises one or more processors; a digital electronic memory storing a set of program instructions which when executed using the one or more processors cause the one or more processors to: process a first set of original instructions that produce a first set of outputs or effects; generate a first set of interpreter instructions that define a first interpreter; generate a first set of alternate instructions from the first set of original instructions, wherein the first set of alternate instructions is functionally equivalent to the first set of original instructions when the first set of alternate instructions is executed by the first interpreter; send, to the first client computer, the first set of alternate instructions and the first set of interpreter instructions.",SHAPE SECURITY INC,FICARRA MICHAEL J;;GIBBONS KEVIN,SHAPE SECURITY INC (2017-03-07),https://lens.org/049-087-471-577-715,Granted Patent,yes,59,1,6,6,0,H04L2463/144;;G06F9/45529;;G06F9/45504;;G06F21/53;;G06F21/14;;H04L2463/144;;G06F9/455;;G06F21/71;;G06F9/45529;;G06F9/45504;;G06F9/30021;;H04L63/1416,H04L29/06;;G06F9/30;;G06F9/455;;G06F21/71,,37,1,003-164-258-961-301,10.1109/icastech.2009.5409720,"CTNF, dated Dec. 26, 2018, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTFR, dated Jan. 17, 2019, re: Wesley Hales, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;CTFR, dated Jun. 7, 2019, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTNF, dated Jun. 5, 2019, re: Xinran Wang, U.S. Appl. No. 15/859,694, filed Jan. 1, 2018.;;CTNF, dated Aug. 8, 2019, re: Marc R. Hansen, U.S. Appl. No. 16/233,455, filed Dec. 27, 2018.;;CTFR, dated Oct. 1, 2019, re: Xinran Wang, U.S. Appl. No. 15/859,694, filed Jan. 1, 2018.;;CTNF, dated Sep. 30, 2019, re: Justin Call, U.S. Appl. No. 15/808,504, filed Nov. 9, 2017.;;NOA, dated Aug. 24, 2015, re: Subramanian Varadarajan, U.S. Appl. No. 14/290,805, filed May 29, 2014.;;CTFR, dated Jan. 14, 2015, re: Subramanian Varadarajan, U.S. Appl. No. 14/290,805, filed May 29, 2014.;;CTNF, dated Sep. 5, 2014, re: Subramanian Varadarajan, U.S. Appl. No. 14/290,805, filed May 29, 2014.;;NOA, dated Apr. 27, 2016, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;CTNF, dated Oct. 28, 2015, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;NOA, dated May 24, 2016, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;NOA, dated Jul. 25, 2016, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;CTNF, dated Aug. 12, 2016, re: Jarrod Overson, U.S. Appl. No. 14/706,346, filed May 7, 2015.;;NOA, dated Oct. 19, 2016, re: Jarrod Overson, U.S. Appl. No. 14/706,346, filed May 7, 2015.;;CTFR, dated Aug. 12, 2016, re: Subramanian Varadarajan, U.S. Appl. No. 14/923,603, filed Oct. 27, 2015.;;NOA, dated Dec. 1, 2016, re: Subramanian Varadarajan, U.S. Appl. No. 14/923,603, filed Oct. 27, 2015.;;CTNF, dated Apr. 4, 2017, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;CTNF, dated Aug. 4, 2017, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;NOA, dated Sep. 18, 2017, re: Xinran Wang, U.S. Appl. No. 14/286,324, filed May 23, 2014.;;NOA, dated Oct. 25, 2017, re: Xinran Wang, U.S. Appl. No. 14/286,324, filed May 23, 2014.;;CTFR, dated Oct. 30, 2017, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;NOA, dated Nov. 29, 2017, re: Xinran Wang, U.S. Appl. No. 14/286,324, filed May 23, 2014.;;CTFR, dated Feb. 23, 2018, re: Wesley Hayes, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;CTFR, dated Apr. 9, 2018, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTNF, dated May 23, 2018, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;CTNF, dated Feb. 1, 2018, re: Nwokedi Idika, U.S. Appl. No. 15/204,710, filed Jul. 7, 2016.;;CTNF, dated Jul. 31, 2018, re: Wesley Hales, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;NOA, dated Sep. 19, 2018, re: Nwokedi Idika, U.S. Appl. No. 15/204,710, filed Jul. 7, 2016.;;NOA, dated Oct. 24, 2018, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;NOA, dated Nov. 27, 2018, re: Nwokedi Idika, U.S. Appl. No. 15/204,710, filed Jul. 7, 2016.;;CTNF, dated Jan. 9, 2019, re: Michael J. Ficarra, U.S. Appl. No. 15/453,048, filed Mar. 8, 2017.;;In-the-wire authentication: Protecting client-side critical data fields in secure network transactions,Jan. 14, 2009.;;International Search Report, dated Oct. 11, 2016, PCT/US16/41337.;;International Search Report for PCT/US17/21409, dated May 23, 2017.;;European Search Report for Corresponding EP Application Serial No. 17764019.0, dated Feb. 4, 2020.",ACTIVE
52,CA,C,CA 2736449 C,099-406-138-897-618,2015-11-24,2015,CA 2736449 A,2011-04-06,US 78684410 A,2010-05-25,FUEL PUMPING SYSTEM FOR A GAS TURBINE ENGINE,"A fuel supply system for a gas turbine engine has a first pump for delivering fuel to a first use on a gas turbine engine, and a second pump for delivering fuel to a second use on the gas turbine engine. A valve allows flow from the first pump to be delivered to the first use, but also routes some flow from the first pump to supplement fuel flow from the second pump until a pressure downstream of the second pump increases. The valve then allows flow from the second pump to flow to the first use to supplement the flow from the first pump.",HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,,https://lens.org/099-406-138-897-618,Granted Patent,no,0,0,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/236;;F02C7/232,,0,0,,,,ACTIVE
53,US,B2,US 8793971 B2,161-333-800-335-188,2014-08-05,2014,US 78684410 A,2010-05-25,US 78684410 A,2010-05-25,Fuel pumping system for a gas turbine engine,"A fuel supply system for a gas turbine engine has a first pump for delivering fuel to a first use on a gas turbine engine, and a second pump for delivering fuel to a second use on the gas turbine engine. A valve allows flow from the first pump to be delivered to the first use, but also routes some flow from the first pump to supplement fuel flow from the second pump until a pressure downstream of the second pump increases. The valve then allows flow from the second pump to flow to the first use to supplement the flow from the first pump.",DYER GERALD P;;GIBBONS KEVIN;;HAMILTON SUNDSTRAND CORP,DYER GERALD P;;GIBBONS KEVIN,HAMILTON SUNDSTRAND CORPORATION (2010-05-20),https://lens.org/161-333-800-335-188,Granted Patent,yes,21,10,9,9,0,F02C7/236;;F02C9/263;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/232;;Y10T137/86767;;Y10T137/85986;;Y10T137/2572;;Y10T137/2663;;F02C7/236;;F02C9/263;;F02C7/232;;F02C7/22,F02C7/22;;F02C7/236;;F02C7/232,60/39.281;;60/734;;137/625.34;;137/118.06;;137/114,1,0,,,"European Search Report for corresponding European Application No. 11167781.1 completed on Mar. 13, 2013.",ACTIVE
54,US,A,US 6077000 A,127-286-239-916-312,2000-06-20,2000,US 80585597 A,1997-03-03,US 80585597 A;;GB 9606433 A,1996-03-27,Pipework template,"A template 20 with which pipework may be correctly positioned in a wall for connection to a wall mounted unit, the template comprising first apertures 24 for guiding drills at desired positions of pipes in the wall, and second apertures 22 for screwing the template to a wall, wherein the second apertures 22 are spaced and dimensioned such that the wall mounted unit may be mounted on the wall using the screw holes created by the second apertures 22 and be correctly aligned with pipework positioned according to the first apertures 24, each of the first apertures 24 may comprise a centrally mounted annular member 28 defining an aperture through which a center hole may be drilled.",AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE;;SPALDING TOM,AQUALISA PRODUCTS LIMITED (1997-06-23),https://lens.org/127-286-239-916-312,Granted Patent,yes,25,41,5,6,0,B23B47/28;;B25H7/02;;E03C1/02;;E03C2001/028;;Y10T408/569;;Y10T408/55;;Y10T408/569;;Y10T408/55;;B23B47/28;;E03C2001/028;;B25H7/02;;E03C1/02,B23B47/28;;B25H7/02;;E03C1/02,408 72B;;33/529;;33/563;;33/613;;33/645;;X408 72 R,1,0,,,"EPO Search Report dated Nov. 26, 1997 (3 pages).",EXPIRED
55,EP,B1,EP 0798085 B1,165-052-640-597-887,2003-07-02,2003,EP 97301368 A,1997-02-28,GB 9606433 A;;US 80585597 A,1996-03-27,Pipework template with drill guide,,AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE;;SPALDING TOM,,https://lens.org/165-052-640-597-887,Granted Patent,yes,11,0,5,6,0,B23B47/28;;B25H7/02;;E03C1/02;;E03C2001/028;;Y10T408/569;;Y10T408/55;;Y10T408/569;;Y10T408/55;;B23B47/28;;E03C2001/028;;B25H7/02;;E03C1/02,B23B47/28;;B25H7/02;;E03C1/02,,0,0,,,,EXPIRED
56,WO,A1,WO 2018/102767 A1,050-998-555-347-215,2018-06-07,2018,US 2017/0064336 W,2017-12-01,US 201662429710 P;;US 201662429717 P,2016-12-02,"OBFUSCATING SOURCE CODE SENT, FROM A SERVER COMPUTER, TO A BROWSER ON A CLIENT COMPUTER","Programs written in interpreted languages, such as JavaScript, are distributed in source form, which is helpful to attackers so that they can more easily derive the purposes and effects of a program. As discussed herein, a program's high-level code may be effectively obfuscated by transforming the program's code from its high-level programming language to low-level processor-specific language, such as x86 instructions for x86 processors, JVM bytecode for JVMs, or proprietary opcodes for a corresponding proprietary processor or interpreter. Additional obfuscation techniques can be applied the program's low-level processor-specific code.",SHAPE SECURITY INC,GIBBONS KEVIN;;DISNEY TIM;;FICARRA MICHAEL,,https://lens.org/050-998-555-347-215,Patent Application,yes,5,2,3,3,0,G06F9/45529;;G06F8/41;;H04L63/1475;;H04L67/02;;G06F9/4498;;G06F21/125;;H04L63/0428;;H04L63/0428;;G06F8/41;;G06F9/45529;;H04L63/1475;;H04L67/02;;G06F21/125;;G06F9/4498,G06F21/14;;G06F17/30,,0,0,,,,PENDING
57,DE,D1,DE 69723138 D1,104-803-159-493-485,2003-08-07,2003,DE 69723138 T,1997-02-28,GB 9606433 A,1996-03-27,Rohrleitungsschablone mit Bohrerführung,,AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE;;SPALDING TOM,,https://lens.org/104-803-159-493-485,Granted Patent,no,0,0,1,6,0,,B23B47/28;;B23B49/02;;B25H7/00;;B25H7/02;;E03D11/00,,0,0,,,,EXPIRED
58,JP,A,JP 2000026967 A,118-420-198-275-368,2000-01-25,2000,JP 10975599 A,1999-04-16,US 6157898 A,1998-04-16,CASCADE CONTROL OF REACTIVE SPUTTERING DEVICE,"PROBLEM TO BE SOLVED: To improve the performance of the process and to swiftly execute the control of sputtering electric power and a gas flow rate by controlling the reactive sputtering process by using two control loops of different systems changing input. SOLUTION: A high speed control loop compares a light emission signal from a light detector with emission set value using a control algorithm, and the control of a power source is executed. The light emission set value is experimentally decided by producing many samples by various set value and analyzing their optical characteristics. In the process of the cycle of the high speed loop, the emission level of titanium from the light detector is measured, the output signal from a computer is fed to the power source to control the electric current, the light emission signal is made closer to the light emission set value. An outside low speed loop measure the electric current, voltage and electric power from a power source control device, operates the flow rate of oxygen in the process and helds the electric power to a desired set level. In this way, it can swiftly correspond to the change of the light emission.",BOC GROUP INC,TERRY ROBERT;;GIBBONS KEVIN;;ZARRABIAN SOHRAB,,https://lens.org/118-420-198-275-368,Patent Application,no,3,8,5,5,0,C23C14/0042;;C23C14/0042;;C23C14/54;;C23C14/54;;H01J37/32935;;H01J37/32935;;H01J37/3299;;H01J37/3299;;H01J37/34;;H01J37/34,H01L21/316;;C23C14/00;;C23C14/34;;C23C14/54;;H01J37/32;;H01L21/203,,0,0,,,,EXPIRED
59,EP,A2,EP 0798085 A2,137-628-984-184-465,1997-10-01,1997,EP 97301368 A,1997-02-28,GB 9606433 A;;US 80585597 A,1996-03-27,Pipework template with drill guide,"A template 20 with which pipework may be correctly positioned in a wall for connection to a wall mounted unit, the template comprising first apertures 24 for guiding drills at desired positions of pipes in the wall, and second apertures 22 for screwing the template to a wall, wherein the second apertures 22 are spaced and dimensioned such that the wall mounted unit may be mounted on the wall using the screw holes created by the second apertures 22 and be correctly aligned with pipework positioned according to the first apertures 24, each of the first apertures 24 may comprise a centrally mounted annular member 28 defining an aperture through which a centre hole may be drilled.",AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE;;SPALDING TOM,,https://lens.org/137-628-984-184-465,Patent Application,yes,0,5,5,6,0,B23B47/28;;B25H7/02;;E03C1/02;;E03C2001/028;;Y10T408/569;;Y10T408/55;;Y10T408/569;;Y10T408/55;;B23B47/28;;E03C2001/028;;B25H7/02;;E03C1/02,B23B47/28;;B25H7/02;;E03C1/02,,0,0,,,,EXPIRED
60,EP,A2,EP 0957184 A2,199-736-847-065-539,1999-11-17,1999,EP 99302695 A,1999-04-07,US 6157898 A,1998-04-16,Sputtering control system,"A method of reactive sputter coating a layer of a compound, the method comprising: sputtering a target in a reactive atmosphere; monitoring a first process parameter; modifying, in a first control loop, a system input in response to the first process parameter; monitoring a second process parameter; and modifying, in a second control loop, a second system input in response to the second process parameter.",BOC GROUP INC,TERRY ROBERT;;GIBBONS KEVIN;;ZARRABIAN SOHRAB,VON ARDENNE ANLAGENTECHNIK GMBH (2004-12-08),https://lens.org/199-736-847-065-539,Patent Application,yes,0,16,5,5,0,C23C14/0042;;C23C14/0042;;C23C14/54;;C23C14/54;;H01J37/32935;;H01J37/32935;;H01J37/3299;;H01J37/3299;;H01J37/34;;H01J37/34,H01L21/316;;C23C14/00;;C23C14/34;;C23C14/54;;H01J37/32;;H01L21/203,,0,0,,,,DISCONTINUED
61,EP,A3,EP 0957184 A3,196-322-204-039-514,2003-09-03,2003,EP 99302695 A,1999-04-07,US 6157898 A,1998-04-16,Sputtering control system,"A method of reactive sputter coating a layer of a compound, the method comprising: sputtering a target in a reactive atmosphere; monitoring a first process parameter; modifying, in a first control loop, a system input in response to the first process parameter; monitoring a second process parameter; and modifying, in a second control loop, a second system input in response to the second process parameter.",BOC GROUP INC,TERRY ROBERT;;GIBBONS KEVIN;;ZARRABIAN SOHRAB,VON ARDENNE ANLAGENTECHNIK GMBH (2004-12-08),https://lens.org/196-322-204-039-514,Search Report,yes,5,0,5,5,0,C23C14/0042;;C23C14/0042;;C23C14/54;;C23C14/54;;H01J37/32935;;H01J37/32935;;H01J37/3299;;H01J37/3299;;H01J37/34;;H01J37/34,H01L21/316;;C23C14/00;;C23C14/34;;C23C14/54;;H01J37/32;;H01L21/203,,0,0,,,,DISCONTINUED
62,GB,A,GB 2101647 A,180-872-343-412-812,1983-01-19,1983,GB 8219786 A,1982-07-08,GB 8219786 A;;GB 8121737 A,1981-07-14,Retaining cord,"The cord 1 has a helical part which is longitudinally extensible and two spaced clips 4, 5 one for attaching the cord to a hand-held tool and the other for securing to a support, eg scaffolding or operator's belt or wrist. The cord may include electric conductors.",BICC PLC,BRINSLEY PETER ALFRED;;GIBBONS KEVIN CHARLES,,https://lens.org/180-872-343-412-812,Patent Application,no,0,3,1,1,0,A45F5/00;;A45F2005/006;;A45F2005/008;;B65H75/36,A45F5/00;;B65H75/36,B4K KSH           KSH;;B4K K3A           K3;;D1T T1B           T1;;D1T T1H           T1;;D1T T1K           T1;;H1A AKG           KG;;H1A A2E3D2        AZ1;;H1A A6G           AZ1,0,0,,,,DISCONTINUED
63,US,A,US 6106676 A,071-189-672-325-842,2000-08-22,2000,US 6157898 A,1998-04-16,US 6157898 A,1998-04-16,Method and apparatus for reactive sputtering employing two control loops,"The present invention is a cascade control system for reactive sputtering deposition. A first control loop modifies the power supply in order to keep a monitored value nearly constant. This first control loop can be done relatively quickly. A second control loop monitors a second measure parameter in order to control the reactive gas flow to the system. In a preferred embodiment, the slower control loop is used to maintain a relatively constant power at the power supply.",BOC GROUP INC,TERRY ROBERT;;GIBBONS KEVIN;;ZARRABIAN SOHRAB,VON ARDENNE ANLAGENTECHNIK GMBH (2002-04-04);;COATING INDUSTRIES INVESTMENT CORP (2004-07-30);;APPLIED FILMS CORPORATION (2005-11-28);;BOC GROUP INC. THE (1998-07-27),https://lens.org/071-189-672-325-842,Granted Patent,yes,15,29,5,5,0,C23C14/0042;;C23C14/0042;;C23C14/54;;C23C14/54;;H01J37/32935;;H01J37/32935;;H01J37/3299;;H01J37/3299;;H01J37/34;;H01J37/34,H01L21/316;;C23C14/00;;C23C14/34;;C23C14/54;;H01J37/32;;H01L21/203,204/192.13;;204/298.01;;204/298.08;;204/192.12;;204/192.15,1,0,,,"str o m, Karl J. and H a gglund, Tore; PID Controllers: Theory, Design, and Tuning; Second Edition; Instrument Society of America; 1995.",EXPIRED
64,EP,A3,EP 0798085 A3,030-593-595-470-225,1998-01-14,1998,EP 97301368 A,1997-02-28,GB 9606433 A;;US 80585597 A,1996-03-27,Pipework template with drill guide,"A template 20 with which pipework may be correctly positioned in a wall for connection to a wall mounted unit, the template comprising first apertures 24 for guiding drills at desired positions of pipes in the wall, and second apertures 22 for screwing the template to a wall, wherein the second apertures 22 are spaced and dimensioned such that the wall mounted unit may be mounted on the wall using the screw holes created by the second apertures 22 and be correctly aligned with pipework positioned according to the first apertures 24, each of the first apertures 24 may comprise a centrally mounted annular member 28 defining an aperture through which a centre hole may be drilled.",AQUALISA PRODUCTS LTD,GIBBONS KEVIN NORMAN WHITE;;SPALDING TOM,,https://lens.org/030-593-595-470-225,Search Report,yes,11,0,5,6,0,B23B47/28;;B25H7/02;;E03C1/02;;E03C2001/028;;Y10T408/569;;Y10T408/55;;Y10T408/569;;Y10T408/55;;B23B47/28;;E03C2001/028;;B25H7/02;;E03C1/02,B23B47/28;;B25H7/02;;E03C1/02,,0,0,,,,EXPIRED
65,US,A1,US 2018/0159830 A1,107-180-456-184-612,2018-06-07,2018,US 201715829751 A,2017-12-01,US 201715829751 A;;US 201662429710 P;;US 201662429717 P,2016-12-02,"Obfuscating Source Code Sent, from a Server Computer, to a Browser on a Client Computer","Programs written in interpreted languages, such as JavaScript, are distributed in source form, which is helpful to attackers so that they can more easily derive the purposes and effects of a program. As discussed herein, a program's high-level code may be effectively obfuscated by transforming the program's code from its high-level programming language to low-level processor-specific language, such as x86 instructions for x86 processors, JVM bytecode for JVMs, or proprietary opcodes for a corresponding proprietary processor or interpreter. Additional obfuscation techniques can be applied the program's low-level processor-specific code.",SHAPE SECURITY INC,GIBBONS KEVIN;;DISNEY TIM;;FICARRA MICHAEL J,SHAPE SECURITY INC (2018-01-29);;F5 NETWORKS INC (2020-09-18),https://lens.org/107-180-456-184-612,Patent Application,yes,2,8,3,3,0,G06F9/45529;;G06F8/41;;H04L63/1475;;H04L67/02;;G06F9/4498;;G06F21/125;;H04L63/0428;;H04L63/0428;;G06F8/41;;G06F9/45529;;H04L63/1475;;H04L67/02;;G06F21/125;;G06F9/4498,H04L29/06,,0,0,,,,ACTIVE
66,GB,A,GB 2237437 A,075-025-474-640-272,1991-05-01,1991,GB 8923961 A,1989-10-24,GB 8923961 A,1989-10-24,Removable video cassette recorder facia shield,"A removable video cassette recorder facia shield, with means for releasably securing the shield to the facia of the video recorder, comprising a sheet of perspex/plastic 1, coincident in dimensions to the facia of the video recorder 4, and releasably secured by means of ""Velcro"" type nylon hooked tapes 2 and 3/3A and or a strap or straps 5. ""Velcro"" is a Registered Trade Mark, <IMAGE>",GIBBONS GARY KEVIN DAVID;;GIBBONS JACQUELINE;;RUSSELL MICHAEL FRANKLYN;;RUSSELL ADELE MARIE,GIBBONS GARY KEVIN DAVID;;GIBBONS JACQUELINE;;RUSSELL MICHAEL FRANKLYN;;RUSSELL ADELE MARIE,,https://lens.org/075-025-474-640-272,Patent Application,no,3,0,2,2,0,G11B33/027,G11B33/02,G5R RB15          RB15;;G5R RB25          RB25;;G5R RB43X         RB15;;G5R RB43X         RB25,0,0,,,,DISCONTINUED
67,US,A,US 5962862 A,072-513-855-076-402,1999-10-05,1999,US 90957097 A,1997-08-12,US 90957097 A,1997-08-12,Method and apparatus for verifying the presence or absence of a component,"Apparatuses and methods are disclosed for verifying the presence or absence of a die in a location, dice in a cut wafer or other components in a pattern. The apparatuses includes a wafer support, a radiation source, a radiation detector and a controller. The radiation source is positioned to direct radiation toward the wafer support and a radiation detector is positioned to detect radiation from the direction of said wafer support. Preferably, a visible light source, such as an arc lamp, is used to illuminate a wafer from the substrate side of the wafer and a charge coupled device (CCD) camera is positioned to detect light from the light source passing through locations in the wafer where the dice have been removed. The charge coupled device camera is connected to the controller, which is preferably a computer connected to a display monitor. The computer calculates the location of the removed dice based on the intensity of the detected light and produces a wafer verification map based on the calculated locations. The wafer verification map is compared to a planned or selected die pick pattern map of dice that were to be picked to identify any mispicked dice. In alternative embodiments, the apparatus can be included semi-integrally or integrally with a die attach machine to provide in-line verification of the die pick process. In a fully integral embodiment of the method, the picked die can be verified as correct prior to being placed onto a substrate.",MICRON TECHNOLOGY INC,EVERS SVEN;;GIBBONS KEVIN;;SCHROCK EDWARD A,MICRON TECHNOLOGY INC (1997-07-31),https://lens.org/072-513-855-076-402,Granted Patent,yes,11,42,1,1,0,H01L21/67259;;H01L21/67259,H01L21/00,250/559.4;;356/237.1,1,0,,,"Zmation, Inc. advertisement, Semiconductor International, Oct., 1996, p. 254.",EXPIRED
68,US,B2,US 11349816 B2,042-316-155-425-850,2022-05-31,2022,US 201715829751 A,2017-12-01,US 201715829751 A;;US 201662429710 P;;US 201662429717 P,2016-12-02,"Obfuscating source code sent, from a server computer, to a browser on a client computer","Programs written in interpreted languages, such as JavaScript, are distributed in source form, which is helpful to attackers so that they can more easily derive the purposes and effects of a program. As discussed herein, a program's high-level code may be effectively obfuscated by transforming the program's code from its high-level programming language to low-level processor-specific language, such as x86 instructions for x86 processors, JVM bytecode for JVMs, or proprietary opcodes for a corresponding proprietary processor or interpreter. Additional obfuscation techniques can be applied the program's low-level processor-specific code.",SHAPE SECURITY INC;;F5 INC,GIBBONS KEVIN;;DISNEY TIM;;FICARRA MICHAEL J,SHAPE SECURITY INC (2018-01-29);;F5 NETWORKS INC (2020-09-18),https://lens.org/042-316-155-425-850,Granted Patent,yes,69,0,3,3,0,G06F9/45529;;G06F8/41;;H04L63/1475;;H04L67/02;;G06F9/4498;;G06F21/125;;H04L63/0428;;H04L63/0428;;G06F8/41;;G06F9/45529;;H04L63/1475;;H04L67/02;;G06F21/125;;G06F9/4498,G06F21/00;;G06F8/41;;G06F9/448;;G06F9/455;;G06F21/12;;H04L9/40;;H04L67/02,,43,3,109-389-660-489-587;;080-913-960-639-599;;003-164-258-961-301,10.1109/icts.2016.7910274;;10.1109/adcom.2012.6563578;;10.1109/icastech.2009.5409720,"Karnalim, Oscar. Detecting source code plagiarism on introductory programming course assignments using a bytecode approach. 2016 International Conference on Information & Communication Technology and Systems (ICTS), https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=7910274 (Year: 2016).;;Joy, Mabel Mary et al. Automated source code annotation for timing analysis of embedded software. 2012 18th International Conference on Advanced Computing and Communications (ADCOM). https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=6563578 (Year: 2012).;;NOA, mailed on Aug. 24, 2015, re: Subramanian Varadarajan, U.S. Appl. No. 14/290,805, filed May 29, 2014.;;CTFR, mailed on Jan. 14, 2015, re: Subramanian Varadarajan, U.S. Appl. No. 14/290,805, filed May 29, 2014.;;CTNF, mailed on Sep. 5, 2014, re: Subramanian Varadarajan, U.S. Appl. No. 14/290,805, filed May 29, 2014.;;NOA, mailed on Apr. 27, 2016, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;CTNF, mailed on Oct. 28, 2015, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;NOA, mailed on May 24, 2016, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;NOA, mailed on Jul. 25, 2016, re: Siying Yang, U.S. Appl. No. 14/481,835, filed Sep. 9, 2014.;;CTNF, mailed on Aug. 12, 2016, re: Jarrod Overson, U.S. Appl. No. 14/706,346, filed May 7, 2015.;;NOA, mailed on Oct. 19, 2016, re: Jarrod Overson, U.S. Appl. No. 14/706,346, filed May 7, 2015.;;CTFR, mailed on Aug. 12, 2016, re: Subramanian Varadarajan, U.S. Appl. No. 14/923,603, filed Oct. 27, 2015.;;NOA, mailed on Dec. 1, 2016, re: Subramanian Varadarajan, U.S. Appl. No. 14/923,603, filed Oct. 27, 2015.;;CTNF, mailed on Apr. 4, 2017, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;CTNF, mailed on Aug. 4, 2017, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;NOA, mailed on Sep. 18, 2017, re: Xinran Wang, U.S. Appl. No. 14/286,324, filed May 23, 2014.;;NOA, mailed on Oct. 25, 2017, re: Xinran Wang, U.S. Appl. No. 14/286,324, filed May 23, 2014.;;CTFR, mailed on Oct. 30, 2017, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;NOA, mailed on Nov. 29, 2017, re: Xinran Wang, U.S. Appl. No. 14/286,324, filed May 23, 2014.;;CTFR, mailed on Feb. 23, 2018, re: Wesley Hayes, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;CTFR, mailed on Apr. 9, 2018, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTNF, mailed on May 23, 2018, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;CTNF, mailed on Feb. 1, 2018, re: Nwokedi Idika, U.S. Appl. No. 15/204,710, filed Jul. 7, 2016.;;CTNF, mailed on Jul. 31, 2018, re: Wesley Hales, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;NOA, mailed on Sep. 19, 2018, re: Nwokedi Idika, U.S. Appl. No. 15/204,710, filed Jul. 7, 2016.;;NOA, mailed on Oct. 24, 2018, re: Jarrod Overson, U.S. Appl. No. 15/069,667, filed Mar. 14, 2016.;;NOA, mailed on Nov. 27, 2018, re: Nwokedi Idika, U.S. Appl. No. 15/204,710, filed Jul. 7, 2016.;;CTNF, mailed on Jan. 9, 2019, re: Michael J. Ficarra, U.S. Appl. No. 15/453,048, filed Mar. 8, 2017.;;CTNF, mailed on Dec. 26, 2018, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTFR, mailed on Jan. 17, 2019, re: Wesley Hales, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;CTFR, mailed on Jun. 7, 2019, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTNF, mailed on Jun. 5, 2019, re: Xinran Wang, U.S. Appl. No. 15/859,694, filed Jan. 1, 2018.;;CTNF, mailed on Aug. 8, 2019, re: Marc R. Hansen, U.S. Appl. No. 16/233,455, filed Dec. 27, 2018.;;CTFR, mailed on Oct. 1, 2019, re: Xinran Wang, U.S. Appl. No. 15/859,694, filed Jan. 1, 2018.;;CTNF, mailed on Sep. 30, 2019, re: Justin Call, U.S. Appl. No. 15/808,504, filed Nov. 9, 2017.;;CTFR, mailed on Nov. 20, 2019, re: Siying Yang, U.S. Appl. No. 15/242,062, filed Aug. 19, 2016.;;CTNF, mailed on Dec. 13, 2019, re: Wesley Hayes, U.S. Appl. No. 15/011,237, filed Jan. 29, 2016.;;CTNF, mailed on Jan. 2, 2020, re: Xinran Wang, U.S. Appl. No. 15/859,694, filed Jan. 1, 2018.;;In-the-wire authentication: Protecting client-side critical data fields in secure network transactions, Jan. 14, 2009.;;International Search Report, dated Oct. 11, 2016, PCT/US16/41337, Shape.;;International Search Report for PCT/US17/21409, dated May 23, 2017, Shape.;;https://urldefense.com/v3/_https:/web.archive.org/web/20210624011617if_/https:/api.nike.com/149e9513-01fa-4fb0-aad4-566afd725d1b/2d206a39-8ed7-437e-a3be-862e0f06eea3/ips.js_;!!PoWafIF1wM8F24I!I9vJGvL53pB9jSk8XN5fQgaKliP6Fd-VbGB59ABduqE2UXU8m8b7ZQC5L8gXBt_mUgKaw$, Archived on Jun. 24, 2021 and retrieved from the internet archive on Aug. 2, 2021.;;“A Brief Survey of Code Obfuscation Techniques”, https://urldefense.com/v3/_https:/chris124567.github.io/2021-06-23-survey-obfuscation/_;!!PoWaflF1wM8F24III9vJGvL53pB9jSk8XN5fQgaKliP6Fd--VbGB59ABduqE2UXU8m8b7ZQC5L8gXBvVuxOMbg$, Jun. 23, 2021.",ACTIVE
69,EP,B1,EP 2138217 B1,047-036-720-839-956,2016-03-30,2016,EP 09251020 A,2009-03-31,US 14656208 A,2008-06-26,Wash filter with wash velocity control cone,,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;LEUTWILER TOMAS R;;MAROCCHINI FRANCIS P,,https://lens.org/047-036-720-839-956,Granted Patent,yes,4,0,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,B01D29/11;;B01D29/25;;B01D29/90;;B01D37/00;;F02C7/22;;F02M37/38,,0,0,,,,ACTIVE
70,US,B1,US 6829160 B1,015-898-895-740-315,2004-12-07,2004,US 7911602 A,2002-02-20,US 7911602 A;;US 28193601 P,2001-04-06,Magnetic ram cell with amplification circuitry and MRAM memory array formed using the MRAM cells,"
    A magnetic random access memory (MRAM) cell and a memory array formed from the MRAM cells are disclosed. The MRAM cell includes a magnetic tunneling junction and a transistor. The magnetic tunneling junction includes a first ferromagnetic layer, a second ferromagnetic layer and an insulating layer between the first ferromagnetic layer and the second ferromagnetic layer. The gate of the transistor is coupled to a first end of the magnetic tunneling junction. The source of the transistor is coupled to a second end the magnetic tunneling junction. The drain of the transistor is coupled with an output for reading the magnetic memory cell. During reading, a read current is applied to the magnetic tunneling junction and the transistor is preferably operated in a saturation region. 
",WESTERN DIGITAL FREMONT INC,QI QUIQUN KEVIN;;SHI XIZENG STONE;;GIBBONS MATTHEW,READ-RITE CORPORATION (2002-02-14);;WESTERN DIGITAL TECHNOLOGIES INC (2019-05-08);;WESTERN DIGITAL (FREMONT) INC (2003-07-31),https://lens.org/015-898-895-740-315,Granted Patent,yes,3,37,1,1,0,G11C11/16;;G11C11/16,G11C5/06;;G11C7/00;;G11C11/00;;G11C11/15;;G11C11/16,365/158;;365/72;;365/173;;365/189.09;;365/189.11,0,0,,,,EXPIRED
71,US,A1,US 2010/0177490 A1,017-514-583-770-061,2010-07-15,2010,US 35377309 A,2009-01-14,US 35377309 A,2009-01-14,COMPUTER MODULES WITH SMALL THICKNESSES AND ASSOCIATED METHODS OF MANUFACTURING,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,MICRON TECHNOLOGY INC (2009-01-07),https://lens.org/017-514-583-770-061,Patent Application,yes,16,12,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H01L21/77;;H05K1/18;;H01L23/28;;H01L23/488;;H01L25/10,361/764;;438/106;;X257E25023;;X257E23116;;X257E23023;;X257E21598,0,0,,,,ACTIVE
72,US,B2,US 10256214 B2,028-486-081-657-396,2019-04-09,2019,US 201715626843 A,2017-06-19,US 201715626843 A;;US 201514617523 A;;US 201414171584 A;;US 35377309 A,2009-01-14,Computer modules with small thicknesses and associated methods of manufacturing,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/028-486-081-657-396,Granted Patent,yes,23,2,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H05K1/18;;H01L23/00;;H01L25/065;;H01L25/10;;H01L25/18;;H05K1/11;;H05K3/34;;H05K7/02,,2,0,,,"International Search Report and Written Opinion dated Mar. 26, 2010 in International Application No. PCT/US2009/068568, 11 pages.;;Office Action dated Aug. 16, 2012 in Taiwan Application No. 098146477, 24 pages.",ACTIVE
73,US,A1,US 2015/0156908 A1,166-285-444-102-967,2015-06-04,2015,US 201514617523 A,2015-02-09,US 201514617523 A;;US 201414171584 A;;US 35377309 A,2009-01-14,COMPUTER MODULES WITH SMALL THICKNESSES AND ASSOCIATED METHODS OF MANUFACTURING,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/166-285-444-102-967,Patent Application,yes,6,1,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H05K1/11;;H05K7/02,,0,0,,,,ACTIVE
74,US,A1,US 2009/0321334 A1,030-175-788-722-503,2009-12-31,2009,US 14656208 A,2008-06-26,US 14656208 A,2008-06-26,WASH FILTER WITH WASH VELOCITY CONTROL CONE,A variable wash flow filter assembly includes a wash velocity control cone movable between a minimal position and a maximum position.,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R,HAMILTON SUNDSTRAND CORPORATION (2008-06-24),https://lens.org/030-175-788-722-503,Patent Application,yes,46,0,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,B01D29/62;;B01D35/22;;B60K15/00;;F02M37/38,210/172.2;;210/409;;210/791;;210/106;;210/741;;210/111;;210/767;;210/416.4,0,0,,,,ACTIVE
75,US,B2,US 8615982 B2,105-746-784-741-50X,2013-12-31,2013,US 201113252305 A,2011-10-04,US 201113252305 A;;US 201161504375 P,2011-07-05,Integrated electric variable area fan nozzle thrust reversal actuation system,An integrated variable area fan nozzle (VAFN) and thrust reversing actuation system (TRAS) system includes movable surfaces for adjusting an exit area for bypass flow and cowls moved for directing discharge flow in a reverser manner. The movable surfaces of the VAFN and TRAS systems are both coupled for movement by a common actuator arrangement. A power drive unit drives each of the actuators on each of the actuators through a gearbox or other linkage such that one common motor or motor combination is utilized for driving all of the actuators. A series of redundant and separately actuateable locks control deployment of the surfaces of the thrust reverse system such that thrust reversing system can move to an open or deployed position only in response to each of the locks being actuated to an unlocked condition.,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L;;HAMILTON SUNDSTRAND CORP,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,HAMILTON SUNDSTRAND CORPORATION (2011-10-03),https://lens.org/105-746-784-741-50X,Granted Patent,yes,25,11,7,7,0,F02K1/72;;F02K1/72;;F02K1/12;;F02K1/12;;F02K1/763;;F02K1/763;;F02K1/766;;F02K1/766,F02K3/075;;F02K1/72,60/226.3;;60/226.2;;60/771;;60/230;;X244110 B,0,0,,,,ACTIVE
76,US,A1,US 2014/0154844 A1,179-369-132-127-794,2014-06-05,2014,US 201414171584 A,2014-02-03,US 201414171584 A;;US 35377309 A,2009-01-14,COMPUTER MODULES WITH SMALL THICKNESSES AND ASSOCIATED METHODS OF MANUFACTURING,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/179-369-132-127-794,Patent Application,yes,0,3,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H01L23/00,438/125,0,0,,,,ACTIVE
77,CN,A,CN 102865156 A,004-601-109-895-40X,2013-01-09,2013,CN 201210231023 A,2012-07-05,US 201161504375 P;;US 201113252305 A,2011-07-05,Integrated variable area fan nozzle and thrust reversal actuation system,"An integrated variable area fan nozzle (VAFN) and thrust reversing actuation system (TRAS) system (15) includes movable surfaces (46) for adjusting an exit area (48) for bypass flow and cowls (52) moved for directing discharge flow in a reverser manner. The movable surfaces of the VAFN and TRAS systems are both coupled for movement by a common actuator arrangement. A power drive unit (68) drives each of the actuators (56A-B,53A-B;96A-B,98A-B) through a gearbox (64A-B,66A-B;112) or other linkage such that one common motor (72) or motor combination is utilized for driving all of the actuators. A series of redundant and separately actuateable locks (84A-B,86A-B;108,110) control deployment of the surfaces of the thrust reverse system (50) such that thrust reversing system (50) can move to an open or deployed position only in response to each of the locks being actuated to an unlocked condition.",HAMILTON SUNDSTRAND CORP,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,,https://lens.org/004-601-109-895-40X,Patent Application,no,5,8,7,7,0,F02K1/72;;F02K1/72;;F02K1/12;;F02K1/12;;F02K1/763;;F02K1/763;;F02K1/766;;F02K1/766,F02K1/76,,0,0,,,,DISCONTINUED
78,WO,A1,WO 2010/083001 A1,044-217-666-143-416,2010-07-22,2010,US 2009/0068568 W,2009-12-17,US 35377309 A,2009-01-14,COMPUTER MODULES WITH PRINTED CIRCUIT BOARD HAVING AN APERTURE IN WHICH A SEMICONDUCTOR DIE IS INSERTED AND ASSOCIATED METHODS OF MANUFACTURING,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the module material via the aperture.",MICRON TECHNOLOGY INC;;GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/044-217-666-143-416,Patent Application,yes,7,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H01L25/10;;H01L25/065;;H05K1/14;;H05K1/18,,0,0,,,,PENDING
79,US,B2,US 9717157 B2,101-026-881-067-050,2017-07-25,2017,US 201514617523 A,2015-02-09,US 201514617523 A;;US 201414171584 A;;US 35377309 A,2009-01-14,Computer modules with small thicknesses and associated methods of manufacturing,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/101-026-881-067-050,Granted Patent,yes,20,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H05K1/18;;H01L23/00;;H01L25/065;;H01L25/10;;H01L25/18;;H05K1/11;;H05K3/34;;H05K7/02,,2,0,,,"International Search Report and Written Opinion dated Mar. 26, 2010 in International Application No. PCT/US2009/068568, 11 pages.;;Office Action issued Aug. 16, 2012 in Taiwan Application No. 098146477, 24 pages.",ACTIVE
80,US,A1,US 2017/0294414 A1,034-388-395-377-918,2017-10-12,2017,US 201715626843 A,2017-06-19,US 201715626843 A;;US 201514617523 A;;US 201414171584 A;;US 35377309 A,2009-01-14,COMPUTER MODULES WITH SMALL THICKNESSES AND ASSOCIATED METHODS OF MANUFACTURING,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/034-388-395-377-918,Patent Application,yes,14,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H01L25/10;;H01L25/065;;H05K1/18;;H05K3/34,,0,0,,,,ACTIVE
81,US,A1,US 2013/0008145 A1,130-025-475-722-82X,2013-01-10,2013,US 201113252305 A,2011-10-04,US 201113252305 A;;US 201161504375 P,2011-07-05,INTEGRATED ELECTRIC VARIABLE AREA FAN NOZZLE THRUST REVERSAL ACTUATION SYSTEM,An integrated variable area fan nozzle (VAFN) and thrust reversing actuation system (TRAS) system includes movable surfaces for adjusting an exit area for bypass flow and cowls moved for directing discharge flow in a reverser manner. The movable surfaces of the VAFN and TRAS systems are both coupled for movement by a common actuator arrangement. A power drive unit drives each of the actuators on each of the actuators through a gearbox or other linkage such that one common motor or motor combination is utilized for driving all of the actuators. A series of redundant and separately actuateable locks control deployment of the surfaces of the thrust reverse system such that thrust reversing system can move to an open or deployed position only in response to each of the locks being actuated to an unlocked condition.,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,HAMILTON SUNDSTRAND CORPORATION (2011-10-03),https://lens.org/130-025-475-722-82X,Patent Application,yes,15,17,7,7,0,F02K1/72;;F02K1/72;;F02K1/12;;F02K1/12;;F02K1/763;;F02K1/763;;F02K1/766;;F02K1/766,F02K1/54,60/226.2,0,0,,,,ACTIVE
82,TW,B,TW I445468 B,083-262-252-647-46X,2014-07-11,2014,TW 98146477 A,2009-12-31,US 35377309 A,2009-01-14,Computer modules with small thicknesses and associated methods of manufacturing,,MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/083-262-252-647-46X,Granted Patent,no,0,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,,,0,0,,,,ACTIVE
83,EP,A3,EP 2543863 A3,194-453-360-150-676,2016-12-07,2016,EP 12175012 A,2012-07-04,US 201161504375 P;;US 201113252305 A,2011-07-05,Integrated variable area fan nozzle and thrust reversal actuation system,"An integrated variable area fan nozzle (VAFN) and thrust reversing actuation system (TRAS) system (15) includes movable surfaces (46) for adjusting an exit area (48) for bypass flow and cowls (52) moved for directing discharge flow in a reverser manner. The movable surfaces of the VAFN and TRAS systems are both coupled for movement by a common actuator arrangement. A power drive unit (68) drives each of the actuators (56A-B,53A-B;96A-B,98A-B) through a gearbox (64A-B,66A-B;112) or other linkage such that one common motor (72) or motor combination is utilized for driving all of the actuators. A series of redundant and separately actuateable locks (84A-B,86A-B;108,110) control deployment of the surfaces of the thrust reverse system (50) such that thrust reversing system (50) can move to an open or deployed position only in response to each of the locks being actuated to an unlocked condition.
 
",HAMILTON SUNDSTRAND CORP,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,,https://lens.org/194-453-360-150-676,Search Report,yes,7,0,7,7,0,F02K1/72;;F02K1/72;;F02K1/12;;F02K1/12;;F02K1/763;;F02K1/763;;F02K1/766;;F02K1/766,F02K1/72;;F02K1/12;;F02K1/76,,0,0,,,,ACTIVE
84,US,A1,US 2019/0279964 A1,059-150-318-724-063,2019-09-12,2019,US 201916285081 A,2019-02-25,US 201916285081 A;;US 201715626843 A;;US 201514617523 A;;US 201414171584 A;;US 35377309 A,2009-01-14,COMPUTER MODULES WITH SMALL THICKNESSES AND ASSOCIATED METHODS OF MANUFACTURING,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,MICRON TECHNOLOGY INC (2009-01-07),https://lens.org/059-150-318-724-063,Patent Application,yes,7,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H01L25/065;;H01L23/00;;H01L25/10;;H05K1/11;;H05K1/18;;H05K3/34;;H05K7/02,,0,0,,,,ACTIVE
85,EP,B1,EP 2543863 B1,066-621-319-631-004,2019-06-19,2019,EP 12175012 A,2012-07-04,US 201161504375 P;;US 201113252305 A,2011-07-05,Integrated variable area fan nozzle and thrust reversal actuation system and method of operating movable structures of a nacelle,,HAMILTON SUNDSTRAND CORP,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,,https://lens.org/066-621-319-631-004,Granted Patent,yes,7,0,7,7,0,F02K1/12;;F02K1/72;;F02K1/763;;F02K1/766;;F02K1/72;;F02K1/12;;F02K1/766;;F02K1/763,F02K1/72;;F02K1/12;;F02K1/76,,0,0,,,,ACTIVE
86,US,B2,US 8313656 B2,184-972-655-714-872,2012-11-20,2012,US 201113228606 A,2011-09-09,US 201113228606 A;;US 14656208 A,2008-06-26,Wash filter with wash velocity control cone,A variable wash flow filter assembly includes guide that is operable to guide a wash velocity control cone between a minimal position and a maximum position. The guide defines at least one activation deltaP window downstream of a conical gap between the wash velocity control cone and a frusto-conical wash filter. The fuel flow through the conical gap and the activation deltaP window is operable to position the wash velocity control cone between the minimal position and maximum position to selectively split a fuel flow through an inlet into a burn flow through a thru flow port and a filtered flow thru the frusto-conical wash filter and filtered flow port.,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R;;HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R,,https://lens.org/184-972-655-714-872,Granted Patent,yes,50,0,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,B01D35/00;;F02M37/38,210/741;;210/117;;210/118;;210/409;;210/416.4;;210/428;;210/429;;210/430;;210/433.1;;210/497.3,1,0,,,"European Search Report for Application No. 09251020.5-2113 dated Jun. 15, 2009.",ACTIVE
87,FR,A1,FR 2968374 A1,092-922-411-178-144,2012-06-08,2012,FR 1161130 A,2011-12-05,US 96215810 A,2010-12-07,SYSTEME D' ACTIONNEMENT,"Un système pour fournir un mouvement différentiel entre une première surface, une deuxième surface et une surface fixe comprend une première surface mobile entre une première position et une deuxième position ; une deuxième surface mobile avec la première surface et mobile en outre au-delà de la première surface ; un arbre raccordé à la deuxième surface pour déplacer la deuxième surface ; et une unité d'entraînement raccordée à la surface fixe pour entraîner l'arbre afin de déplacer la deuxième surface par rapport à la première surface et permettre à l'arbre de se déplacer par le biais de l'unité d'entraînement lorsque la deuxième surface est déplacée par la première surface.",HAMILTON SUNDSTRAND CORP,JONES TEDDY;;WALLEN GREGORY;;GIBBONS KEVIN;;VILLANO WILLIAM,,https://lens.org/092-922-411-178-144,Patent Application,no,0,0,5,5,0,F02K1/763;;F02K1/763;;Y02T50/60;;Y02T50/60;;Y10T29/49826;;Y10T29/49826;;Y10T74/19698;;Y10T74/19698;;Y10T74/19744;;Y10T74/19744,F16H25/02;;F02K1/76,,0,0,,,,INACTIVE
88,US,B2,US 10522515 B2,160-651-623-885-361,2019-12-31,2019,US 201916285081 A,2019-02-25,US 201916285081 A;;US 201715626843 A;;US 201514617523 A;;US 201414171584 A;;US 35377309 A,2009-01-14,Computer modules with small thicknesses and associated methods of manufacturing,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,MICRON TECHNOLOGY INC (2009-01-07),https://lens.org/160-651-623-885-361,Granted Patent,yes,27,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H05K1/18;;H01L23/00;;H01L25/065;;H01L25/10;;H01L25/18;;H05K1/11;;H05K3/34;;H05K7/02,,3,0,,,"Office Action dated Apr. 18, 2013 in Taiwan Application No. 098146477, 33 pages.;;“International Search Report and Written Opinion dated Mar. 26, 2010 in International Application No. PCT/US2009/068568, 11 pages.”;;“Office Action dated Aug. 16, 2012 in Taiwan Application No. 098146477, 24 pages.”",ACTIVE
89,EP,A1,EP 2138217 A1,091-021-848-301-980,2009-12-30,2009,EP 09251020 A,2009-03-31,US 14656208 A,2008-06-26,Wash filter with wash velocity control cone,"A variable wash flow filter assembly (54) includes a wash velocity control cone (68) movable between a minimal position and a maximum position.
",HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;LEUTWILER TOMAS R;;MAROCCHINI FRANCIS P,,https://lens.org/091-021-848-301-980,Patent Application,yes,5,2,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,B01D29/11;;B01D29/25;;B01D29/90;;B01D37/00;;F02C7/22;;F02M37/38,,0,0,,,,ACTIVE
90,FR,B1,FR 2968374 B1,022-306-954-620-842,2020-11-13,2020,FR 1161130 A,2011-12-05,US 96215810 A,2010-12-07,SYSTEME D' ACTIONNEMENT,"Un système pour fournir un mouvement différentiel entre une première surface, une deuxième surface et une surface fixe comprend une première surface mobile entre une première position et une deuxième position ; une deuxième surface mobile avec la première surface et mobile en outre au-delà de la première surface ; un arbre raccordé à la deuxième surface pour déplacer la deuxième surface ; et une unité d'entraînement raccordée à la surface fixe pour entraîner l'arbre afin de déplacer la deuxième surface par rapport à la première surface et permettre à l'arbre de se déplacer par le biais de l'unité d'entraînement lorsque la deuxième surface est déplacée par la première surface.",HAMILTON SUNDSTRAND CORP,JONES TEDDY;;WALLEN GREGORY;;GIBBONS KEVIN;;VILLANO WILLIAM,,https://lens.org/022-306-954-620-842,Granted Patent,no,0,0,5,5,0,F02K1/763;;F02K1/763;;Y02T50/60;;Y02T50/60;;Y10T29/49826;;Y10T29/49826;;Y10T74/19698;;Y10T74/19698;;Y10T74/19744;;Y10T74/19744,F16H25/02;;F02K1/76,,0,0,,,,INACTIVE
91,US,A1,US 2012/0000844 A1,029-137-879-294-636,2012-01-05,2012,US 201113228606 A,2011-09-09,US 201113228606 A;;US 14656208 A,2008-06-26,WASH FILTER WITH WASH VELOCITY CONTROL CONE,A variable wash flow filter assembly includes a wash velocity control cone movable between a minimal position and a maximum position.,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R,,https://lens.org/029-137-879-294-636,Patent Application,yes,0,2,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,B01D35/02;;F02M37/38,210/435,0,0,,,,ACTIVE
92,US,B2,US 8029664 B2,189-708-314-388-115,2011-10-04,2011,US 14656208 A,2008-06-26,US 14656208 A,2008-06-26,Wash filter with wash velocity control cone,A variable wash flow filter assembly includes a wash velocity control cone movable between a minimal position and a maximum position.,HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;LEUTWILER TOMAS R,HAMILTON SUNDSTRAND CORPORATION (2008-06-24),https://lens.org/189-708-314-388-115,Granted Patent,yes,48,0,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,B01D35/157;;B01D29/00;;B01D29/88;;B01D35/02;;F02M37/38,210/137;;210/409;;210/416.4;;210/428;;210/429;;210/430;;210/433.1;;210/497.3,1,0,,,"European Search Report for Application No. 09251020.5-2113 dated Jun. 15, 2009.",ACTIVE
93,JP,A,JP 2010007661 A,003-748-382-618-892,2010-01-14,2010,JP 2009135623 A,2009-06-05,US 14656208 A,2008-06-26,"VARIABLE WASH FLOW FILTER ASSEMBLY, FUEL SYSTEM AND FUEL FLOW FILTERING METHOD","<P>PROBLEM TO BE SOLVED: To provide a variable wash flow filter assembly. <P>SOLUTION: The variable wash flow filter assembly 54 includes an inlet 62, a housing 60 for demarcating a filtered flow port 64 and a combustion flow port 66, a wash filter 74, and a wash velocity control cone 68. The wash velocity control cone 68 is guided by a guide 76 along the axis A of the variable wash flow filter assembly 54, urged by an urging member 70 in the housing 60, and movable between a minimal position and a maximum position. The fuel flow F flows into the variable wash flow filter assembly 54 from the inlet 62, and flows between the wash velocity control cone 68 and the wash filter 74, and is divided into the combustion flow and the filtered flow. The combustion flow works as the wash flow to carry away foreign matters captured by the wash filter 74. <P>COPYRIGHT: (C)2010,JPO&INPIT",HAMILTON SUNDSTRAND CORP,GIBBONS KEVIN;;MAROCCHINI FRANCIS P;;TOMAS R LEUTWILER,,https://lens.org/003-748-382-618-892,Patent Application,no,1,0,7,7,0,B01D29/118;;B01D29/25;;B01D29/904;;B01D37/00;;F02M37/38;;B01D29/25;;B01D29/118;;B01D37/00;;B01D29/904;;F02M37/38,F02C7/22;;B01D29/60;;B01D35/02;;F01D25/00;;F02M37/38,,0,0,,,,PENDING
94,TW,A,TW 201034538 A,047-080-529-924-958,2010-09-16,2010,TW 98146477 A,2009-12-31,US 35377309 A,2009-01-14,Computer modules with small thicknesses and associated methods of manufacturing,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/047-080-529-924-958,Patent of Addition,no,0,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H05K1/18;;H05K3/30,,0,0,,,,ACTIVE
95,US,B2,US 8959759 B2,141-176-226-251-438,2015-02-24,2015,US 201414171584 A,2014-02-03,US 201414171584 A;;US 35377309 A,2009-01-14,Method for assembling computer modules small in thickness,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,,https://lens.org/141-176-226-251-438,Granted Patent,yes,17,0,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H01L23/00;;H01L25/065;;H01L25/10;;H01L25/18;;H05K1/18;;H05K3/34,29/832;;29/830;;361/760;;361/764,2,0,,,"International Search Report and Written Opinion dated Mar. 26, 2010 in International Application No. PCT/US2009/068568.;;Office Action issued Aug. 16, 2012 in Taiwan Application No. 098146477, 24 pages.",ACTIVE
96,US,B2,US 8644030 B2,152-135-410-927-889,2014-02-04,2014,US 35377309 A,2009-01-14,US 35377309 A,2009-01-14,Computer modules with small thicknesses and associated methods of manufacturing,"Computer modules with small thicknesses and associated methods of manufacturing are disclosed. In one embodiment, the computer modules can include a module substrate having a module material and an aperture extending at least partially into the module material. The computer modules can also include a microelectronic package carried by the module substrate. The microelectronic package includes a semiconductor die carried by a package substrate. At least a portion of the semiconductor die extends into the substrate material via the aperture.",GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J;;MICRON TECHNOLOGY INC,GIBBONS KEVIN;;REYNOLDS TRACY V;;CORISIS DAVID J,MICRON TECHNOLOGY INC (2009-01-07),https://lens.org/152-135-410-927-889,Granted Patent,yes,15,5,13,13,0,H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L24/73;;H01L2924/14;;H01L2924/00014;;H01L2924/00011;;H01L25/0657;;Y10T29/49126;;Y10T29/4913;;H05K3/3436;;Y10T29/49126;;Y10T29/4913;;H01L25/105;;H01L25/18;;H01L2225/0651;;H01L2225/06513;;H01L2225/06555;;H01L2924/19104;;H05K1/182;;H05K1/183;;H05K2201/10515;;H05K2201/10545;;H05K2201/10727;;H05K2203/1572;;H01L2924/00014;;H01L24/73;;H01L2924/14;;H01L2224/16145;;H01L2224/73265;;H01L2225/1088;;H01L2225/1023;;H01L2225/1058;;H01L2225/107;;H01L2924/00011;;H01L25/0657;;H01L24/83;;H05K1/111;;H05K7/02,H05K1/18;;H01L25/065,361/764;;361/760,2,0,,,"International Search Report and Written Opinion dated Mar. 26, 2010 in International Application No. PCT/US2009/068568.;;Office Action issued Aug. 16, 2012 in Taiwan Application No. 098146477, 24 pages.",ACTIVE
97,EP,A2,EP 2543863 A2,103-419-227-557-709,2013-01-09,2013,EP 12175012 A,2012-07-04,US 201161504375 P;;US 201113252305 A,2011-07-05,Integrated variable area fan nozzle and thrust reversal actuation system and method of operating movable structures of a nacelle,"An integrated variable area fan nozzle (VAFN) and thrust reversing actuation system (TRAS) system (15) includes movable surfaces (46) for adjusting an exit area (48) for bypass flow and cowls (52) moved for directing discharge flow in a reverser manner. The movable surfaces of the VAFN and TRAS systems are both coupled for movement by a common actuator arrangement. A power drive unit (68) drives each of the actuators (56A-B,53A-B;96A-B,98A-B) through a gearbox (64A-B,66A-B;112) or other linkage such that one common motor (72) or motor combination is utilized for driving all of the actuators. A series of redundant and separately actuateable locks (84A-B,86A-B;108,110) control deployment of the surfaces of the thrust reverse system (50) such that thrust reversing system (50) can move to an open or deployed position only in response to each of the locks being actuated to an unlocked condition.
 
",HAMILTON SUNDSTRAND CORP,SUNDSTROM DALE B;;GIBBONS KEVIN;;JONES TEDDY L,,https://lens.org/103-419-227-557-709,Patent Application,yes,0,2,7,7,0,F02K1/72;;F02K1/72;;F02K1/12;;F02K1/12;;F02K1/763;;F02K1/763;;F02K1/766;;F02K1/766,F02K1/72;;F02K1/12;;F02K1/76,,0,0,,,,ACTIVE
98,EP,B1,EP 0686093 B1,037-714-383-065-765,2000-08-09,2000,EP 94908723 A,1994-02-04,US 9401320 W;;US 1444793 A,1993-02-05,METAL ON PLASTIC FILMS WITH ADHESION-PROMOTING LAYER,,SOUTHWALL TECHNOLOGIES INC,GIBBONS KEVIN P;;LAU LOUIS C;;WOODARD FLOYD E,,https://lens.org/037-714-383-065-765,Granted Patent,yes,10,0,10,10,0,C23C14/205;;C23C14/205;;C23C14/024;;C23C14/024;;H05K1/0313;;H05K1/0313;;H05K3/388;;H05K3/388;;Y10S428/913;;Y10S428/913;;Y10T428/12569;;Y10T428/12569;;Y10T428/1259;;Y10T428/1259;;Y10T428/12806;;Y10T428/12806;;Y10T428/12819;;Y10T428/12819;;Y10T428/12826;;Y10T428/12826;;Y10T428/12993;;Y10T428/12993;;Y10T428/31681;;Y10T428/31681;;Y10T428/31786;;Y10T428/31786,B32B15/09;;C23C14/02;;C23C14/08;;C23C14/20;;C23C14/34;;C23C28/00;;H05K1/03;;H05K3/38,,0,0,,,,EXPIRED
99,EP,A1,EP 0686093 A1,043-083-307-579-114,1995-12-13,1995,EP 94908723 A,1994-02-04,US 9401320 W;;US 1444793 A,1993-02-05,METAL ON PLASTIC FILMS WITH ADHESION-PROMOTING LAYER,,SOUTHWALL TECHNOLOGIES INC,GIBBONS KEVIN P;;LAU LOUIS C;;WOODARD FLOYD E,,https://lens.org/043-083-307-579-114,Patent Application,yes,0,0,10,10,0,C23C14/205;;C23C14/205;;C23C14/024;;C23C14/024;;H05K1/0313;;H05K1/0313;;H05K3/388;;H05K3/388;;Y10S428/913;;Y10S428/913;;Y10T428/12569;;Y10T428/12569;;Y10T428/1259;;Y10T428/1259;;Y10T428/12806;;Y10T428/12806;;Y10T428/12819;;Y10T428/12819;;Y10T428/12826;;Y10T428/12826;;Y10T428/12993;;Y10T428/12993;;Y10T428/31681;;Y10T428/31681;;Y10T428/31786;;Y10T428/31786,B32B15/09;;C23C14/02;;C23C14/08;;C23C14/20;;C23C14/34;;C23C28/00;;H05K1/03;;H05K3/38,,0,0,,,,EXPIRED
100,US,A,US 5589280 A,013-044-252-619-368,1996-12-31,1996,US 1444793 A,1993-02-05,US 1444793 A,1993-02-05,Metal on plastic films with adhesion-promoting layer,"The adhesion to plastic substrates of thick layers of functional metals having an oxide heat of formation that is greater than -40,000 calories/gram atom of metal, such as silver, copper, gold, and the like, is improved if a thin layer of a metal having an oxide heat of formation of less than -50,000 calories/gram atom of metal is present as an adhesion-promoting primer layer. When the primer layer metal has a melting point greater than 1100.degree. C., it should be present as the metal or as a substoichiometric oxide. When the primer layer metal has a melting point less than 1100.degree. C., it may be present as the metal, as a substoichiometric oxide, or as a full stoichiometric oxide. Processes for preparing these materials using sputter-depositing and reflectors incorporating these materials are also disclosed.",SOUTHWALL TECHNOLOGIES INC,GIBBONS KEVIN P;;LAU LOUIS C;;WOODARD FLOYD E,SOUTHWALL TECHNOLOGIES INC (1993-04-01),https://lens.org/013-044-252-619-368,Granted Patent,yes,12,96,10,10,0,C23C14/205;;C23C14/205;;C23C14/024;;C23C14/024;;H05K1/0313;;H05K1/0313;;H05K3/388;;H05K3/388;;Y10S428/913;;Y10S428/913;;Y10T428/12569;;Y10T428/12569;;Y10T428/1259;;Y10T428/1259;;Y10T428/12806;;Y10T428/12806;;Y10T428/12819;;Y10T428/12819;;Y10T428/12826;;Y10T428/12826;;Y10T428/12993;;Y10T428/12993;;Y10T428/31681;;Y10T428/31681;;Y10T428/31786;;Y10T428/31786,B32B15/09;;C23C14/02;;C23C14/08;;C23C14/20;;C23C14/34;;C23C28/00;;H05K1/03;;H05K3/38,428/626;;204/192.15;;204/192.16;;204/192.27;;359/584;;359/585;;359/839;;428/627;;428/660;;428/662;;428/663;;428/687;;428/458;;428/469;;428/480;;428/912.2;;428/913,1,0,,,"Hass, George, et al., eds., Physics of Thin Films: Advances in Research and Development; Academic Press, NY, (1982) 12:36 39.",EXPIRED
101,WO,A1,WO 1994/018003 A1,076-521-557-384-234,1994-08-18,1994,US 9401320 W,1994-02-04,US 1444793 A,1993-02-05,METAL ON PLASTIC FILMS WITH ADHESION-PROMOTING LAYER,"The adhesion to plastic substrates (112) of thick layers of functional metals (116) having an oxide heat of formation that is greater than -40,000 calories/gram atom of metal, such as silver, copper, gold, and the like, is improved if a thin layer of a metal having an oxide heat of formation of less than -50,000 calories/gram atom of metal is present as an adhesion-promoting primer layer metal has a melting point greater than 1100 °C, it should be present as the metal or as a substoichiometric oxide. When the primer layer metal (114) has a melting point less than 1100 °C, it may be present as the metal, as a substoichiometric oxide, or as a full stoichiometric oxide. Processes for preparing these materials using sputter-depositing and reflectors incorporating these materials are also disclosed.",SOUTHWALL TECHNOLOGIES INC,GIBBONS KEVIN P;;LAU LOUIS C;;WOODARD FLOYD E,,https://lens.org/076-521-557-384-234,Patent Application,yes,3,19,10,10,0,C23C14/024;;C23C14/205;;H05K1/0313;;H05K3/388;;Y10S428/913;;Y10T428/12819;;Y10T428/1259;;Y10T428/12826;;Y10T428/12569;;Y10T428/12806;;Y10T428/12993;;Y10T428/31681;;Y10T428/31786;;Y10T428/12819;;Y10T428/1259;;Y10T428/12826;;Y10T428/12569;;Y10T428/12806;;Y10T428/12993;;Y10T428/31681;;Y10T428/31786;;C23C14/205;;H05K1/0313;;H05K3/388;;C23C14/024;;Y10S428/913,C23C14/02;;C23C14/08;;B32B15/09;;C23C14/20;;C23C14/34;;C23C28/00;;H05K1/03;;H05K3/38,,0,0,,,,PATENTED
102,EP,A4,EP 0686093 A4,055-667-022-266-442,1996-02-28,1996,EP 94908723 A,1994-02-04,US 9401320 W;;US 1444793 A,1993-02-05,METAL ON PLASTIC FILMS WITH ADHESION-PROMOTING LAYER,,SOUTHWALL TECHNOLOGIES INC,GIBBONS KEVIN P;;LAU LOUIS C;;WOODARD FLOYD E,,https://lens.org/055-667-022-266-442,Search Report,no,7,0,10,10,0,C23C14/205;;C23C14/205;;C23C14/024;;C23C14/024;;H05K1/0313;;H05K1/0313;;H05K3/388;;H05K3/388;;Y10S428/913;;Y10S428/913;;Y10T428/12569;;Y10T428/12569;;Y10T428/1259;;Y10T428/1259;;Y10T428/12806;;Y10T428/12806;;Y10T428/12819;;Y10T428/12819;;Y10T428/12826;;Y10T428/12826;;Y10T428/12993;;Y10T428/12993;;Y10T428/31681;;Y10T428/31681;;Y10T428/31786;;Y10T428/31786,B32B15/09;;C23C14/02;;C23C14/08;;C23C14/20;;C23C14/34;;C23C28/00;;H05K1/03;;H05K3/38,,1,0,,,See also references of WO 9418003A1,EXPIRED
103,US,B2,US 7414414 B2,172-583-440-961-177,2008-08-19,2008,US 48935606 A,2006-07-19,US 48935606 A,2006-07-19,Spatially distributed guarded impedance,A guarded sense impedance for use in a measurement instrument includes a sense impedance adapted to have a spatially distributed electrical potential and at least one guard structure adapted to have the spatially distributed electrical potential. The guard structure is arranged to provide a spatially distributed guard potential for the sense impedance.,KEITHLEY INSTRUMENTS,NIEMANN JAMES A;;GIBBONS JOHN;;CAWLEY KEVIN;;GOEKE WAYNE C,KEITHLEY INSTRUMENTS INC (2006-08-04),https://lens.org/172-583-440-961-177,Granted Patent,yes,5,0,4,4,0,G01R1/18;;G01R1/203;;G01R1/18;;G01R1/203,G01R27/26;;G01F23/00,324/688;;324/627;;324/705;;X 73304 C,0,0,,,,ACTIVE
104,WO,A1,WO 2021/127240 A1,142-796-704-445-151,2021-06-24,2021,US 2020/0065698 W,2020-12-17,US 201962949417 P;;US 201962949414 P,2019-12-17,SYSTEM AND METHOD FOR ASSESSING A DIGITAL INTERACTION WITH A DIGITAL THIRD PARTY ACCOUNT SERVICE,"A system and method for assessing digital interactions with a digital third party accounts can include receiving user account credentials for authentication with an external computing system, storing the user account credentials in association with a authentication token and communicating the authentication token to a computing device of an external application service; receiving, through a programmatic communication interface, a request that references the authentication token and digital interaction details; programmatically authenticating, using the stored user account credentials, as a user account with the external computing system and retrieving account data; processing the account data in combination with the digital interaction details and thereby generating a digital interact assessment; and initiating execution of a digital interaction based in part on the digital interaction assessment.",PLAID INC,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN;;HU KEVIN;;NAIK SAMIR,,https://lens.org/142-796-704-445-151,Patent Application,yes,4,0,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06F21/31;;G06F21/45;;H04L9/32;;H04W12/06,,1,0,,,See also references of EP 4070211A4,PENDING
105,US,A1,US 2008/0018348 A1,010-892-459-613-070,2008-01-24,2008,US 48935606 A,2006-07-19,US 48935606 A,2006-07-19,Spatially distributed guarded impedance,A guarded sense impedance for use in a measurement instrument includes a sense impedance adapted to have a spatially distributed electrical potential and at least one guard structure adapted to have the spatially distributed electrical potential. The guard structure is arranged to provide a spatially distributed guard potential for the sense impedance.,NIEMANN JAMES A;;GIBBONS JOHN;;CAWLEY KEVIN;;GOEKE WAYNE C,NIEMANN JAMES A;;GIBBONS JOHN;;CAWLEY KEVIN;;GOEKE WAYNE C,KEITHLEY INSTRUMENTS INC (2006-08-04),https://lens.org/010-892-459-613-070,Patent Application,yes,5,0,4,4,0,G01R1/18;;G01R1/203;;G01R1/18;;G01R1/203,G01R27/26,324/688,0,0,,,,ACTIVE
106,JP,A,JP 2008026300 A,156-219-788-558-951,2008-02-07,2008,JP 2007000581 A,2007-01-05,US 48935606 A,2006-07-19,SPATIALLY DISTRIBUTED PROTECTED IMPEDANCE,"<P>PROBLEM TO BE SOLVED: To protect a node in an area surrounding an important measuring node by driving it to a potential same to that of the node itself. <P>SOLUTION: This protected sensing impedance 20 used in a measuring instrument 10 includes a sensing impedance 14 constituted to have a spatially distributed electric potential, an at least one protection constitutive body 16 or 18 constituted to have the spatially distributed electric potential. The protection constitutive body 16 or 18 imparts the spatially distributed electric potential to the sensing impedance 14. <P>COPYRIGHT: (C)2008,JPO&INPIT",KEITHLEY INSTRUMENTS,NIEMANN JAMES A;;GIBBONS JOHN;;CAWLEY KEVIN;;GOEKE WAYNE C,,https://lens.org/156-219-788-558-951,Patent Application,no,2,0,4,4,0,G01R1/18;;G01R1/203;;G01R1/18;;G01R1/203,G01R19/00,,0,0,,,,INACTIVE
107,AU,A1,AU 2020/405098 A1,060-839-824-747-108,2022-07-07,2022,AU 2020/405098 A,2020-12-17,US 201962949417 P;;US 201962949414 P;;US 2020/0065698 W,2019-12-17,System and method for assessing a digital interaction with a digital third party account service,"A system and method for assessing digital interactions with a digital third party accounts can include receiving user account credentials for authentication with an external computing system, storing the user account credentials in association with a authentication token and communicating the authentication token to a computing device of an external application service; receiving, through a programmatic communication interface, a request that references the authentication token and digital interaction details; programmatically authenticating, using the stored user account credentials, as a user account with the external computing system and retrieving account data; processing the account data in combination with the digital interaction details and thereby generating a digital interact assessment; and initiating execution of a digital interaction based in part on the digital interaction assessment.",PLAID INC,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN LIN;;HU KEVIN;;NAIK SAMIR,,https://lens.org/060-839-824-747-108,Patent Application,no,0,0,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06F21/31;;G06F21/45;;H04L9/32;;H04W12/06,,0,0,,,,PENDING
108,GB,A,GB 2560266 A,069-142-263-649-66X,2018-09-05,2018,GB 201804900 A,2012-04-11,US 201113083826 A;;GB 201206403 A,2011-04-11,Actuation control system,"A method of controlling an actuator 16a,16b for positioning a movable aircraft component 12a,12b such as a variable area fan nozzle (VAFN) door or thrust reverse doors or flaps. The method comprises: connecting electrically a first component control channel 26a of a component controller 14 to an actuator 16a attached to the movable aircraft component 12a; connecting electrically a second component control channel 26b of the component controller 14 to the actuator 16a; detecting a position of the movable aircraft component 12a with a first position sensor 18a and a second position sensor 18b; and controlling the actuator 16a in response to the detected position of the movable aircraft component 12a. Controlling the actuator 16a comprises: controlling a first portion of the actuator 16a with the first component channel 26a in response to the position detected by the first position sensor 18a; and controlling a second portion of the actuator 16a with the second component channel 26b in response to the position detected by the second position sensor 18b. The first and second portion of each actuator 16a,16b may each comprise a motor (40a,40b figure 2) and a brake (44a,44b).",HAMILTON SUNDSTRAND CORP,WILLIAM E VILLANO;;KEVIN GIBBONS;;TEDDY L JONES;;FRANCIS W RECCK,,https://lens.org/069-142-263-649-66X,Patent Application,no,1,0,8,8,0,B64C13/505;;B64C13/505;;B64C13/00;;B64C13/42;;F02K1/763;;F02K1/15;;F02K1/76,F02K1/76;;B64C13/00;;B64C13/42;;F02K1/15,,0,0,,,,ACTIVE
109,US,A1,US 2012/0259483 A1,040-054-662-385-769,2012-10-11,2012,US 201113083826 A,2011-04-11,US 201113083826 A,2011-04-11,ACTUATION CONTROL SYSTEM,A dual redundant actuation control system for controlling a plurality of actuators for positioning a plurality of moveable aircraft components. The actuation control system includes a component controller. The component controller includes two component control channels. Each of the plurality of actuators is electrically connected to each of the two component control channels such that either of the two component control channels may control any or all of the plurality of actuators.,VILLANO WILLIAM E;;GIBBONS KEVIN;;JONES TEDDY L;;RECCK FRANCIS W;;HAMILTON SUNDSTRAND CORP,VILLANO WILLIAM E;;GIBBONS KEVIN;;JONES TEDDY L;;RECCK FRANCIS W,HAMILTON SUNDSTRAND CORPORATION (2011-04-04),https://lens.org/040-054-662-385-769,Patent Application,yes,6,24,8,8,0,B64C13/505;;B64C13/505;;B64C13/00;;B64C13/42;;F02K1/763;;F02K1/15;;F02K1/76,F02C9/18;;F02K3/04,701/3;;701/100,0,0,,,,ACTIVE
110,EP,A4,EP 4070211 A4,011-026-767-108-143,2023-11-29,2023,EP 20903299 A,2020-12-17,US 201962949417 P;;US 201962949414 P;;US 2020/0065698 W,2019-12-17,SYSTEM AND METHOD FOR ASSESSING A DIGITAL INTERACTION WITH A DIGITAL THIRD PARTY ACCOUNT SERVICE,,PLAID INC,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN LIN;;HU KEVIN;;NAIK SAMIR,,https://lens.org/011-026-767-108-143,Search Report,no,3,0,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06Q20/40;;G06Q20/02;;G06Q20/38,,1,0,,,See also references of WO 2021127240A1,PENDING
111,GB,A,GB 2490032 A,052-007-301-004-215,2012-10-17,2012,GB 201206403 A,2012-04-11,US 201113083826 A,2011-04-11,A variable area nozzle actuation control system,"A dual redundant variable area fan nozzle (VAFN) actuation system 10, for an aircraft engine, comprising a VAFN. The VAFN comprises a first VAFN door 12a, a second VAFN door 12b and a control system for controlling the position of the VAFN doors. The control system comprises a first actuator 16a attached to the first VAFN door, a second actuator 16b attached to the second VAFN door, and a VAFN controller 14 linked to each of the first actuator and the second actuator. The VAFN controller comprises a first VAFN control channel 26a, a second VAFN control channel 26b and a channel communication link 28. The first VAFN control channel is electrically connected to each of the first and the second actuator to communicate control information between the VASFN controller and the first and second actuators; and the second VAFN control channel is electrically connected to each of the first and the second actuator to communicate control information between the VAFN controller and the first and second actuators. At least one of the VAFN control channels controls the first actuator and the second actuator.",HAMILTON SUNDSTRAND CORP,VILLANO WILLIAM E;;GIBBONS KEVIN;;JONES TEDDY L;;RECCK FRANCIS W,,https://lens.org/052-007-301-004-215,Patent Application,no,5,0,8,8,0,B64C13/505;;B64C13/505;;B64C13/00;;B64C13/42;;F02K1/763;;F02K1/15;;F02K1/76,F02K1/76;;B64C13/00;;B64C13/42;;F02K1/15,,0,0,,,,ACTIVE
112,GB,B,GB 2490032 B,075-044-325-244-43X,2018-05-09,2018,GB 201206403 A,2012-04-11,US 201113083826 A,2011-04-11,Actuation control system,,HAMILTON SUNDSTRAND CORP,WILLIAM E VILLANO;;KEVIN GIBBONS;;TEDDY L JONES;;FRANCIS W RECCK,,https://lens.org/075-044-325-244-43X,Granted Patent,no,6,0,8,8,0,B64C13/505;;B64C13/505;;B64C13/00;;B64C13/42;;F02K1/763;;F02K1/15;;F02K1/76,F02K1/76;;B64C13/00;;B64C13/42;;F02K1/15,,0,0,,,,ACTIVE
113,CA,A1,CA 3165099 A1,134-393-249-026-580,2021-06-24,2021,CA 3165099 A,2020-12-17,US 201962949417 P;;US 201962949414 P;;US 2020/0065698 W,2019-12-17,SYSTEM AND METHOD FOR ASSESSING A DIGITAL INTERACTION WITH A DIGITAL THIRD PARTY ACCOUNT SERVICE,"A system and method for assessing digital interactions with a digital third party accounts can include receiving user account credentials for authentication with an external computing system, storing the user account credentials in association with a authentication token and communicating the authentication token to a computing device of an external application service; receiving, through a programmatic communication interface, a request that references the authentication token and digital interaction details; programmatically authenticating, using the stored user account credentials, as a user account with the external computing system and retrieving account data; processing the account data in combination with the digital interaction details and thereby generating a digital interact assessment; and initiating execution of a digital interaction based in part on the digital interaction assessment.",PLAID INC,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN LIN;;HU KEVIN;;NAIK SAMIR,,https://lens.org/134-393-249-026-580,Patent Application,no,0,0,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06F21/31;;G06F21/45;;H04L9/32;;H04W12/06,,0,0,,,,PENDING
114,US,B2,US 9416751 B2,149-269-029-156-726,2016-08-16,2016,US 96215810 A,2010-12-07,US 96215810 A,2010-12-07,Actuation system,"A system to provide differential movement between a first surface, a second surface and a fixed surface includes a first surface movable between a first position and a second position; a second surface movable with the first surface and further movable beyond the first surface; a shaft connected to the second surface to move the second surface; and a drive unit connected to the fixed surface to drive the shaft to move the second surface relative to the first surface and to allow the shaft to move through the drive unit when the second surface is being moved by the first surface.",JONES TEDDY L;;WALLEN GREGORY T;;GIBBONS KEVIN;;VILLANO WILLIAM E;;HAMILTON SUNDSTRAND CORP,JONES TEDDY L;;WALLEN GREGORY T;;GIBBONS KEVIN;;VILLANO WILLIAM E,HAMILTON SUNDSTRAND CORPORATION (2010-11-30),https://lens.org/149-269-029-156-726,Granted Patent,yes,27,4,5,5,0,F02K1/763;;F02K1/763;;Y02T50/60;;Y02T50/60;;Y10T29/49826;;Y10T29/49826;;Y10T74/19698;;Y10T74/19698;;Y10T74/19744;;Y10T74/19744,F02K1/72;;F02K1/76,,0,0,,,,ACTIVE
115,CN,A,CN 115398457 A,060-736-629-388-363,2022-11-25,2022,CN 202080095467 A,2020-12-17,US 201962949414 P;;US 201962949417 P;;US 2020/0065698 W,2019-12-17,Systems and methods for evaluating digital interactions using digital third party account services,"Systems and methods for evaluating digital interactions using a digital third party account may include receiving user account credentials for authentication by an external computing system, storing the user account credentials in association with an authentication token, and transmitting the authentication token to a computing device of an external application service; receiving a request for referencing the authentication token and the digital interaction detail information through the programmed communication interface; programmatically authenticating, by the external computing system, a user account using the stored user account credentials and retrieving account data; processing the account data in combination with the digital interaction detailed information to generate digital interaction evaluation; and initiating execution of the digital interaction based in part on the digital interaction evaluation.",PRAD LTD,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN LYNN;;HU KEVIN;;NAIK SAMIR,,https://lens.org/060-736-629-388-363,Patent Application,no,0,0,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06Q20/38;;G06N3/04;;G06N5/00;;G06N7/00;;G06N20/20;;G06Q20/02;;G06Q40/00,,0,0,,,,PENDING
116,US,A1,US 2012/0137656 A1,105-031-356-810-418,2012-06-07,2012,US 96215810 A,2010-12-07,US 96215810 A,2010-12-07,ACTUATION SYSTEM,"A system to provide differential movement between a first surface, a second surface and a fixed surface includes a first surface movable between a first position and a second position; a second surface movable with the first surface and further movable beyond the first surface; a shaft connected to the second surface to move the second surface; and a drive unit connected to the fixed surface to drive the shaft to move the second surface relative to the first surface and to allow the shaft to move through the drive unit when the second surface is being moved by the first surface.",JONES TEDDY L;;WALLEN GREGORY T;;GIBBONS KEVIN;;VILLANO WILLIAM E;;HAMILTON SUNDSTRAND CORP,JONES TEDDY L;;WALLEN GREGORY T;;GIBBONS KEVIN;;VILLANO WILLIAM E,HAMILTON SUNDSTRAND CORPORATION (2010-11-30),https://lens.org/105-031-356-810-418,Patent Application,yes,17,4,5,5,0,F02K1/763;;F02K1/763;;Y02T50/60;;Y02T50/60;;Y10T29/49826;;Y10T29/49826;;Y10T74/19698;;Y10T74/19698;;Y10T74/19744;;Y10T74/19744,F02K1/62;;B23P11/00;;F16H25/20;;F16H25/22,60/226.2;;29/428;;74/424.5;;74/424.81,0,0,,,,ACTIVE
117,GB,B,GB 2560266 B,015-523-362-175-48X,2018-11-28,2018,GB 201804900 A,2012-04-11,US 201113083826 A;;GB 201206403 A,2011-04-11,Actuation control system,,HAMILTON SUNDSTRAND CORP,WILLIAM E VILLANO;;KEVIN GIBBONS;;TEDDY L JONES;;FRANCIS W RECCK,,https://lens.org/015-523-362-175-48X,Granted Patent,no,1,0,8,8,0,B64C13/505;;B64C13/505;;B64C13/00;;B64C13/42;;F02K1/763;;F02K1/15;;F02K1/76,F02K1/76;;B64C13/00;;B64C13/42;;F02K1/15,,0,0,,,,ACTIVE
118,EP,A1,EP 4070211 A1,095-952-746-760-837,2022-10-12,2022,EP 20903299 A,2020-12-17,US 201962949417 P;;US 201962949414 P;;US 2020/0065698 W,2019-12-17,SYSTEM AND METHOD FOR ASSESSING A DIGITAL INTERACTION WITH A DIGITAL THIRD PARTY ACCOUNT SERVICE,,PLAID INC,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN LIN;;HU KEVIN;;NAIK SAMIR,,https://lens.org/095-952-746-760-837,Patent Application,yes,0,0,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06F21/31;;G06F21/45;;H04L9/32;;H04W12/06,,0,0,,,,PENDING
119,US,A1,US 2021/0182850 A1,112-787-114-567-834,2021-06-17,2021,US 202017125544 A,2020-12-17,US 202017125544 A;;US 201962949417 P;;US 201962949414 P,2019-12-17,SYSTEM AND METHOD FOR ASSESSING A DIGITAL INTERACTION WITH A DIGITAL THIRD PARTY ACCOUNT SERVICE,"A system and method for assessing digital interactions with a digital third party accounts can include receiving user account credentials for authentication with an external computing system, storing the user account credentials in association with a authentication token and communicating the authentication token to a computing device of an external application service; receiving, through a programmatic communication interface, a request that references the authentication token and digital interaction details; programmatically authenticating, using the stored user account credentials, as a user account with the external computing system and retrieving account data; processing the account data in combination with the digital interaction details and thereby generating a digital interact assessment; and initiating execution of a digital interaction based in part on the digital interaction assessment.",PLAID INC,MORSE ERIC;;JOHNSON MAX;;GIBBONS AUSTIN LIN;;HU KEVIN;;NAIK SAMIR,PLAID INC (2020-12-16),https://lens.org/112-787-114-567-834,Patent Application,yes,9,15,7,7,0,G06Q20/4016;;G06Q20/02;;G06Q20/385;;G06Q20/405;;G06N20/20;;G06N3/04;;G06N5/01;;G06N7/01;;G06Q20/38215;;G06Q20/4016;;G06Q20/4014;;G06N20/00,G06Q20/38;;G06N20/00;;G06Q20/40,,0,0,,,,PENDING
120,US,B2,US 8583294 B2,131-660-725-350-475,2013-11-12,2013,US 201113083826 A,2011-04-11,US 201113083826 A,2011-04-11,Actuation control system,A dual redundant actuation control system for controlling a plurality of actuators for positioning a plurality of moveable aircraft components. The actuation control system includes a component controller. The component controller includes two component control channels. Each of the plurality of actuators is electrically connected to each of the two component control channels such that either of the two component control channels may control any or all of the plurality of actuators.,VILLANO WILLIAM E;;GIBBONS KEVIN;;JONES TEDDY L;;RECCK FRANCIS W;;HAMILTON SUNDSTRAND CORP,VILLANO WILLIAM E;;GIBBONS KEVIN;;JONES TEDDY L;;RECCK FRANCIS W,HAMILTON SUNDSTRAND CORPORATION (2011-04-04),https://lens.org/131-660-725-350-475,Granted Patent,yes,15,15,8,8,0,B64C13/505;;B64C13/505;;B64C13/00;;B64C13/42;;F02K1/763;;F02K1/15;;F02K1/76,F02K1/76;;G06F19/00,701/3;;701/100;;60/228,2,0,,,"Search Report of the UKIPO in Application No. GB1206403.6, dated Jul. 20, 2012.;;Corrected Search Report of the UKIPO in Application No. GB1206403.6, dated Aug. 21, 2012.",ACTIVE
121,US,A1,US 2017/0227425 A1,138-087-423-238-088,2017-08-10,2017,US 201615018651 A,2016-02-08,US 201615018651 A,2016-02-08,SYSTEM AND METHOD FOR THE CALCULATION OF A FUEL LACQUER INDEX,"A system and method for the calculation of a fuel lacquer index using environmental monitoring is disclosed. The system and method may comprise: capturing a fuel temperature data; determining a fuel quality rating; calculating a volumetric fuel flow; calculating a fuel filter differential pressure; and calculating a fuel lacquer index. The fuel lacquer index may be calculated as a percentage value based upon the fuel temperature data, the fuel quality rating, the volumetric fuel flow, and the fuel filter differential pressure.",UNITED TECHNOLOGIES CORP,MARTUCCI ANGELO;;DONAT WILLIAM;;GRACE AMY;;HETTLER ERIC;;MCCORMICK KEVIN;;GIBBONS KEVIN;;CORDATOS HARALAMBOS;;MAZELLA CHRISTOPHER,RTX CORPORATION (2016-02-08),https://lens.org/138-087-423-238-088,Patent Application,yes,6,9,3,3,0,B01D46/0086;;F02C7/22;;G05B23/0229;;F05D2260/607;;G01N33/22;;Y02T50/60;;B01D46/0086;;G05B23/0229;;F05D2260/607;;F02C7/22;;Y02T50/60;;F01D21/003;;F02C7/222;;G01M15/14;;G01N33/22,G01M15/14;;F01D21/00;;F02C7/22;;G01N33/22,,2,0,,,"Ã˜yvind Buhaug.,""Deposit formation on cylinder liner surfaces in medium-speed engines""., Faculty of Engineering Science and Technology Norwegian University of Science and Technology., Trondheim, Sept 15, 2003;;Øyvind Buhaug.,""Deposit formation on cylinder liner surfaces in medium-speed engines""., Faculty of Engineering Science and Technology Norwegian University of Science and Technology., Trondheim, Sept 15, 2003",ACTIVE
122,EP,A1,EP 3208447 A1,079-145-014-787-70X,2017-08-23,2017,EP 17155065 A,2017-02-07,US 201615018651 A,2016-02-08,SYSTEM AND METHOD FOR THE CALCULATION OF A FUEL LACQUER INDEX,"A system and method for the calculation of a fuel lacquer index using environmental monitoring is disclosed. The system and method may comprise: capturing a fuel temperature data; determining a fuel quality rating; calculating a volumetric fuel flow; calculating a fuel filter differential pressure; and calculating a fuel lacquer index. The fuel lacquer index may be calculated as a percentage value based upon the fuel temperature data, the fuel quality rating, the volumetric fuel flow, and the fuel filter differential pressure.
",UNITED TECHNOLOGIES CORP,MARTUCCI ANGELO;;DONAT WILLIAM;;GRACE AMY;;HETTLER ERIC;;MCCORMICK KEVIN;;GIBBONS KEVIN;;CORDATOS HARALAMBOS;;MAZELLA CHRISTOPHER,RAYTHEON TECHNOLOGIES CORPORATION (2021-03-24);;RTX CORPORATION (2023-11-01),https://lens.org/079-145-014-787-70X,Patent Application,yes,2,0,3,3,0,B01D46/0086;;F02C7/22;;G05B23/0229;;F05D2260/607;;G01N33/22;;Y02T50/60;;B01D46/0086;;G05B23/0229;;F05D2260/607;;F02C7/22;;Y02T50/60;;F01D21/003;;F02C7/222;;G01M15/14;;G01N33/22,F02C7/22;;B01D46/00;;F02D41/22;;G05B23/02,,0,0,,,,PENDING
123,US,B2,US 10241007 B2,097-656-949-326-025,2019-03-26,2019,US 201615018651 A,2016-02-08,US 201615018651 A,2016-02-08,System and method for the calculation of a fuel lacquer index,"A system and method for the calculation of a fuel lacquer index using environmental monitoring is disclosed. The system and method may comprise: capturing a fuel temperature data; determining a fuel quality rating; calculating a volumetric fuel flow; calculating a fuel filter differential pressure; and calculating a fuel lacquer index. The fuel lacquer index may be calculated as a percentage value based upon the fuel temperature data, the fuel quality rating, the volumetric fuel flow, and the fuel filter differential pressure.",UNITED TECHNOLOGIES CORP,MARTUCCI ANGELO;;DONAT WILLIAM;;GRACE AMY;;HETTLER ERIC;;MCCORMICK KEVIN;;GIBBONS KEVIN;;CORDATOS HARALAMBOS;;MAZELLA CHRISTOPHER,RTX CORPORATION (2016-02-08),https://lens.org/097-656-949-326-025,Granted Patent,yes,4,0,3,3,0,B01D46/0086;;F02C7/22;;G05B23/0229;;F05D2260/607;;G01N33/22;;Y02T50/60;;B01D46/0086;;G05B23/0229;;F05D2260/607;;F02C7/22;;Y02T50/60;;F01D21/003;;F02C7/222;;G01M15/14;;G01N33/22,G01M15/14;;F01D21/00;;F02C7/22;;G01N33/22,,2,0,,,"Øyvind Buhaug.,“Deposit formation on cylinder liner surfaces in medium-speed engines”., Faculty of Engineering Science and Technology Norwegian University of Science and Technology., Trondheim, Sep. 15, 2003.;;EP Search Report dated Jul. 21, 2017 in EP Application No. 17155065.0.",ACTIVE
124,CN,A,CN 106663154 A,105-236-765-028-805,2017-05-10,2017,CN 201480080621 A,2014-07-22,US 2014/0047580 W,2014-07-22,Authorizing a bios policy change for storage,"Examples herein disclose receiving a basic input output system (BIOS) policy change and authorizing the BIOS policy change. Upon the authorization of the BIOS policy change, a first copy of the BIOS policy is stored in a first memory accessible by a central processing unit. Additionally, a second copy of the BIOS policy change is transmitted for storage in a second memory electrically isolated from the central processing unit.",HEWLETT PACKARD DEVELOPMENT CO LP,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,,https://lens.org/105-236-765-028-805,Patent Application,no,5,3,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F21/30;;G06F13/14,,0,0,,,,ACTIVE
125,EP,B1,EP 3172687 B1,140-923-362-138-018,2018-12-19,2018,EP 14897933 A,2014-07-22,US 2014/0047580 W,2014-07-22,AUTHORIZING A BIOS POLICY CHANGE FOR STORAGE,,HEWLETT PACKARD DEVELOPMENT CO,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/140-923-362-138-018,Granted Patent,yes,8,0,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F21/30;;G06F9/445;;G06F11/14;;G06F13/14;;G06F21/57;;G06F21/62;;G06F21/79,,0,0,,,,ACTIVE
126,TW,B,TW I564800 B,044-650-899-200-917,2017-01-01,2017,TW 104120554 A,2015-06-25,US 2014/0047580 W,2014-07-22,Authorizing a bios policy change for storage,,HEWLETT PACKARD DEVELOPMENT CO LP,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,,https://lens.org/044-650-899-200-917,Granted Patent,no,8,0,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,,,0,0,,,,INACTIVE
127,EP,A1,EP 3172687 A1,126-079-052-321-791,2017-05-31,2017,EP 14897933 A,2014-07-22,US 2014/0047580 W,2014-07-22,AUTHORIZING A BIOS POLICY CHANGE FOR STORAGE,,HEWLETT PACKARD DEVELOPMENT CO LP,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/126-079-052-321-791,Patent Application,yes,0,0,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F21/30;;G06F13/14,,0,0,,,,ACTIVE
128,US,B2,US 7395434 B2,151-157-664-903-60X,2008-07-01,2008,US 13624502 A,2002-05-01,US 13624502 A,2002-05-01,"Method for secure storage and verification of the administrator, power-on password and configuration information","A computer includes a processor, an input device and a read only memory (“ROM”). One or more passwords are flashed in the ROM in encoded form. The encoding process may include any well-known encryption or hash process. The password may include a power-on password usable to change the operating state of the computer and/or an administrator password. Such configuration data preferably also is stored on the ROM in encoded form. The encoded nature of the passwords makes it difficult for an unauthorized entity to gain access to the usable form of the passwords. Further, by storing the passwords and configuration in ROM, such as the computer's main system ROM, it is possible to control write access to the ROM because a computer's ROM can generally only be flashed using SMI code which operates outside the control of the computer's operating system and requires entry of a correct password.",HEWLETT PACKARD DEVELOPMENT CO,PIWONKA MARK A;;SHUTT MARK W;;WONG KEVIN K;;GIBBONS PATRICK L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2002-04-30),https://lens.org/151-157-664-903-60X,Granted Patent,yes,11,17,2,2,0,G06F21/57;;G06F21/57;;G06F21/31;;G06F21/31,H04L9/00;;G06F11/00;;G06F13/24;;G06F13/32;;G06F21/00,713/183;;710/260;;710/266;;711/164;;713/2,2,0,,,"Intel's SL Enhanced Intel486(TM) Microprocessor Family, Jun. 1993, http://www.intel.com/design/intarch/applnots/7014.htm, Aug. 17, 2006.;;Announcing the Standard for Secure Hash Standard, Federal Information Processing Standards Publication 180-1, Apr. 17, 1995, 18 pp.",ACTIVE
129,TW,A,TW 201604784 A,079-585-556-187-505,2016-02-01,2016,TW 104120554 A,2015-06-25,US 2014/0047580 W,2014-07-22,Authorizing a BIOS policy change for storage,"Examples herein disclose receiving a basic input output system (BIOS) policy change and authorizing the BIOS policy change. Upon the authorization of the BIOS policy change, a first copy of the BIOS policy is stored in a first memory accessible by a central processing unit. Additionally, a second copy of the BIOS policy change is transmitted for storage in a second memory electrically isolated from the central processing unit.",HEWLETT PACKARD DEVELOPMENT CO,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,,https://lens.org/079-585-556-187-505,Patent of Addition,no,0,1,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F9/445;;G06F13/12,,0,0,,,,INACTIVE
130,EP,A4,EP 3172687 A4,103-162-570-980-482,2018-02-21,2018,EP 14897933 A,2014-07-22,US 2014/0047580 W,2014-07-22,AUTHORIZING A BIOS POLICY CHANGE FOR STORAGE,,HEWLETT PACKARD DEVELOPMENT CO LP,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,"HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (2019-05-15)",https://lens.org/103-162-570-980-482,Search Report,no,3,0,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F21/30;;G06F13/14;;G06F21/57;;G06F21/62;;G06F21/79,,1,0,,,See also references of WO 2016014031A1,ACTIVE
131,US,A1,US 2003/0208696 A1,097-698-676-057-805,2003-11-06,2003,US 13624502 A,2002-05-01,US 13624502 A,2002-05-01,"Method for secure storage and verification of the administrator, power-on password and configuration information","
   A computer includes a processor, an input device and a read only memory (ROM). One or more passwords are flashed in the ROM in encoded form. The encoding process may include any well-known encryption or hash process. The password may include a power-on password usable to change the operating state of the computer and/or an administrator password. Such configuration data preferably also is stored on the ROM in encoded form. The encoded nature of the passwords makes it difficult for an unauthorized entity to gain access to the usable form of the passwords. Further, by storing the passwords and configuration in ROM, such as the computer's main system ROM, it is possible to control write access to the ROM because a computer's ROM can generally only be flashed using SMI code which operates outside the control of the computer's operating system and requires entry of a correct password. 
",COMPAQ INFORMATION TECHNOLOGIE,PIWONKA MARK A;;SHUTT MARK W;;WONG KEVIN K;;GIBBONS PATRICK L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2002-04-30),https://lens.org/097-698-676-057-805,Patent Application,yes,11,19,2,2,0,G06F21/57;;G06F21/57;;G06F21/31;;G06F21/31,G06F21/00,713/202;;713/193,0,0,,,,EXPIRED
132,WO,A1,WO 2016/014031 A1,124-199-938-706-483,2016-01-28,2016,US 2014/0047580 W,2014-07-22,US 2014/0047580 W,2014-07-22,AUTHORIZING A BIOS POLICY CHANGE FOR STORAGE,"Examples herein disclose receiving a basic input output system (BIOS) policy change and authorizing the BIOS policy change. Upon the authorization of the BIOS policy change, a first copy of the BIOS policy is stored in a first memory accessible by a central processing unit. Additionally, a second copy of the BIOS policy change is transmitted for storage in a second memory electrically isolated from the central processing unit.",HEWLETT PACKARD DEVELOPMENT CO,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,,https://lens.org/124-199-938-706-483,Patent Application,yes,5,0,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F13/14;;G06F21/30,,1,0,,,See also references of EP 3172687A4,PENDING
133,US,A1,US 2019/0102207 A1,092-289-377-354-341,2019-04-04,2019,US 201816194169 A,2018-11-16,US 201816194169 A;;US 201615309486 A;;US 2014/0047580 W,2014-07-22,AUTHORIZING A BIOS POLICY CHANGE FOR STORAGE,"Examples herein disclose receiving a basic input output system (BIOS) policy change and authorizing the BIOS policy change. Upon the authorization of the BIOS policy change, a first copy of the BIOS policy is stored in a first memory accessible by a central processing unit. Additionally, a second copy of the BIOS policy change is transmitted for storage in a second memory electrically isolated from the central processing unit.",HEWLETT PACKARD DEVELOPMENT CO,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2014-07-21),https://lens.org/092-289-377-354-341,Patent Application,yes,2,1,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F21/44;;G06F9/445;;G06F21/57;;G06F21/62;;G06F21/79;;H04L9/06;;H04L9/32,,0,0,,,,ACTIVE
134,US,B2,US 10585676 B2,160-517-140-419-596,2020-03-10,2020,US 201816194169 A,2018-11-16,US 201816194169 A;;US 201615309486 A;;US 2014/0047580 W,2014-07-22,Authorizing a bios policy change for storage,"Examples herein disclose receiving a basic input output system (BIOS) policy change and authorizing the BIOS policy change. Upon the authorization of the BIOS policy change, a first copy of the BIOS policy is stored in a first memory accessible by a central processing unit. Additionally, a second copy of the BIOS policy change is transmitted for storage in a second memory electrically isolated from the central processing unit.",HEWLETT PACKARD DEVELOPMENT CO,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2014-07-21),https://lens.org/160-517-140-419-596,Granted Patent,yes,12,0,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,G06F9/445;;G06F11/14;;G06F21/44;;G06F21/57;;G06F21/62;;G06F21/79;;H04L9/06;;H04L9/32,,3,0,,,"Cooper, D., et al., “Bios Protection Guidelines,” National Institute of Standards and Technology, Special Publication 800-147, Apr. 2011, 26 pages.;;Trusted Execution Environment EFI Protocol, Feb. 2, 2013, Microsoft, 17 pages.;;Futral, W., et al., “Intel® Trusted Execution Technology for Server Platforms,” Research Paper, Sep. 26, 2013, it-ebooks.info, 149 pages.",ACTIVE
135,US,B2,US 10169052 B2,012-299-768-157-350,2019-01-01,2019,US 201415309486 A,2014-07-22,US 2014/0047580 W,2014-07-22,Authorizing a bios policy change for storage,"Examples herein disclose receiving a basic input output system (BIOS) policy change and authorizing the BIOS policy change. Upon the authorization of the BIOS policy change, a first copy of the BIOS policy is stored in a first memory accessible by a central processing unit. Additionally, a second copy of the BIOS policy change is transmitted for storage in a second memory electrically isolated from the central processing unit.",HEWLETT PACKARD DEVELOPMENT CO,JEANSONNE JEFFREY KEVIN;;ALI VALIUDDIN;;WANG LAN;;ANBAZHAGAN BARANEEDHARAN;;GIBBONS PATRICK L,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2014-07-21),https://lens.org/012-299-768-157-350,Granted Patent,yes,12,2,12,12,0,G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F21/572;;G06F21/6218;;G06F11/1417;;G06F21/575;;G06F21/79;;G06F2221/2141;;G06F9/44505;;G06F21/44;;H04L9/0643;;H04L9/3242,H04L9/06;;G06F9/445;;G06F11/14;;G06F21/44;;G06F21/57;;G06F21/62;;G06F21/79;;H04L9/32,,0,0,,,,ACTIVE
136,EP,A1,EP 3228832 A1,098-472-344-369-874,2017-10-11,2017,EP 17164225 A,2017-03-31,US 201615091793 A,2016-04-06,FUEL ECOLOGY SYSTEM,"A fuel ecology system (100) includes a fuel ecology reservoir (120) having a reservoir volume, includes a moveable barrier (130) disposed within the reservoir volume, the movable barrier (130) defining a first volume (122) and a second volume (124) within the reservoir volume, a fuel inlet port (121) in fluid communication with the first volume (122), a fuel outlet port (123) in fluid communication with the first volume (122), and a vent port (125) in fluid communication with the second volume (124).
 
",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;BHADANGE SUSHANT S;;RIBAROV LUBOMIR A;;NORTHROP ERIC,,https://lens.org/098-472-344-369-874,Patent Application,yes,4,0,2,2,0,F01D21/00;;F02C7/232;;F05D2260/602;;B64D37/06;;F02C7/232;;F01D21/00;;F05D2260/602;;B64D37/06;;F02C3/04;;F02C7/22;;F02C9/36,F01D21/00;;F02C7/232,,0,0,,,,DISCONTINUED
137,US,A1,US 2017/0292459 A1,172-569-286-263-803,2017-10-12,2017,US 201615091793 A,2016-04-06,US 201615091793 A,2016-04-06,FUEL ECOLOGY SYSTEM,"A fuel ecology system includes a fuel ecology reservoir having a reservoir volume, includes a moveable barrier disposed within the reservoir volume, the movable barrier defining a first volume and a second volume within the reservoir volume, a fuel inlet port in fluid communication with the first volume, a fuel outlet port in fluid communication with the first volume, and a vent port in fluid communication with the second volume.",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;BHADANGE SUSHANT S;;RIBAROV LUBOMIR A;;NORTHROP ERIC,HAMILTON SUNDSTRAND CORPORATION (2016-03-30),https://lens.org/172-569-286-263-803,Patent Application,yes,10,1,2,2,0,F01D21/00;;F02C7/232;;F05D2260/602;;B64D37/06;;F02C7/232;;F01D21/00;;F05D2260/602;;B64D37/06;;F02C3/04;;F02C7/22;;F02C9/36,F02C9/36;;F02C3/04;;F02C7/22,,0,0,,,,DISCONTINUED
138,EP,A2,EP 0554904 A2,087-127-677-187-466,1993-08-11,1993,EP 93101855 A,1993-02-05,US 83160992 A,1992-02-05,"Organosilicon polymers, and dyes, exhibiting nonlinear optical response.","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",HERCULES INC,GIBBONS WAYNE MICHAEL;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SUN SHAO-TANG;;SHANNON PAUL JOSEPH,ALLIANT TECHSYSTEMS INC. (1998-03-25),https://lens.org/087-127-677-187-466,Patent Application,yes,0,2,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/06;;C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,,0,0,,,,EXPIRED
139,DE,D1,DE 69318996 D1,123-055-399-156-451,1998-07-16,1998,DE 69318996 T,1993-02-05,US 83160992 A,1992-02-05,"Organosilikonpolymere und Farbstoffe, die eine nichtlineare Reaktion zeigen","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",ALLIANT TECHSYSTEMS INC,GIBBONS WAYNE MICHAEL;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SUN SHAO-TANG;;SHANNON PAUL JOSEPH,,https://lens.org/123-055-399-156-451,Granted Patent,no,0,0,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/06;;C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,,0,0,,,,EXPIRED
140,DE,T2,DE 69318996 T2,194-193-879-665-256,1998-10-08,1998,DE 69318996 T,1993-02-05,US 83160992 A,1992-02-05,"Organosilikonpolymere und Farbstoffe, die eine nichtlineare Reaktion zeigen","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",ALLIANT TECHSYSTEMS INC,GIBBONS WAYNE MICHAEL;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SUN SHAO-TANG;;SHANNON PAUL JOSEPH,,https://lens.org/194-193-879-665-256,Granted Patent,no,0,1,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/06;;C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,,0,0,,,,EXPIRED
141,US,B2,US 10399690 B2,149-595-845-798-181,2019-09-03,2019,US 201615235522 A,2016-08-12,US 201615235522 A;;US 201414340275 A,2014-07-24,Ecology fuel return systems,"A shut-off valve system includes a tank having an inlet and an outlet with a flow path defined therebetween. A float within the tank occludes the tank outlet at a first fluid level under positive G forces and unoccludes the tank outlet at a second fluid level under positive G forces. A flow restricting orifice and/or a hydraulic fuse is downstream of float and tank outlet to restrict fluid communication between tank outlet and an ejector pump. A method for restricting flow in an ecology fuel return system includes recovering fuel from engine components, communicating the fuel to an inlet of a fuel tank, pumping the fuel from an outlet of fuel tank to an inlet of an engine when a float within tank unoccludes the outlet of the fuel tank, and restricting fluid flow from tank outlet to an ejector pump with a flow restricting orifice and/or a hydraulic fuse.",HAMILTON SUNDSTRAND CORP,RIBAROV LUBOMIR A;;GIBBONS KEVIN;;REUTER CHARLES E;;VEILLEUX JR LEO J;;CARPENTER RICHARD J,HAMILTON SUNDSTRAND CORPORATION (2016-08-11),https://lens.org/149-595-845-798-181,Granted Patent,yes,51,0,2,11,0,F05D2300/507;;Y10T137/0898;;Y10T137/7442;;Y10T137/7436;;Y10T137/0826;;Y10T137/7323;;F02C7/22;;Y02T50/60;;B64D37/02;;B64D37/005;;F02C7/236;;F05D2300/507;;Y10T137/0898;;Y10T137/7442;;Y10T137/7436;;Y10T137/0826;;Y10T137/7323;;F02C7/22;;Y02T50/60,F16K31/22;;B64D37/00;;B64D37/02;;F02C7/22;;F02C7/236,,1,0,,,"Extended European Search Report dated Dec. 14, 2015, issued on corresponding European Patent Application No. 15173904.2.",ACTIVE
142,US,A1,US 2018/0096154 A1,058-613-748-700-872,2018-04-05,2018,US 201715715020 A,2017-09-25,IN 201641033600 A,2016-09-30,MULTIPLE ROOTS OF TRUST TO VERIFY INTEGRITY,"An example computing system in accordance with an aspect of the present disclosure includes a first controller and a second controller. The first controller is to verify integrity of a first root of trust (ROT), and generate an integrity signal indicating the results. The second controller is to verify integrity of a second ROT, write the firmware image to the first controller, and verify integrity of the written firmware image.",HEWLETT PACKARD ENTPR DEV LP,SHIVANNA SUHAS;;GIBBONS PATRICK L;;DASARI SHIVA R;;LUCIANI JR LUIS E;;DEPEW KEVIN G,HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (2016-09-29),https://lens.org/058-613-748-700-872,Patent Application,yes,12,25,2,2,0,G06F21/572;;G06F21/575;;G06F2221/034;;G06F21/577;;G06F21/575;;G06F21/572,G06F21/57,,0,0,,,,ACTIVE
143,CA,A1,CA 2893177 A1,129-154-289-669-477,2015-11-30,2015,CA 2893177 A,2015-05-29,US 201462005291 P,2014-05-30,SELF-CLEANING SPRINKLER,"A self-cleaning sprinkler is disclosed, generally comprised of an upper and lower housing, which encase a nozzle and a diaphragm. The diaphragm moves in an upward and downward position relative to the nozzle, which allows water located within a chamber to be expelled out of an exit aperture of the nozzle. A needle is secured within the diaphragm to correspondingly move in an upward and downward position, such that once in a closed position, the needle will penetrate the exit aperture of the nozzle in order to clean any debris that may have accumulated therein. The diaphragm moves in from a closed position to an open position depending on the incoming water pressure.",RHIZA IRRIGATIONAL LTD,SMITH KENJI;;SMITH KIYOSHI;;BAILEY KEVIN;;BAILEY MATTHEW;;GIBBONS DUNCAN J;;KIM JOHN;;WILLIAMS PATRICK,,https://lens.org/129-154-289-669-477,Patent Application,no,0,0,4,4,0,B05B1/306;;B05B15/5225;;B05B15/622;;B05B1/265;;B05B1/306;;B05B15/622;;B05B15/5225;;B05B1/265,B05B15/02,,0,0,,,,ACTIVE
144,US,A1,US 2015/0343475 A1,194-379-667-830-585,2015-12-03,2015,US 201514723252 A,2015-05-27,US 201514723252 A;;US 201462005291 P,2014-05-30,SELF-CLEANING SPRINKLER,"A self-cleaning sprinkler is disclosed, generally comprised of an upper and lower housing, which encase a nozzle and a diaphragm. The diaphragm moves in an upward and downward position relative to the nozzle, which allows water located within a chamber to be expelled out of an exit aperture of the nozzle. A needle is secured within the diaphragm to correspondingly move in an upward and downward position, such that once in a closed position, the needle will penetrate the exit aperture of the nozzle in order to clean any debris that may have accumulated therein. The diaphragm moves in from a closed position to an open position depending on the incoming water pressure.",RHIZA IRRIGATION LTD,SMITH KENJI;;SMITH KIYOSHI;;BAILEY KEVIN;;BAILEY MATTHEW;;GIBBONS DUNCAN J;;KIM JOHN;;WILLIAMS PATRICK,RHIZA IRRIGATION LTD (2015-06-09),https://lens.org/194-379-667-830-585,Patent Application,yes,5,0,4,4,0,B05B1/306;;B05B15/5225;;B05B15/622;;B05B1/265;;B05B1/306;;B05B15/622;;B05B15/5225;;B05B1/265,B05B15/02,,0,0,,,,ACTIVE
145,EP,A3,EP 0554904 A3,136-424-294-746-888,1993-09-29,1993,EP 93101855 A,1993-02-05,US 83160992 A,1992-02-05,"ORGANOSILICON POLYMERS, AND DYES, EXHIBITING NONLINEAR OPTICAL RESPONSE","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",HERCULES INCORPORATED,"GIBBONS, WAYNE MICHAEL;;GRASSO, ROBERT PAUL;;O'BRIEN, MICHAEL KEVIN;;SUN, SHAO-TANG;;SHANNON, PAUL JOSEPH",ALLIANT TECHSYSTEMS INC. (1998-03-25),https://lens.org/136-424-294-746-888,Search Report,yes,7,0,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/06;;C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,,0,0,,,,EXPIRED
146,CA,C,CA 2893177 C,072-956-831-480-008,2021-05-25,2021,CA 2893177 A,2015-05-29,US 201462005291 P,2014-05-30,SELF-CLEANING SPRINKLER,"A self-cleaning sprinkler is disclosed, generally comprised of an upper and lower housing, which encase a nozzle and a diaphragm. The diaphragm moves in an upward and downward position relative to the nozzle, which allows water located within a chamber to be expelled out of an exit aperture of the nozzle. A needle is secured within the diaphragm to correspondingly move in an upward and downward position, such that once in a closed position, the needle will penetrate the exit aperture of the nozzle in order to clean any debris that may have accumulated therein. The diaphragm moves in from a closed position to an open position depending on the incoming water pressure.",RHIZA IRRIGATIONAL LTD,SMITH KENJI;;SMITH KIYOSHI;;BAILEY KEVIN;;BAILEY MATTHEW;;GIBBONS DUNCAN J;;KIM JOHN;;WILLIAMS PATRICK,,https://lens.org/072-956-831-480-008,Granted Patent,no,0,0,4,4,0,B05B1/306;;B05B15/5225;;B05B15/622;;B05B1/265;;B05B1/306;;B05B15/622;;B05B15/5225;;B05B1/265,B05B15/522,,0,0,,,,ACTIVE
147,US,A1,US 2016/0349766 A1,081-631-897-734-227,2016-12-01,2016,US 201615235522 A,2016-08-12,US 201615235522 A;;US 201414340275 A,2014-07-24,ECOLOGY FUEL RETURN SYSTEMS,"A shut-off valve system includes a tank having an inlet and an outlet with a flow path defined therebetween. A float within the tank occludes the tank outlet at a first fluid level under positive G forces and unoccludes the tank outlet at a second fluid level under positive G forces. A flow restricting orifice and/or a hydraulic fuse is downstream of float and tank outlet to restrict fluid communication between tank outlet and an ejector pump. A method for restricting flow in an ecology fuel return system includes recovering fuel from engine components, communicating the fuel to an inlet of a fuel tank, pumping the fuel from an outlet of fuel tank to an inlet of an engine when a float within tank unoccludes the outlet of the fuel tank, and restricting fluid flow from tank outlet to an ejector pump with a flow restricting orifice and/or a hydraulic fuse.",HAMILTON SUNDSTRAND CORP,RIBAROV LUBOMIR A;;GIBBONS KEVIN;;REUTER CHARLES E;;VEILLEUX JR LEO J;;CARPENTER RICHARD J,HAMILTON SUNDSTRAND CORPORATION (2016-08-11),https://lens.org/081-631-897-734-227,Patent Application,yes,17,4,2,11,0,F05D2300/507;;Y10T137/0898;;Y10T137/7442;;Y10T137/7436;;Y10T137/0826;;Y10T137/7323;;F02C7/22;;Y02T50/60;;B64D37/02;;B64D37/005;;F02C7/236;;F05D2300/507;;Y10T137/0898;;Y10T137/7442;;Y10T137/7436;;Y10T137/0826;;Y10T137/7323;;F02C7/22;;Y02T50/60,B64D37/00;;G05D7/06;;B64D37/02;;F02C7/22;;G05D9/12,,0,0,,,,ACTIVE
148,US,B2,US 10740468 B2,026-709-048-968-873,2020-08-11,2020,US 201715715020 A,2017-09-25,IN 201641033600 A,2016-09-30,Multiple roots of trust to verify integrity,"An example computing system in accordance with an aspect of the present disclosure includes a first controller and a second controller. The first controller is to verify integrity of a first root of trust (ROT), and generate an integrity signal indicating the results. The second controller is to verify integrity of a second ROT, write the firmware image to the first controller, and verify integrity of the written firmware image.",HEWLETT PACKARD ENTPR DEV LP,SHIVANNA SUHAS;;GIBBONS PATRICK L;;DASARI SHIVA R;;LUCIANI JR LUIS E;;DEPEW KEVIN G,HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (2016-09-29),https://lens.org/026-709-048-968-873,Granted Patent,yes,12,4,2,2,0,G06F21/572;;G06F21/575;;G06F2221/034;;G06F21/577;;G06F21/575;;G06F21/572,G06F21/57,,1,0,,,"Jill Caugherty, “System x Trusted Platform Assurance Establishes a Secure Foundation for Upper Layer Workloads”, IBM X86 Servers, available online at <https://web.archive.org/web/20150405004606/https://www304.ibm.com/connections/blogs/ibmx86/entry/trusted_platform_assurance?lang=en_us>, Sep. 26, 2014, pp. 1-2.",ACTIVE
149,US,B2,US 9616435 B2,115-578-374-361-232,2017-04-11,2017,US 201514723252 A,2015-05-27,US 201514723252 A;;US 201462005291 P,2014-05-30,Self-cleaning sprinkler,"A self-cleaning sprinkler is disclosed, generally comprised of an upper and lower housing, which encase a nozzle and a diaphragm. The diaphragm moves in an upward and downward position relative to the nozzle, which allows water located within a chamber to be expelled out of an exit aperture of the nozzle. A needle is secured within the diaphragm to correspondingly move in an upward and downward position, such that once in a closed position, the needle will penetrate the exit aperture of the nozzle in order to clean any debris that may have accumulated therein. The diaphragm moves in from a closed position to an open position depending on the incoming water pressure.",RHIZA IRRIGATION LTD,SMITH KENJI;;SMITH KIYOSHI;;BAILEY KEVIN;;BAILEY MATTHEW;;GIBBONS DUNCAN J;;KIM JOHN;;WILLIAMS PATRICK,RHIZA IRRIGATION LTD (2015-06-09),https://lens.org/115-578-374-361-232,Granted Patent,yes,8,11,4,4,0,B05B1/306;;B05B15/5225;;B05B15/622;;B05B1/265;;B05B1/306;;B05B15/622;;B05B15/5225;;B05B1/265,B05B1/00;;B05B1/26;;B05B1/30;;B05B15/02;;B05B15/06,,1,0,,,"1-JS Humidifiers plc. JS JetSpray Atomising Nozzle System Humidifier Manual—Installation, Commisioning, Operation and Maintenance. JS60/JS600/JS600DS/JS600M. Version 1.34 (UK). 70 pgs. May 30, 2014.",ACTIVE
150,US,A,US 5663308 A,096-214-630-279-71X,1997-09-02,1997,US 19290094 A,1994-02-07,US 19290094 A;;US 9638993 A;;US 83160992 A,1992-02-05,"Organosilicon polymers, and dyes, exhibiting nonlinear optical response","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxane, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",HERCULES INC,GIBBONS WAYNE MICHAEL;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SHANNON PAUL JOSEPH;;SUN SHAO-TANG,ALLIANT TECHSYSTEMS INC (1998-10-02);;ELSICON INC (1998-10-14),https://lens.org/096-214-630-279-71X,Granted Patent,yes,9,20,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C08G77/06;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,534/573;;534/795;;534/852;;534/856;;548/565;;560/142;;560/221;;564/441;;252/299.01;;252/299.66;;252/299.68,1,0,,,"Kastyukov et al. Chemical Abstracts, 83: 61596 (1975).",EXPIRED
151,EP,B1,EP 0554904 B1,041-703-697-999-756,1998-06-10,1998,EP 93101855 A,1993-02-05,US 83160992 A,1992-02-05,"Organosilicon polymers, and dyes, exhibiting nonlinear optical response","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",ALLIANT TECHSYSTEMS INC,GIBBONS WAYNE MICHAEL;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SUN SHAO-TANG;;SHANNON PAUL JOSEPH,ALLIANT TECHSYSTEMS INC. (1998-03-25),https://lens.org/041-703-697-999-756,Granted Patent,yes,7,1,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/06;;C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,,0,0,,,,EXPIRED
152,AT,T1,AT E167309 T1,160-435-286-164-689,1998-06-15,1998,AT 93101855 T,1993-02-05,US 83160992 A,1992-02-05,"ORGANOSILIKONPOLYMERE UND FARBSTOFFE, DIE EINE NICHTLINEARE REAKTION ZEIGEN","Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon-carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",ALLIANT TECHSYSTEMS INC,GIBBONS WAYNE MICHAEL;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SUN SHAO-TANG;;SHANNON PAUL JOSEPH,,https://lens.org/160-435-286-164-689,Granted Patent,no,0,0,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/06;;C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,,0,0,,,,DISCONTINUED
153,US,A,US 5714304 A,153-557-727-998-921,1998-02-03,1998,US 45841295 A,1995-06-02,US 45841295 A;;US 19290094 A;;US 9638993 A;;US 83160992 A,1992-02-05,Nonlinear optical media of organosilicon crosslinked polymer,"Organosilicon polymers, including crosslinked polymers and crosslinkable prepolymers, of cyclic polysiloxanes, organic dyes, and, optionally, polyenes. The dyes include those with delocalized Pi electron systems linking electron donor groups and electron acceptor groups, and with at least two carbon--carbon double bond-containing pendant groups attached to at least two different sites from among the indicated delocalized Pi electron systems, donor groups, and acceptor groups.",HERCULES INC,GIBBONS WAYNE M;;GRASSO ROBERT PAUL;;O'BRIEN MICHAEL KEVIN;;SHANNON PAUL JOSEPH;;SUN SHAO-TANG,ALLIANT TECHSYSTEMS INC (1998-10-02);;ELSICON INC (1998-10-14),https://lens.org/153-557-727-998-921,Granted Patent,yes,65,56,12,12,0,C08G77/50;;C08L83/14;;C09B23/148;;C09B29/0003;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/3617;;G02F1/3619;;Y10T428/31663;;C09K2323/023;;Y10T428/31663;;G02F1/3619;;C09B29/0003;;G02F1/3617;;C09B51/00;;C09B31/043;;C08G77/50;;C09B69/10;;C09B23/148;;C08L83/14;;C09K2323/023,C08G77/38;;C08G77/50;;C08L83/14;;C09B23/14;;C09B29/01;;C08G77/06;;C09B31/043;;C09B51/00;;C09B69/10;;G02F1/35;;G02F1/355;;G02F1/361;;G03F7/075,430/270.11;;430/270.14;;385/130;;526/312;;350/96.34;;350/311;;252/582;;252/583;;252/587,13,7,005-418-710-937-229;;027-223-944-146-719;;053-682-345-206-586;;045-719-678-171-63X;;000-669-243-337-703;;109-036-889-451-700;;122-365-228-819-908,10.1021/ma00198a003;;10.1063/1.102853;;10.1063/1.348645;;10.1063/1.344115;;10.1080/00268949008037225;;10.1002/pat.1990.220010208;;10.1016/s0040-4039(01)90997-9,"Abstract, JP 60031565 A2, 18 Feb. 1985.;;Abstract, Kostyukov et al, Synthesis of allyl derivatives of azo dyes and their capacity for copolymerization with vinyl monomers , 1974.;;Risse, et al, Di and Tetrafunctional Initiators for the Living Pin Opening Olefin Metathesis Polymerization of Strained Cyclic Olefins, Macromolecules , 1989, vol. 22, No. 8.;;Reck et al, Crosslinked Epoxy Polymers with Large and Stable Non Linear Optical Susceptibilities SPIE vol. 1147, Non Linear Optical Properties of Organic Materials II , 1989 (pp. 74 83.;;Jungbauer et al, Highly Efficient and Stable Nonlinear Optical Polymers Via Chemical Crosslinking Under Electric Field Appl. Phys. Lett. , vol. 56, No. 26, 25 Jun. 1990 (pp. 2610 2612).;;Hubbard et al, Poled Polymeric Nonlinear Optical Materials. Ehanced Second Harmonic Generation Stability of Crosslinkable Matrix/Chromophere Essemblies, Chemistry of Materials , vol. 1, No. 2, Mar./Arp. 1980 (pp. 167 169).;;Teraoka et al, Stability of Nonlinear Optical Characteristics and Dielectric Relaxations of Poled Amorphous Polymers with Main Chain Chromophores, J. Appl. Phys. 64(4), 15 Feb. 1991 (pp. 2568 2576).;;Eich et al, Novel Second Order Nonlinear Optical Polymers Via Chemical Cross linking induced Vitrification under Electric Field J. Appl. Phys. 66(7), 1 Oct. 1989 (pp. 3241 3243).;;Dai et al, Rational Design and Construction of Polymers with Large Second Order Optical Nonlinearities. Synthetic Strategies for Enhanced Chromophore Number Densities and Frequency Doubling Temporal Stabilities Mol. Cryst. Liq. Cryst. , 1990, vol. 189 (pp. 93 106).;;Eich, et al Poled Amorphous Polyumers for Second Order Nonlinear Optics , Polymers for Advanced Technologies , 1990, vol. 1 (pp. 189 198).;;Kasahara et al. Chemical Abstracts , vol. 106, 1987, 156217u.;;Strantzalis et al., Polymer Bulletin , Synthesis of 4 Chloro 3 Nitrostyrene , vol. 15, Springer Verlag, 1986, pp. 431 438.;;Danishefsky et al., Tetrahedron Letters , A Rapid Route to Ergot Precursors Via Aza Claisen Rearrangement , vol. 25, No. 30, Pergamon Press, Great Britain, pp. 3159 3162.",EXPIRED
154,US,A1,US 2016/0025015 A1,063-078-935-045-278,2016-01-28,2016,US 201414340275 A,2014-07-24,US 201414340275 A,2014-07-24,ECOLOGY FUEL RETURN SYSTEMS,"A shut-off valve includes a float and a negative G control component. The float is configured to occlude a tank outlet at a first fluid level and 1 G and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between a tank outlet and an ejector pump during negative G events. An ecology fuel return system includes a tank, an ejector pump, a float, and a negative G control component, as described above. The tank has an inlet and an outlet. The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;FLOW ETHAN,HAMILTON SUNDSTRAND CORPORATION (2014-07-21),https://lens.org/063-078-935-045-278,Patent Application,yes,38,2,9,11,0,F02C7/232;;F02C7/232;;F01D17/141;;F01D17/141;;F01D17/145;;F01D17/145;;F02C9/26;;F02C9/263;;F02C9/263;;F05D2220/323;;F05D2260/601;;F05D2300/507;;F05D2300/507;;F16K31/22;;Y10T137/0826;;Y10T137/0826;;Y10T137/0898;;Y10T137/0898;;Y10T137/7323;;Y10T137/7323;;Y10T137/7436;;Y10T137/7436;;Y10T137/7442;;Y10T137/7442,F02C9/26;;F16K31/18,,0,0,,,,ACTIVE
155,EP,A1,EP 2977846 A1,181-926-052-800-468,2016-01-27,2016,EP 15173904 A,2015-06-25,US 201414340275 A,2014-07-24,FUEL RETURN SYSTEMS,"A shut-off valve (105; 205; 405; 505) includes a float (106; 206; 306; 406; 506) and a negative G control component (108; 208; 308; 408; 508). The float is configured to occlude a tank outlet (114; 214; 314; 414; 514) at a first fluid level and 1 G (F G ) and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between the tank outlet and an ejector pump (104; 504) during negative G events. An ecology fuel return system (100; 200; 300; 400; 500) includes a tank (102; 202; 302; 402; 502), an ejector pump (104; 504), a float (106; 206; 306; 406; 506), and a negative G control component (108; 208; 308; 408; 508), as described above. The tank has an inlet (112) and an outlet (114; 214; 314; 414; 514). The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.
",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX LEO J JR;;FLOW ETHAN,,https://lens.org/181-926-052-800-468,Patent Application,yes,6,10,9,11,0,F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F02C7/232;;F02C9/26;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;F02C7/232;;F05D2220/323;;F05D2260/601;;F16K31/22,G05D11/13;;F01D17/14;;F02C7/232;;F02C9/26;;F16K31/24,,0,0,,,,ACTIVE
156,EP,A1,EP 3540554 A1,132-346-590-277-493,2019-09-18,2019,EP 19172144 A,2015-06-25,US 201414340275 A;;EP 15173904 A,2014-07-24,ECOLOGY FUEL RETURN SYSTEMS,"A shut-off valve (105; 205; 405; 505) includes a float (106; 206; 306; 406; 506) and a negative G control component (108; 208; 308; 408; 508). The float is configured to occlude a tank outlet (114; 214; 314; 414; 514) at a first fluid level and 1 G (F G ) and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between the tank outlet and an ejector pump (104; 504) during negative G events. An ecology fuel return system (100; 200; 300; 400; 500) includes a tank (102; 202; 302; 402; 502), an ejector pump (104; 504), a float (106; 206; 306; 406; 506), and a negative G control component (108; 208; 308; 408; 508), as described above. The tank has an inlet (112) and an outlet (114; 214; 314; 414; 514). The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.
",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX LEO J JR;;FLOW ETHAN,,https://lens.org/132-346-590-277-493,Patent Application,yes,6,0,9,11,0,F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F02C7/232;;F02C9/26;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;F02C7/232;;F05D2220/323;;F05D2260/601;;F16K31/22,G05D11/13;;F01D17/14;;F02C7/232;;F02C9/26;;F16K31/22;;F16K31/24,,0,0,,,,ACTIVE
157,EP,B1,EP 2977846 B1,115-817-980-815-72X,2019-05-08,2019,EP 15173904 A,2015-06-25,US 201414340275 A,2014-07-24,FUEL RETURN SYSTEMS,,HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX LEO J JR;;FLOW ETHAN,,https://lens.org/115-817-980-815-72X,Granted Patent,yes,6,0,9,11,0,F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F02C7/232;;F02C9/26;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;F02C7/232;;F05D2220/323;;F05D2260/601;;F16K31/22,G05D11/13;;F01D17/14;;F02C7/232;;F02C9/26;;F16K31/24,,0,0,,,,ACTIVE
158,US,B2,US 10082084 B2,053-164-816-955-795,2018-09-25,2018,US 201715460681 A,2017-03-16,US 201715460681 A;;US 201414340275 A,2014-07-24,Ecology fuel return systems,"A shut-off valve includes a float and a negative G control component. The float is configured to occlude a tank outlet at a first fluid level and 1 G and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between a tank outlet and an ejector pump during negative G events. An ecology fuel return system includes a tank, an ejector pump, a float, and a negative G control component, as described above. The tank has an inlet and an outlet. The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;FLOW ETHAN,,https://lens.org/053-164-816-955-795,Granted Patent,yes,36,0,9,11,0,F02C7/232;;F02C7/232;;F01D17/141;;F01D17/141;;F01D17/145;;F01D17/145;;F02C9/26;;F02C9/263;;F02C9/263;;F05D2220/323;;F05D2260/601;;F05D2300/507;;F05D2300/507;;F16K31/22;;Y10T137/0826;;Y10T137/0826;;Y10T137/0898;;Y10T137/0898;;Y10T137/7323;;Y10T137/7323;;Y10T137/7436;;Y10T137/7436;;Y10T137/7442;;Y10T137/7442,F02C7/22;;F02C7/232;;F16K31/22,,1,0,,,"Extended European Search Report dated Dec. 14, 2015, issued on corresponding European Patent Application No. 15173904.2.",ACTIVE
159,EP,B1,EP 3540554 B1,163-774-457-627-314,2020-10-28,2020,EP 19172144 A,2015-06-25,US 201414340275 A;;EP 15173904 A,2014-07-24,FUEL RETURN SYSTEM,,HAMILTON SUNDSTRAND CORP,RIBAROV LUBOMIR A;;VEILLEUX LEO J JR;;FLOW ETHAN;;CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E,,https://lens.org/163-774-457-627-314,Granted Patent,yes,6,0,9,11,0,F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F02C7/232;;F02C9/26;;Y10T137/0826;;Y10T137/7323;;Y10T137/7442;;Y10T137/7436;;Y10T137/0898;;F01D17/141;;F01D17/145;;F02C9/263;;F05D2300/507;;F02C7/232;;F05D2220/323;;F05D2260/601;;F16K31/22,G05D11/13;;F01D17/14;;F02C7/232;;F02C9/26;;F16K31/22;;F16K31/24,,0,0,,,,ACTIVE
160,US,A1,US 2019/0024588 A1,186-441-997-280-883,2019-01-24,2019,US 201816139686 A,2018-09-24,US 201816139686 A;;US 201715460681 A;;US 201414340275 A,2014-07-24,ECOLOGY FUEL RETURN SYSTEMS,"A shut-off valve includes a float and a negative G control component. The float is configured to occlude a tank outlet at a first fluid level and 1 G and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between a tank outlet and an ejector pump during negative G events. An ecology fuel return system includes a tank, an ejector pump, a float, and a negative G control component, as described above. The tank has an inlet and an outlet. The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;FLOW ETHAN,,https://lens.org/186-441-997-280-883,Patent Application,yes,13,0,9,11,0,F02C7/232;;F02C7/232;;F01D17/141;;F01D17/141;;F01D17/145;;F01D17/145;;F02C9/26;;F02C9/263;;F02C9/263;;F05D2220/323;;F05D2260/601;;F05D2300/507;;F05D2300/507;;F16K31/22;;Y10T137/0826;;Y10T137/0826;;Y10T137/0898;;Y10T137/0898;;Y10T137/7323;;Y10T137/7323;;Y10T137/7436;;Y10T137/7436;;Y10T137/7442;;Y10T137/7442,F02C7/232;;F01D17/14;;F02C9/26,,0,0,,,,DISCONTINUED
161,US,A1,US 2017/0191422 A1,183-696-123-458-359,2017-07-06,2017,US 201715460681 A,2017-03-16,US 201715460681 A;;US 201414340275 A,2014-07-24,ECOLOGY FUEL RETURN SYSTEMS,"A shut-off valve includes a float and a negative G control component. The float is configured to occlude a tank outlet at a first fluid level and 1 G and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between a tank outlet and an ejector pump during negative G events. An ecology fuel return system includes a tank, an ejector pump, a float, and a negative G control component, as described above. The tank has an inlet and an outlet. The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;FLOW ETHAN,,https://lens.org/183-696-123-458-359,Patent Application,yes,24,0,9,11,0,F02C7/232;;F02C7/232;;F01D17/141;;F01D17/141;;F01D17/145;;F01D17/145;;F02C9/26;;F02C9/263;;F02C9/263;;F05D2220/323;;F05D2260/601;;F05D2300/507;;F05D2300/507;;F16K31/22;;Y10T137/0826;;Y10T137/0826;;Y10T137/0898;;Y10T137/0898;;Y10T137/7323;;Y10T137/7323;;Y10T137/7436;;Y10T137/7436;;Y10T137/7442;;Y10T137/7442,F02C7/232,,0,0,,,,ACTIVE
162,US,B2,US 9624835 B2,085-311-174-428-27X,2017-04-18,2017,US 201414340275 A,2014-07-24,US 201414340275 A,2014-07-24,Ecology fuel return systems,"A shut-off valve includes a float and a negative G control component. The float is configured to occlude a tank outlet at a first fluid level and 1 G and unocclude the tank outlet at a second fluid level and 1 G. The negative G control component is operatively connected to the float to limit fluid, e.g. liquid or gas, communication between a tank outlet and an ejector pump during negative G events. An ecology fuel return system includes a tank, an ejector pump, a float, and a negative G control component, as described above. The tank has an inlet and an outlet. The inlet is configured to be in fluid communication with components of an engine. The ejector pump is in fluid communication with the tank outlet and is configured to pump fuel from the tank to a fuel pump inlet of an engine.",HAMILTON SUNDSTRAND CORP,CARPENTER RICHARD J;;GIBBONS KEVIN;;REUTER CHARLES E;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;FLOW ETHAN,HAMILTON SUNDSTRAND CORPORATION (2014-07-21),https://lens.org/085-311-174-428-27X,Granted Patent,yes,52,4,9,11,0,F02C7/232;;F02C7/232;;F01D17/141;;F01D17/141;;F01D17/145;;F01D17/145;;F02C9/26;;F02C9/263;;F02C9/263;;F05D2220/323;;F05D2260/601;;F05D2300/507;;F05D2300/507;;F16K31/22;;Y10T137/0826;;Y10T137/0826;;Y10T137/0898;;Y10T137/0898;;Y10T137/7323;;Y10T137/7323;;Y10T137/7436;;Y10T137/7436;;Y10T137/7442;;Y10T137/7442,B64D37/28;;B64D37/32;;F01D17/14;;F02C7/232;;F02C9/26;;F16K31/08;;F16K31/22,,1,0,,,"Extended European Search Report dated Dec. 14, 2015, issued on corresponding European Patent Application No. 15173904.2.",ACTIVE
163,EP,A1,EP 3144507 A1,038-617-259-059-570,2017-03-22,2017,EP 16189655 A,2016-09-20,US 201514860118 A,2015-09-21,"INTEGRATED BYPASS VALVE WITH PRESSURE, POSITION, AND FLOWRATE FEEDBACK CAPABILITIES","A bypass valve (120) includes a housing (100) for directing fluid flow through the bypass valve (120). A disc (110) is positioned within the flow path having an inner perimeter (130) and an outer perimeter (132). The bypass valve (120) further includes at least one strain gauge disposed on the disc (110). One of the inner and outer perimeters of the disc (110) is fixed to the bypass valve housing (100) and one of the inner and outer perimeter of the disc (110) is free to deflect from the bypass valve housing (100) in response to fluid flow through the bypass valve (120) such that a measurement of deflection of the disc (110) induces strain on the strain gauge.
",HAMILTON SUNDSTRAND CORP,RIBAROV LUBOMIR A;;CARPENTER RICHARD J;;ROURKE RUSSEL P;;GIBBONS KEVIN;;LUKER WILLLIAM;;RUSSO CHARLES J;;SCHMIDT SAMUEL,,https://lens.org/038-617-259-059-570,Patent Application,yes,3,1,3,3,0,F02C7/232;;F16K15/148;;F16K37/0041;;F16K15/148;;F02C7/232;;F16K37/0041;;F16K1/18;;F16K1/36;;F16K1/42;;F16K25/005;;G01B7/18,F02C7/232;;F16K15/14;;G01F1/28,,0,0,,,,ACTIVE
164,US,A1,US 2024/0068401 A1,060-653-864-102-982,2024-02-29,2024,US 202217896773 A,2022-08-26,US 202217896773 A,2022-08-26,VARIABLE RESTRICTION OF FUEL NOZZLE WITH AN AUXILIARY CIRCUIT,"A fuel injector for a turbine engine includes a fuel scheduling valve configured for regulation of fuel flow from a fuel inlet, in response to fuel pressure received at the fuel inlet. Primary, secondary and auxiliary fuel circuits receive fuel from the scheduling valve, and an electrically-controlled valve is provided in fluid communication with the auxiliary circuit, which electrically-controlled valve is adapted and configured to actively control fuel through the auxiliary circuit in response to a control signal.",HAMILTON SUNDSTRAND CORP,LOKHANDWALLA MURTUZA;;WILLIAMS BRANDON P;;HAUGSJAAHABINK TODD;;REUTER CHARLES E;;RYON JASON A;;GIBBONS KEVIN;;PETERS JESSE C,HAMILTON SUNDSTRAND CORPORATION (2022-08-23),https://lens.org/060-653-864-102-982,Patent Application,yes,24,0,1,3,0,F02C7/232;;F02C7/222;;F02C7/228;;F02C9/263;;F23R3/346;;F02C9/34,F02C7/22;;F02C7/232,,0,0,,,,PENDING
165,EP,B1,EP 3144507 B1,042-822-405-374-075,2020-08-26,2020,EP 16189655 A,2016-09-20,US 201514860118 A,2015-09-21,"INTEGRATED BYPASS VALVE WITH PRESSURE, POSITION, AND FLOWRATE FEEDBACK CAPABILITIES",,HAMILTON SUNDSTRAND CORP,RIBAROV LUBOMIR A;;CARPENTER RICHARD J;;ROURKE RUSSEL P;;GIBBONS KEVIN;;LUKER WILLLIAM;;RUSSO CHARLES J;;SCHMIDT SAMUEL,,https://lens.org/042-822-405-374-075,Granted Patent,yes,3,0,3,3,0,F02C7/232;;F16K15/148;;F16K37/0041;;F16K15/148;;F02C7/232;;F16K37/0041;;F16K1/18;;F16K1/36;;F16K1/42;;F16K25/005;;G01B7/18,F02C7/232;;F16K15/14;;G01F1/28,,0,0,,,,ACTIVE
166,GB,B,GB 2547314 B,196-697-771-759-260,2021-09-29,2021,GB 201621161 A,2016-12-13,US 201514969743 A,2015-12-15,Ecology system ejector pump shutoff valve,,HAMILTON SUNDSTRAND CORP,ERICK RAMOS;;KEVIN GIBBONS;;LUBOMIR A RIBAROV;;LEO J VEILLEUX;;JAMES S ELDER;;RICHARD J CARPENTER;;SUSHANT S BHADANGE,,https://lens.org/196-697-771-759-260,Granted Patent,no,7,0,5,5,0,B64C3/34;;B64D27/12;;B64D37/04;;F02C7/232;;F02C7/236;;F02C9/36;;Y02T50/60;;F02C7/22;;F02C7/232;;F02C7/236;;Y02T50/60;;B64C3/34;;B64D27/12;;B64D37/04;;F02C3/04;;F02C7/232;;F02C7/236;;F02C9/36,F02C7/232;;F02C7/22;;F02C7/236,,0,0,,,,ACTIVE
167,US,A1,US 2017/0082205 A1,027-740-258-396-254,2017-03-23,2017,US 201514860118 A,2015-09-21,US 201514860118 A,2015-09-21,"INTEGRATED BYPASS VALVE WITH PRESSURE, POSITION, AND FLOWRATE FEEDBACK CAPABILITIES",A bypass valve includes a housing for directing fluid flow through the bypass valve. A disc is positioned within the flow path having an inner perimeter and an outer perimeter. The bypass valve further includes at least one strain gauge disposed on the disc. One of the inner and outer perimeters of the disc is fixed to the bypass valve housing and one of the inner and outer perimeter of the disc is free to deflect from the bypass valve housing in response to fluid flow through the bypass valve such that a measurement of deflection of the disc induces strain on the strain gauge.,HAMILTON SUNDSTRAND CORP,RIBAROV LUBOMIR A;;CARPENTER RICHARD J;;ROURKE JR RUSSELL P;;GIBBONS KEVIN;;LUKER WILLIAM;;RUSSO CHARLES J;;SCHMIDT SAMUEL,HAMILTON SUNDSTRAND CORPORATION (2015-09-12),https://lens.org/027-740-258-396-254,Patent Application,yes,3,0,3,3,0,F02C7/232;;F16K15/148;;F16K37/0041;;F16K15/148;;F02C7/232;;F16K37/0041;;F16K1/18;;F16K1/36;;F16K1/42;;F16K25/005;;G01B7/18,F16K1/18;;F16K1/36;;F16K1/42;;F16K25/00;;G01B7/16,,0,0,,,,DISCONTINUED
168,US,B2,US 10094298 B2,055-163-623-096-793,2018-10-09,2018,US 201514969743 A,2015-12-15,US 201514969743 A,2015-12-15,Ecology system ejector pump shutoff valve,"An ecology system includes an ecology tank, a check valve, a shutoff valve, and an ejector pump. The check valve is fluidly connected to the ecology tank and is configured to allow flow from the ecology tank. The shutoff valve is fluidly connected to the check valve, and the ejector pump is fluidly connected to the shutoff valve. The ejector pump is configured to draw fuel from the ecology tank when the shutoff valve is in an open configuration.",HAMILTON SUNDSTRAND CORP;;HAMILTON SUNSTRAND CORP,RAMOS ERICK;;GIBBONS KEVIN;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;ELDER JAMES S;;CARPENTER RICHARD J;;BHADANGE SUSHANT S,HAMILTON SUNDSTRAND CORPORATION (2015-12-09),https://lens.org/055-163-623-096-793,Granted Patent,yes,22,1,5,5,0,B64C3/34;;B64D27/12;;B64D37/04;;F02C7/232;;F02C7/236;;F02C9/36;;Y02T50/60;;F02C7/22;;F02C7/232;;F02C7/236;;Y02T50/60;;B64C3/34;;B64D27/12;;B64D37/04;;F02C3/04;;F02C7/232;;F02C7/236;;F02C9/36,B64D37/02;;B64C3/34;;B64D27/12;;B64D37/04;;F02C3/04;;F02C7/232;;F02C7/236;;F02C9/36,,2,0,,,"UTC U.S. Appl. No. 14/340,275, entitled “Ecology Fuel Return Systems”, by Carpenter R.J., filed Jul. 24, 2014.;;Extended British Search Report, for British Patent Application No. 1621161.7, dated Jun. 12, 2017, 6 pages.",ACTIVE
169,GB,A,GB 2547314 A,023-628-923-430-200,2017-08-16,2017,GB 201621161 A,2016-12-13,US 201514969743 A,2015-12-15,Ecology system ejector pump shutoff valve,"An ecology system includes an ecology tank 36, a check valve 40, a shutoff valve 42, and an ejector pump 44. The check valve is connected to the ecology tank. The shutoff valve is connected to the check valve, and the ejector pump is connected to the shutoff valve. The ejector pump draws fuel from the ecology tank when the shutoff valve is open. A fuel system comprising a first 46a and second 46b pump for pumping fuel from a fuel tank 30 to a gas turbine engine 18 having an ecology system with an ecology tank connected to the gas turbine engine. An aircraft comprising a wing 14, a gas turbine engine 18 connected to the wing wherein the engine comprises a fuel nozzle. An ecology system includes an ecology tank fluidly connected to the fuel nozzle 28 and to an overboard vent 38. The shutoff valve may comprise a spool 50 located in a cavity and biased into a closed configuration. The shutoff valve may further comprise a first pressurised pilot control 60A and a second pressurized pilot control 60B for movement of the spool.",HAMILTON SUNDSTRAND CORP,ERICK RAMOS;;KEVIN GIBBONS;;LUBOMIR A RIBAROV;;LEO J VEILLEUX JR;;JAMES S ELDER;;RICHARD J CARPENTER;;SUSHANT S BHADANGE,,https://lens.org/023-628-923-430-200,Patent Application,no,7,0,5,5,0,B64C3/34;;B64D27/12;;B64D37/04;;F02C7/232;;F02C7/236;;F02C9/36;;Y02T50/60;;F02C7/22;;F02C7/232;;F02C7/236;;Y02T50/60;;B64C3/34;;B64D27/12;;B64D37/04;;F02C3/04;;F02C7/232;;F02C7/236;;F02C9/36,F02C7/22;;F02C7/232;;F02C7/236,,0,0,,,,ACTIVE
170,US,A1,US 2017/0167392 A1,172-325-601-218-260,2017-06-15,2017,US 201514969743 A,2015-12-15,US 201514969743 A,2015-12-15,ECOLOGY SYSTEM EJECTOR PUMP SHUTOFF VALVE,"An ecology system includes an ecology tank, a check valve, a shutoff valve, and an ejector pump. The check valve is fluidly connected to the ecology tank and is configured to allow flow from the ecology tank. The shutoff valve is fluidly connected to the check valve, and the ejector pump is fluidly connected to the shutoff valve. The ejector pump is configured to draw fuel from the ecology tank when the shutoff valve is in an open configuration.",HAMILTON SUNDSTRAND CORP,RAMOS ERICK;;GIBBONS KEVIN;;RIBAROV LUBOMIR A;;VEILLEUX JR LEO J;;ELDER JAMES S;;CARPENTER RICHARD J;;BHADANGE SUSHANT S,HAMILTON SUNDSTRAND CORPORATION (2015-12-09),https://lens.org/172-325-601-218-260,Patent Application,yes,0,2,5,5,0,B64C3/34;;B64D27/12;;B64D37/04;;F02C7/232;;F02C7/236;;F02C9/36;;Y02T50/60;;F02C7/22;;F02C7/232;;F02C7/236;;Y02T50/60;;B64C3/34;;B64D27/12;;B64D37/04;;F02C3/04;;F02C7/232;;F02C7/236;;F02C9/36,F02C9/36;;B64C3/34;;B64D27/12;;B64D37/04;;F02C3/04;;F02C7/232;;F02C7/236,,0,0,,,,ACTIVE
171,US,B1,US 9856566 B1,165-470-745-788-948,2018-01-02,2018,US 201514810504 A,2015-07-28,US 201514810504 A;;US 201562143355 P,2015-04-06,Methods and apparatus for monitoring a sacrificial anode,"A monitored anode apparatus is provided. The apparatus includes a metal body having an exterior and a core, and a plurality of electrically conductive probes passing through the exterior and disposed at respective depths within the core. At least one of the plurality of conductive probes is disposed at a first depth, and at least one of the plurality of conductive probes is disposed at a second depth greater than the first depth. A bonding conductor is in electrical communication with the body and configured to create electrical continuity between the body and a protected structure. The metal body is configured as a galvanic anode, and at least one of the plurality of probes is configured to break electrical conductivity with the body upon galvanic consumption thereof.",US AIR FORCE,BURNS ANDREW MICHAEL;;GUTGSELL MATTHEW JAMES;;LEE MICHAEL DAVID;;LEPLEY THOMAS ANTHONY;;SCHROCK ZACHARY PAUL;;ZILLI TONY HARRISON;;GIBBONS KEVIN A,GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (2015-03-06),https://lens.org/165-470-745-788-948,Granted Patent,yes,7,0,1,1,0,C23F13/22;;C23F13/22;;C23F13/04;;C23F2213/10,C23F13/02;;C23F13/04;;C23F13/22,,0,0,,,,ACTIVE
172,WO,A1,WO 2020/176093 A1,077-220-318-475-697,2020-09-03,2020,US 2019/0019963 W,2019-02-28,US 2019/0019963 W,2019-02-28,SIGNED CHANGE REQUESTS TO REMOTELY CONFIGURE SETTINGS,"An example computing device includes a memory accessible at startup of the computing device, a buffer, and a set of instructions. The memory stores a configuration setting that is configurable by the application of a change request. The memory also stores a first public key and a second public key. The buffer stores change requests submitted by a remote entity, including a first change request to make a first setting change and a second change request to make a second setting change. The first change request is signed by a first private key corresponding to the first public key, and the second change request is signed by a second private key corresponding to the second public key. The set of instructions retrieves a change request from the buffer, determines whether the change request is authenticated by a public key, and if authenticated, applies the change request.",HEWLETT PACKARD DEVELOPMENT CO,BRAMLEY JR RICHARD ALDEN;;BARLOW DALLAS M;;GIBBONS PATRICK LEE;;BALDWIN ADRIAN JOHN;;RICHARDS TEVIN JAUPAUL;;CRAIG ROBERT STEPHEN;;ALI VALIUDDIN;;JEANSONNE JEFFREY KEVIN,,https://lens.org/077-220-318-475-697,Patent Application,yes,4,0,3,3,0,G06F12/1408;;G06F2212/1052;;G06F9/44505;;G06F21/44;;H04L9/14,G06F12/14,,0,0,,,,PENDING
173,US,A1,US 2021/0382979 A1,145-830-391-588-383,2021-12-09,2021,US 201917054197 A,2019-02-28,US 2019/0019963 W,2019-02-28,SIGNED CHANGE REQUESTS TO REMOTELY CONFIGURE SETTINGS,"An example computing device includes a memory accessible at startup of the computing device, a buffer, and a set of instructions. The memory stores a configuration setting that is configurable by the application of a change request. The memory also stores a first public key and a second public key. The buffer stores change requests submitted by a remote entity, including a first change request to make a first setting change and a second change request to make a second setting change. The first change request is signed by a first private key corresponding to the first public key, and the second change request is signed by a second private key corresponding to the second public key. The set of instructions retrieves a change request from the buffer, determines whether the change request is authenticated by a public key, and if authenticated, applies the change request.",HEWLETT PACKARD DEVELOPMENT CO,BRAMLEY JR RICHARD ALDEN;;BARLOW DALLAS M;;GIBBONS PATRICK LEE;;BALDWIN ADRIAN JOHN;;RICHARDS TEVIN JAUPAUL;;CRAIG ROBERT STEPHEN;;ALI VALIUDDIN;;JEANSONNE JEFFREY KEVIN,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2019-02-26),https://lens.org/145-830-391-588-383,Patent Application,yes,2,0,3,3,0,G06F12/1408;;G06F2212/1052;;G06F9/44505;;G06F21/44;;H04L9/14,G06F21/44;;G06F9/445;;H04L9/14,,0,0,,,,ACTIVE
174,US,B2,US 11657138 B2,146-536-897-171-998,2023-05-23,2023,US 201917054197 A,2019-02-28,US 2019/0019963 W,2019-02-28,Signed change requests to remotely configure settings,"An example computing device includes a memory accessible at startup of the computing device, a buffer, and a set of instructions. The memory stores a configuration setting that is configurable by the application of a change request. The memory also stores a first public key and a second public key. The buffer stores change requests submitted by a remote entity, including a first change request to make a first setting change and a second change request to make a second setting change. The first change request is signed by a first private key corresponding to the first public key, and the second change request is signed by a second private key corresponding to the second public key. The set of instructions retrieves a change request from the buffer, determines whether the change request is authenticated by a public key, and if authenticated, applies the change request.",HEWLETT PACKARD DEVELOPMENT CO,BRAMLEY JR RICHARD ALDEN;;BARLOW DALLAS M;;GIBBONS PATRICK LEE;;BALDWIN ADRIAN JOHN;;RICHARDS TEVIN JAUPAUL;;CRAIG ROBERT STEPHEN;;ALI VALIUDDIN;;JEANSONNE JEFFREY KEVIN,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2019-02-26),https://lens.org/146-536-897-171-998,Granted Patent,yes,16,0,3,3,0,G06F12/1408;;G06F2212/1052;;G06F9/44505;;G06F21/44;;H04L9/14,G06F21/00;;G06F9/445;;G06F21/44;;H04L9/14,,1,0,,,Microsoft Surface Enterprise Management Mode (https://docs.microsoft.com/en-us/surface/surface-enterprise-management-mode).,ACTIVE
175,WO,A1,WO 2021/248141 A1,016-377-042-454-125,2021-12-09,2021,US 2021/0036264 W,2021-06-07,US 202063035661 P,2020-06-05,NUTRIENT MEDIA FOR THE PRODUCTION OF SLAUGHTER-FREE MEAT,"Provided herein are nutrient media formulations and engineered growth factors, and methods thereof, useful for the production of slaughter-free meat.",UPSIDE FOODS INC,JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,,https://lens.org/016-377-042-454-125,Patent Application,yes,6,0,7,7,7,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,C12N5/00;;C12N5/07;;C12N5/071,,8,2,002-463-229-211-572;;082-919-284-826-523,32134068;;10.1039/c9fo02690h;;10.3923/ajft.2011.441.459,"ANDREASSEN R. CHRISTEL ET AL: ""Screening of by-products from the food industry as growth promoting agents in serum-free media for skeletal muscle cell culture"", FOOD & FUNCTION, vol. 11, no. 3, 26 March 2020 (2020-03-26), GB, pages 2477 - 2488, XP055839644, ISSN: 2042-6496, Retrieved from the Internet <URL:https://pubs.rsc.org/en/content/articlepdf/2020/fo/c9fo02690h> DOI: 10.1039/C9FO02690H;;ANONYMOUS: ""11965 - DMEM, high glucose | Thermo Fisher Scientific - DE"", 4 July 1959 (1959-07-04), pages 1 - 2, XP055839688, Retrieved from the Internet <URL:https://www.thermofisher.com/de/de/home/technical-resources/media-formulation.8.html> [retrieved on 20210909];;Z.F. BHAT ET AL: ""Animal-free Meat Biofabrication"", AMERICAL JOURNAL OF FOOD TECHNOLOGY, vol. 6, no. 6, 15 May 2011 (2011-05-15), pages 441 - 459, XP055738784, ISSN: 1557-4571, DOI: 10.3923/ajft.2011.441.459;;ANONYMOUS: ""GSP:BDB47673"", 11 August 2016 (2016-08-11), pages 1 - 1, XP055839615, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=GSP:BDB47673> [retrieved on 20210909];;ANONYMOUS: ""GSP:BDC70983"", 21 July 2016 (2016-07-21), XP055839621, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=GSP:BDC70983> [retrieved on 20210909];;ANONYMOUS: ""UPI0003C87471"", 6 January 2015 (2015-01-06), XP055839625, Retrieved from the Internet <URL:https://www.uniprot.org/uniparc/UPI0003C87471> [retrieved on 20210909];;ANONYMOUS: ""GSP:AFS76940"", 14 June 2007 (2007-06-14), XP055839630, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=GSP:AFS76940> [retrieved on 20210909];;ANONYMOUS: ""EPOP:GN083316"", 2 March 2009 (2009-03-02), pages 1 - 1, XP055839604, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=EPOP:GN083316> [retrieved on 20210909]",PENDING
176,EP,A1,EP 4162026 A1,035-712-521-067-194,2023-04-12,2023,EP 21746583 A,2021-06-07,US 202063035661 P;;US 2021/0036264 W,2020-06-05,NUTRIENT MEDIA FOR THE PRODUCTION OF SLAUGHTER-FREE MEAT,,UPSIDE FOODS INC,JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,,https://lens.org/035-712-521-067-194,Patent Application,yes,0,0,7,7,0,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,C12N5/00;;C12N5/07;;C12N5/071,,0,0,,,,PENDING
177,US,A1,US 2022/0073870 A1,003-354-031-021-849,2022-03-10,2022,US 202117341220 A,2021-06-07,US 202117341220 A;;US 202063035661 P,2020-06-05,NUTRIENT MEDIA FOR THE PRODUCTION OF SLAUGHTER-FREE MEAT,"Provided herein are nutrient media formulations and engineered growth factors, and methods thereof, useful for the production of slaughter-free meat.",UPSIDE FOODS INC,JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,UPSIDE FOODS INC (2021-06-17),https://lens.org/003-354-031-021-849,Patent Application,yes,0,5,7,7,7,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,C12N5/071,,8,1,072-962-397-562-30X,23563583;;10.4161/mabs.23942;;pmc4169041,"Russo et al., 2019, Pharmaceuticals, Vol. 11, pgs. 1-17 (Year: 2019);;FDA List of CFR Title 21, three page web printout (Year: 2022);;ECHEMI.com printout for sodium molybdate, three pages (Year: 2022);;2009, IPCS, Environmental Health Criteria 240, Chapter 5 (Year: 2009);;Five American Food Ingredients That Are Banned in Other Countries, 10 page web printout (Year: 2022);;Final Determination Regarding Partially Hydrogenated Oils - FDA Ruling (Year: 2013);;FDA Notice for Synthetic Flavorings (Year: 2018);;Rouiller et al. (2013, mAbs, Vol. 5:3, pgs. 501-511).",PENDING
178,IL,A,IL 298798 A,085-221-940-016-030,2023-02-01,2023,IL 29879822 A,2022-12-04,US 202063035661 P;;US 2021/0036264 W,2020-06-05,Nutrient media for the production of slaughter-free meat,,UPSIDE FOODS INC;;JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,,https://lens.org/085-221-940-016-030,Patent Application,no,0,0,7,7,0,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,,,0,0,,,,PENDING
179,CA,A1,CA 3179816 A1,128-060-337-651-471,2021-12-09,2021,CA 3179816 A,2021-06-07,US 202063035661 P;;US 2021/0036264 W,2020-06-05,NUTRIENT MEDIA FOR THE PRODUCTION OF SLAUGHTER-FREE MEAT,"Provided herein are nutrient media formulations and engineered growth factors, and methods thereof, useful for the production of slaughter-free meat.",UPSIDE FOODS INC,JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,,https://lens.org/128-060-337-651-471,Patent Application,no,0,0,7,7,0,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,C12N5/00;;C12N5/07;;C12N5/071,,0,0,,,,PENDING
180,AU,A1,AU 2021/286008 A1,094-979-469-022-417,2022-12-08,2022,AU 2021/286008 A,2021-06-07,US 202063035661 P;;US 2021/0036264 W,2020-06-05,Nutrient media for the production of slaughter-free meat,"Provided herein are nutrient media formulations and engineered growth factors, and methods thereof, useful for the production of slaughter-free meat.",UPSIDE FOODS INC,JOHNSON KALLE LUKYAN;;BENTON PATRICIA R;;COPELAND CAMERON GENTRY;;DHADWAR SUKHDEEP SINGH;;FIRPO MERI TERESA;;GIBBONS MARIE ELIZABETH;;HSU STEPHEN K;;SIERRA ROBERT;;KAYSER KEVIN JOHN,,https://lens.org/094-979-469-022-417,Patent Application,no,0,0,7,7,0,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,C12N5/00;;C12N5/07;;C12N5/071,,0,0,,,,PENDING
181,CN,A,CN 115989318 A,105-987-306-709-801,2023-04-18,2023,CN 202180040415 A,2021-06-07,US 202063035661 P;;US 2021/0036264 W,2020-06-05,Nutritional medium for producing slaughter-free meat,Provided herein are nutritional medium formulations and engineered growth factors for producing slaughter-free meat and methods thereof.,APSAED FOODS INC,JONATHAN KENNETH L;;BENTON PAUL ROBERT;;COPELAND CHRIS G;;DADWAL SUDEEP SHRIKANT;;PHILBO MICHAEL TIMOTHY;;GIBBONS MICHAEL E;;HSU STEVEN K;;SELA RAHUL;;KAYSER KEVIN J,,https://lens.org/105-987-306-709-801,Patent Application,no,0,0,7,7,0,C12N5/0031;;C12N5/0043;;C12N2501/115;;C12N2501/135;;C12N2501/165;;C12N2501/105;;C12N2500/24;;A23J3/227;;C12N5/0602;;C12N2500/36;;C12N2501/12;;C12N2501/11;;C12N2501/113;;C12N2501/33;;C12N2501/165;;C12N2500/32;;C12N2500/34;;C12N2500/24;;C12N5/0043;;C12N5/0031;;C12N2501/15;;C12N2500/14;;C12N2501/135;;C12N2501/115;;C12N2501/105;;C12N2501/155;;C12N2501/117;;C12N2500/38;;A23J3/227;;C12N5/0602;;C12N2500/14;;C12N2500/24;;C12N2500/32;;C12N2500/34;;C12N2500/36;;C12N2500/38;;C12N2501/105;;C12N2501/11;;C12N2501/113;;C12N2501/115;;C12N2501/117;;C12N2501/12;;C12N2501/135;;C12N2501/15;;C12N2501/155;;C12N2501/165;;C12N2501/33,C12N5/00,,0,0,,,,PENDING
182,US,B2,US 10010549 B2,187-012-762-378-828,2018-07-03,2018,US 201514927267 A,2015-10-29,US 201514927267 A;;CN 2014076654 W;;US 201361817966 P,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.",GENENTECH INC,ESTRADA ANTHONY;;DONG LITING;;CHEN KEVIN X;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;LYSSIKATOS JOSEPH;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/187-012-762-378-828,Granted Patent,yes,45,2,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/506;;A61K31/444;;A61K31/4545;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00,,62,53,013-241-509-688-565;;055-363-625-771-074;;143-721-218-362-238;;007-324-885-162-969;;016-047-078-541-632;;010-690-954-150-039;;003-101-293-057-686;;008-602-308-653-120;;038-022-163-471-664;;007-339-740-839-088;;040-169-100-598-068;;024-024-199-258-17X;;043-328-638-198-044;;031-490-531-093-269;;040-455-991-439-606;;030-714-548-701-324;;076-377-741-088-482;;032-039-523-018-613;;023-729-114-126-404;;023-330-931-990-046;;061-311-115-443-305;;056-904-015-376-38X;;012-503-389-547-67X;;069-748-915-814-920;;012-490-727-723-374;;062-988-279-579-971;;006-999-952-868-312;;029-410-094-669-826;;066-431-997-219-126;;015-013-876-900-917;;057-916-704-449-999;;056-157-407-319-601;;107-938-918-571-163;;007-364-858-655-289;;044-135-659-393-274;;105-316-509-347-292;;105-804-415-869-201;;012-214-493-070-380;;004-375-576-254-684;;058-849-884-316-235;;113-709-970-063-99X;;004-690-756-818-328;;048-563-040-470-615;;061-115-980-753-297;;117-090-053-538-301;;089-633-612-001-004;;128-901-299-587-74X;;064-792-862-161-861;;093-739-617-741-976;;022-579-586-775-544;;024-403-092-671-968;;066-516-608-807-593;;082-984-043-695-164,22388811;;10.1038/nature10841;;10.1016/j.pharmthera.2005.10.006;;16472864;;10.1038/nrd3248;;21031003;;10.1136/pgmj.2009.080473;;21493636;;10.1016/j.drudis.2013.06.015;;23831857;;10.1038/nrd2217;;17330070;;10.1074/jbc.271.40.24788;;8798750;;10.1101/gad.1592107;;17901218;;pmc2000324;;pmc6674859;;10.1523/jneurosci.2272-06.2006;;17108173;;10.1016/j.bbrc.2009.04.009;;19358824;;10.1083/jcb.201103153;;pmc3171129;;21893599;;pmc3383631;;10.1016/j.neuron.2012.04.028;;22726832;;10.1021/jm5013984;;25341110;;23979718;;pmc3760612;;10.1083/jcb.201303066;;10.1073/pnas.1211284110;;10.3410/f.717992468.793480123;;23431148;;pmc3593842;;10.1523/jneurosci.2132-07.2008;;pmc2896687;;18199767;;17455299;;10.1002/jnr.21298;;10.1074/jbc.m113.451658;;pmc3745324;;23836896;;10.1111/j.1460-9568.2005.04389.x;;16262628;;14657393;;10.1073/pnas.2336254100;;pmc299947;;10.1038/39899;;9349820;;10.1016/j.brainres.2010.01.089;;20138848;;pmc2739046;;19525941;;10.1038/nn.2346;;10.1016/j.brainres.2003.10.029;;14697498;;10.1016/j.exer.2004.11.016;;15862173;;10.1097/nen.0b013e3182419dea;;10.1007/bf01345237;;9871436;;15519530;;10.1016/j.phrs.2004.05.005;;10.1073/pnas.0307453101;;pmc327205;;14704277;;9930727;;10.1046/j.1471-4159.1999.0720557.x;;19022249;;10.1016/j.expneurol.2008.10.008;;10.1111/j.1471-4159.2008.05713.x;;pmc2632584;;19014392;;10.3390/ph4081070;;10.1002/jps.2600660104;;833720;;10.1073/pnas.91.6.2076;;pmc43312;;8134351;;10.1016/s0076-6879(85)12031-8;;4046856;;10.1016/0169-409x(92)90014-h;;10.1016/s0076-6879(85)12029-x;;4046855;;10.1016/s0076-6879(85)12027-6;;4046853;;10.1002/mds.870020302;;2904648;;10.1016/s0076-6879(85)12030-6;;3900636;;10.1016/0169-409x(95)00103-e;;10.1038/news030324-12;;12669033;;10.1038/nm850;;2890709;;10.1055/s-1997-789;;6933450;;pmc349762;;10.1073/pnas.77.7.4030;;10.1002/jbm.820150212;;7348718;;10.1021/cr00039a007;;10.1016/s0076-6879(85)12028-8;;4046854;;10.1002/jps.2600770402;;3379586;;10.1016/s0076-6879(85)12026-4;;4046852;;11960316;;10.1038/sj.gt.3301664;;6201207;;10.1002/bip.360220167,"D.J. Cook et al., 483 Nature 213-218 (2012).;;S. Judge et al., 111 Pharmacology & Therapeutics, 224-259 (2006).;;V. Brinkmann et al., 9 Nature Reviews | Drug Discovery, 883-897 (2010).;;J.M. Zakrzewska et al., 87 Postgraduate medical journal, 410-416 (2011).;;Z. Wang et al., 19 Drug Discovery Today, 145-150 (2014).;;U.K. Marelli et al., 3 Frontiers in Oncology, 1-12 (2013).;;Kinase Inhibitors, Methods in Molecular Biology 795 (B. Kuster ed., 2012).;;Y. Agid et al., 6 Nature Reviews | Drug Discovery 189-201, 189 (2007).;;G. Fan et al., The Journal of Biological Chemistry, 24788-24793 (1996).;;J.A. Bloom et al., 21 Genes & Development, 2593-2606 (2007).;;S. Hirai et al., 26 The Journal of Neuroscience, 11992-12002 (2006).;;A. Itoh et al, 383 Biochemical and Biophysical Research Communications, 258-262 (2009).;;A. Sengupta et al., The Journal of Cell Biology, 751-764 (2011).;;J.E. Shin et al., 74 Neuron, 1015-1022 (2012).;;S. Patel et al., 58 Journal of Medicinal Chemistry, 401-418 (2014).;;S. Huntwork-Rodriguez et al., 202 The Journal of Cell Biology, 747-763 (2013).;;D. Welsbie et al., 110 PNAS, 4045-4050 (2013).;;X. Chen, 28 The Journal of Neuroscience, 672-680 (2008).;;(Office Action issued in U.S. Appl. No. 15/041,375, mailed on Aug. 11, 2016).;;Akanksha Thakur et al., “c-Jun Phosphorylation in Alzheimer Disease” Journal of Neuroscience Research 85(8): 1668-1673 ( 2007).;;Andrew J. Steelman et al., “Galectin-9 Protein is Up-regulated in Astrocytes by Tumor Necrosis Factor and Promotes Encephalitogenic T-cell Apoptosis” The Journal of Biological Chemistry 288(33): 23776-23787 (Aug. 2013).;;Angela S. Vlug et al., “ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation” European Journal of Neuroscience 22(8):1881-1894 ( 2005).;;Chia-Yi Kuan et al., “A critical role of neural-specific JNK3 for ischemic apoptosis” Proceedings of the National Academy of Sciences of the USA 100(25):15184-15189 (Dec. 2003).;;Derek D. Yang et al., “Absense of excitotoxicityinduced apoptosis in the hippocampus of mice lacking the Jnk3 gene” Nature 389(6653):865-870 ( 1997).;;Gabor G. Kovacs et al., “Distribution of apoptosis-related proteins in sporadic Creutzfeldt-Jakob disease” Brain Research 1323:192-199 ( 2010).;;Gerardo A Morfini et al., “Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin” Nature Neuroscience 12(7):864-781 (Jul. 2009).;;Gülgün Tezel et al., “Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice” Brain Research 996(2):202-212 ( 2004).;;Hana Levkovitch-Verbin et al., “The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma” Experimental Eye Research 80(5):663-670 ( 2005).;;Hien T. Tran et al., “Inhibition of JNK by a Peptide Inhibitor Reduces Traumatic Brain InjuryYInduced Tauopathy in Transgenic Mice” Journal of Neuropathology and Experimental Neurology 71(2):116-129 (Feb. 2012).;;L. D. Loopuijt et al. “The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease” Amino Acids 14:17-23 ( 1998).;;S. K. Sonkusare et al., “Dementia of Alzheimer's disease and other neurodegenerative disorders—memantine, a new hope” Pharmacological Research 51:1-17 ( 2005).;;Stéphane Hunot et al., “JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson'disease” Proceedings of the National Academy of Sciences of the USA 101(2):665-670 (Jan. 2004).;;Tinmarla F. Oo et al., “Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a Development Model of Induced Apoptotic Death in Neurons of the Substantia Nigra” Journal of Neurochemistry 72(2):557-564 ( 1999).;;V. Perrin et al., “Implication of the JNK pathway in a rat model of Huntington's disease” Experimental Neurology 215(1):191-200 ( 2009).;;Vincent Ries et al., “JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration” Journal of Neurochemistry 107(6):1578-1588 ( 2008).;;David Heras-Sandoval et al., “The Phosphatidylinositol 3-Kinase/m Tor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration” Pharmaceuticals 4:1070-1087 (2011).;;PCT Written Opinion for PCT/CN2014/076654 dated Jul. 30, 2014.;;(Office Action Issued in U.S. Appl. No. 14/267,011 dated Sep. 23, 2015).;;Berge et al., “Pharmaceutical Salts” Journal of Pharmaceutical Sciences 66(1):1-19 (1977).;;Bobo et al., “Convection-enhanced delivery of macromolecules in the brain” Proc. Natl. Acad. Sci. USA 91:2076-2080 (1994).;;Bodor, “Targeting of Drugs to the Brain” Methods in Enzymology 112:381 (1985).;;Bundgaard A Textbook of Drug Design and Development; Chapter 5 “Design and Application of Prodrugs”:113-191 (1991).;;Bundgaard et al., “(C) means to Enhance Penetration (1) Prodrugs as a means to improve the delivery of peptide drugs” Advanced Drug Delivery Reviews 8:1-38 (1992).;;Bundgaard, “Formation of Prodrugs of Amines, Amides, Ureides and Imides” Methods in Enzymology 112:347 (1985).;;Charton, “Prodrug Lability Prediction through the Use of Substituent Effects” Methods in Enzymology 112:323 (1985).;;De Yebenes et al., “Continuous Intracerebroventricular Infusion of Dopamine and Dopamine Agonists Through a Totally Implanted Drug Delivery System in Animal Models of Parkinson's Disease” Movement Disorders 2(3):143-158 (1987).;;Eppstein et al., “Biological activity of liposome-encapsulated murine interferon γ is mediated by a cell membrane receptor” Proc. Natl. Acad. Sci. USA 82:3688-3692 (1985).;;Fleisher et al., “Design of Prodrugs for Improved Gastrointestinal Absorption by Intestinal Enzyme Targeting” Methods in Enzymology 112:360 (1985).;;Fleisher et al., “Improved oral drug delivery: solubility limitations overcome by the use of prodrugs” Advanced Drug Delivery Reviews 19:115-130 (1996).;;Gill et al., “Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease” Nature Medicine 9(5):589 (2003).;;Harbaugh, “Intracerebroventricular cholinergic drug administration in Alzheimer's disease: preliminary results of a double-blind study” J. Neural. Trans. 24 Suppl.:271-277 (1987).;;Hartwig et al., “Palladium-Catalyzed Amination of Aryl Halides: Mechanism and Rational Catalyst Design” Synlett 4:329-340 (1997).;;Hwang et al., “Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study” Proc. Natl. Acad. Sci. USA 77(7):4030-4034 (1980).;;Kakeya et al., “Studies on Prodrugs of Cephalosporins.I.1Synthesis and Biological Properties of Glycyloxbenzoyloxymethyl and Glycylaminobenzoyloxymethyl Esters of 7β-[2-(2-Aminothiazol-4yl)-(Z)-2-methoxyiminoacetamido]-3-3-methyl-3-cephem-4-carboxylic Acid” Chem. Pharm. Bull. 32(2):692-698 (1984).;;Langer et al., “Biocompatibility of polymeric delivery systems for macromolecules” Journal of Biomedical Materials Research 15:267-277 (1981).;;Miyaura et al., “Palladium-Catalyzed Cross-Coupling Reactions of Organboron Compounds” Chem. Rev. 95:2457-2483 (1995).;;Nelson et al., “Alteration of Drub Metabolism by the Use of Prodrugs” Methods in Enzymology 112:340 (1985).;;Nielsen et al., “Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical Properties” Journal of Pharmaceutical Sciences 77(4):285 (1988).;;Notari, “Theory and Practice of Prodrug Kinetics” Methods in Enzymology 112:309 (1985).;;Papanastassiou et al., “The Potential for Efficacy of The Modified (ICP 34.5) Herpes Simplex Virus HSV1716 Following Intratumoural Injection into Human Malignant Glioma: A Proof of Principle Study” Gene Therapy 9:398-406 (2002).;;Robinson et al., “Discovery of the Hemifumarate and (α-L-Alanyloxy)methyl Esther as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group” J. Med. Chem. 39:10-18 (1996).;;Sidman et al., “Controlled Release of Macromolecules and Pharmaceuticals from Synthetic Polypeptides Based on Glutamic Acid” Biopolymers 22:547-556 (1983).",ACTIVE
183,US,A1,US 2018/0133219 A1,069-453-996-512-01X,2018-05-17,2018,US 201815868301 A,2018-01-11,US 201815868301 A;;US 201514927267 A;;CN 2014076654 W;;US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.",GENENTECH INC,ESTRADA ANTHONY;;DONG LITING;;CHEN KEVIN X;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;LYSSIKATOS JOSEPH;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/069-453-996-512-01X,Patent Application,yes,0,1,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/506;;A61K31/444;;A61K31/4545;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00,,0,0,,,,DISCONTINUED
184,US,A1,US 2020/0188397 A1,160-223-411-236-174,2020-06-18,2020,US 201916666273 A,2019-10-28,US 201916666273 A;;US 201815868301 A;;US 201514927267 A;;CN 2014076654 W;;US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.",GENENTECH INC,ESTRADA ANTHONY;;DONG LITING;;CHEN KEVIN X;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;LYSSIKATOS JOSEPH;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/160-223-411-236-174,Patent Application,yes,0,1,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/506;;A61K31/444;;A61K31/4545;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00,,0,0,,,,ACTIVE
185,US,A1,US 2016/0052940 A1,011-092-887-819-260,2016-02-25,2016,US 201514927267 A,2015-10-29,US 201514927267 A;;CN 2014076654 W;;US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.",GENENTECH INC,ESTRADA ANTHONY;;DONG LITING;;CHEN KEVIN X;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;LYSSIKATOS JOSEPH;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/011-092-887-819-260,Patent Application,yes,3,9,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D519/00;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K31/553;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08,,18,16,013-241-509-688-565;;055-363-625-771-074;;143-721-218-362-238;;007-324-885-162-969;;016-047-078-541-632;;010-690-954-150-039;;003-101-293-057-686;;008-602-308-653-120;;038-022-163-471-664;;007-339-740-839-088;;040-169-100-598-068;;024-024-199-258-17X;;043-328-638-198-044;;031-490-531-093-269;;040-455-991-439-606;;030-714-548-701-324,22388811;;10.1038/nature10841;;10.1016/j.pharmthera.2005.10.006;;16472864;;10.1038/nrd3248;;21031003;;10.1136/pgmj.2009.080473;;21493636;;10.1016/j.drudis.2013.06.015;;23831857;;10.1038/nrd2217;;17330070;;10.1074/jbc.271.40.24788;;8798750;;10.1101/gad.1592107;;17901218;;pmc2000324;;pmc6674859;;10.1523/jneurosci.2272-06.2006;;17108173;;10.1016/j.bbrc.2009.04.009;;19358824;;10.1083/jcb.201103153;;pmc3171129;;21893599;;pmc3383631;;10.1016/j.neuron.2012.04.028;;22726832;;10.1021/jm5013984;;25341110;;23979718;;pmc3760612;;10.1083/jcb.201303066;;10.1073/pnas.1211284110;;10.3410/f.717992468.793480123;;23431148;;pmc3593842;;10.1523/jneurosci.2132-07.2008;;pmc2896687;;18199767,"D.J. Cook et al., 483 Nature 213-218 (2012);;S. Judge et al., 111 Pharmacology & Therapeutics, 224-259 (2006);;V. Brinkmann et al., 9 NATURE Reviews | Drug Discovery, 883-897 (2010);;J.M. Zakrzewska et al., 87 Postgraduate medical journal, 410-416 (2011);;Z. Wang et al., 19 Drug Discovery Today, 145-150 (2014);;U.K. Marelli et al., 3 Frontiers in Oncology, 1-12 (2013);;KINASE INHIBITORS, METHODS IN MOLECULAR BIOLOGY 795 (B. Kuster ed., 2012);;Y. Agid et al., 6 Nature Reviews | Drug Discovery 189-201, 189 (2007);;G. Fan et al., The Journal of Biological Chemistry, 24788-24793 (1996);;J.A. Bloom et al., 21 Genes & Development, 2593-2606 (2007);;S. Hirai et al., 26 The Journal of Neuroscience, 11992-12002 (2006);;A. Itoh et al, 383 Biochemical and Biophysical Research Communications, 258-262 (2009);;A. Sengupta et al., The Journal of Cell Biology, 751-764 (2011);;J.E. Shin et al., 74 Neuron, 1015-1022 (2012);;S. Patel et al., 58 Journal of Medicinal Chemistry, 401-418 (2014);;S. Huntwork-Rodriguez et al., 202 The Journal of Cell Biology, 747-763 (2013);;D. Welsbie et al., 110 PNAS, 4045-4050 (2013);;X. Chen, 28 The Journal of Neuroscience, 672-680 (2008)",ACTIVE
186,EP,A1,EP 2991978 A1,008-626-864-970-967,2016-03-09,2016,EP 14791795 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,,HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/008-626-864-970-967,Patent Application,yes,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,PENDING
187,CA,C,CA 2911051 C,093-343-839-332-560,2021-08-17,2021,CA 2911051 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1, R 2, R 3, X 1, X 2, A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/093-343-839-332-560,Granted Patent,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
188,CN,A,CN 105431420 A,137-661-674-050-52X,2016-03-23,2016,CN 201480024257 A,2014-04-30,CN 2014076654 W;;US 201361817966 P,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1, R 2, R 3, X 1, X 2, A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/137-661-674-050-52X,Patent Application,no,5,1,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
189,NZ,A,NZ 750661 A,009-546-067-269-445,2020-11-27,2020,NZ 75066114 A,2014-04-30,US 201361817966 P;;NZ 71293414 A,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides dual leucine zipper kinase (DLK) inhibitor compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g. neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy of Formula (I-I) are as defined herein. In a preferred embodiment X1 is N.",HOFFMANN LA ROCHE,LYSSIKATOS JOSEPH P;;CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/009-546-067-269-445,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/4427;;A61K31/506;;A61K31/535;;A61K31/5377;;A61P25/16;;A61P25/28;;C07D403/14,,0,0,,,,DISCONTINUED
190,MA,B1,MA 42164 B1,034-101-259-284-257,2019-12-31,2019,MA 42164 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Composes biheteroaryle et leurs utilisations,"La présente invention concerne des composés représentés par la formule i-i ainsi que des modes de réalisation et des sels correspondants qui sont destinés au traitement de maladies (notamment, de maladies neurodégénératives). R 1, r 2, r 3, x 1, x 2, a et la variable cy de la formule i-i possèdent tous la signification telle que définie dans la description.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/034-101-259-284-257,Granted Patent,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/444;;A61K31/503;;A61P25/00;;C07D401/14;;C07D403/14,,0,0,,,,ACTIVE
191,CA,A1,CA 2911051 A1,057-548-016-787-314,2014-11-06,2014,CA 2911051 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1, R 2, R 3, X 1, X 2, A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/057-548-016-787-314,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
192,PE,A1,PE 20161063 A1,195-842-401-654-199,2016-10-22,2016,PE 2016000335 A,2014-04-30,US 201361817966 P,2013-05-01,COMPUESTOS DE BIHETEROARILO Y USOS DE LOS MISMOS,"Se refiere a un compuesto biheteroarilo de formula I-I, o una de sus sales, donde: R1, R2 y R3 son H, F, Cl, Br, I, alquilo C1-C6 o haloalquilo C1-C6; X1 es N o C-R4; R4 es F, -Cl, -Br, entre otros; o R1 y R4 juntos forman un heterocicloalquilo de 5 a 6 miembros; X2 es N o CH; A es alquilo C1-C6, haloalquilo C1-C6, entre otros; Cy es alquilo C1-C6, haloalquilo C1-C6, entre otros. Son compuestos preferidos: [3-[6-[2-amino-4-(trifluorometil)pirimidin-5-il]-2-metil-pirimidin-4-il]pirrolidin-1-il]-fenil-metanona; [3-[6-(2-aminopirimidin-5-il)-2-metil-1-pirimidin-4-il]-1-piperidil]-fenil-metanona; entre otros. Tambien se refiere a un metodo de tratamiento. Dichos compuestos disminuyen la fosforilacion, actividad y/o expresion de JNK, cJun y p38 siendo utiles en el tratamiento de enfermedades o trastornos neurodegenerativos tales como enfermedad de Alzheimer, enfermedad de Huntington, entre otros",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;SIU MICHAEL;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;LIU WEN,,https://lens.org/195-842-401-654-199,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14,,0,0,,,,PENDING
193,PH,A1,PH 12015502410 A1,039-203-569-246-546,2016-02-22,2016,PH 12015502410 A,2015-10-16,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1, R 2, R 3, X 1, X 2, A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;LITING DONG;;ANTHONY ESTRADA;;PAUL GIBBONS;;MALCOLM HUESTIS;;TERRY KELLAR;;WEN LIU;;LYSSIKATOS JOSEPH P;;CHANGYOU MA;;ALAN OLIVERO;;SNAHEL PATEL;;DANIEL SHORE;;MICHAEL SIU,,https://lens.org/039-203-569-246-546,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14,,0,0,,,,PENDING
194,AU,C1,AU 2014/261894 C1,164-432-479-895-543,2019-07-11,2019,AU 2014/261894 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/164-432-479-895-543,Amended Patent,no,2,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
195,EP,A4,EP 2991978 A4,141-035-108-536-062,2016-09-14,2016,EP 14791795 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,,HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/141-035-108-536-062,Search Report,no,2,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,1,0,,,See also references of WO 2014177060A1,PENDING
196,MY,A,MY 182082 A,182-546-519-421-202,2021-01-18,2021,MY PI2015002684 A,2014-04-30,CN 2014076654 W;;US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula 1-1 and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula 1-1 all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/182-546-519-421-202,Granted Patent,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,,,0,0,,,,ACTIVE
197,MA,A1,MA 38624 A1,173-364-390-031-25X,2017-02-28,2017,MA 38624 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Composés bihétéroaryle et leurs utilisations,"La présente invention concerne des composés représentés par la formule i-i ainsi que des modes de réalisation et des sels correspondants qui sont destinés au traitement de maladies (notamment, de maladies neurodégénératives). R 1, r 2, r 3, x 1, x 2, a et la variable cy de la formule i-i possèdent tous la signification telle que définie dans la description.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/173-364-390-031-25X,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14,,0,0,,,,PENDING
198,UA,C2,UA 121016 C2,186-777-535-515-675,2020-03-25,2020,UA A201511803 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-І and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Су variable in Formula (I-І) all have the meaning as defined herein. I-І",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/186-777-535-515-675,Limited Patent,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,,,0,0,,,,ACTIVE
199,MA,A1,MA 42164 A1,044-157-455-503-90X,2019-01-31,2019,MA 42164 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Composes biheteroaryle et leurs utilisations,"La présente invention concerne des composés représentés par la formule i-i ainsi que des modes de réalisation et des sels correspondants qui sont destinés au traitement de maladies (notamment, de maladies neurodégénératives). R 1, r 2, r 3, x 1, x 2, a et la variable cy de la formule i-i possèdent tous la signification telle que définie dans la description.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/044-157-455-503-90X,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/444;;A61K31/503;;A61P25/00;;C07D401/14;;C07D403/14,,0,0,,,,ACTIVE
200,AU,B2,AU 2019/200249 B2,145-211-783-356-677,2020-10-15,2020,AU 2019/200249 A,2019-01-15,AU 2019/200249 A;;AU 2014/261894 A;;US 201361817966 P;;CN 2014076654 W,2013-05-01,Biheteroaryl compounds and uses thereof,"BIHETEROARYL COMPOUNDS AND USES THEREOF The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). RR 2, R 3, X, X2 , 5 A and Cy variable in Formula I-I all have the meaning as defined herein. Cy X 2 A Cy X~kAFormula I-I",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/145-211-783-356-677,Granted Patent,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,1,1,037-967-415-385-364,24900266;;10.3410/f.13357116.14726431;;pmc4017971;;10.1021/ml200156t,"Burger, Matthew T., et al. ""Identification of NVP-BKM120 as a potent, selective, orally bioavailable class I PI3 kinase inhibitor for treating cancer."" ACS medicinal chemistry letters 2, no. 10 (2011): 774-779.",ACTIVE
201,EA,B8,EA 029568 B8,164-300-268-902-606,2018-08-31,2018,EA 201592060 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R, R, R, X, X, A and Cy variable in Formula I-I all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/164-300-268-902-606,Unknown,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
202,CN,A,CN 110003178 A,064-070-844-820-515,2019-07-12,2019,CN 201910136846 A,2014-04-30,US 201361817966 P;;CN 201480024257 A,2013-05-01,Biheteroaryl compounds and uses thereof,"The invention relates to biheteroaryl compounds and uses thereof. Particularly, the present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/064-070-844-820-515,Patent Application,no,4,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/506;;A61P9/10;;A61P21/00;;A61P21/04;;A61P25/00;;A61P25/04;;A61P25/08;;A61P25/16;;A61P25/28;;A61P27/02;;A61P31/18;;C07D401/04;;C07D491/04,,0,0,,,,ACTIVE
203,CR,A,CR 20150589 A,094-273-479-643-124,2015-12-07,2015,CR 20150589 A,2015-10-23,US 201361817966 P;;CN 2014076654 W,2013-05-01,COMPUESTOS DE BIHETEROARILO Y USOS DE LOS MISMOS,"La presente invención proporciona compuestos de Fórmula I-I y realizaciones y sales de los mismos para el tratamiento de enfermedades (por ejemplo, enfermedades neurodegenerativas). Las variables R1, R2, R3, X1, X2, A y Cy en la Fórmula I-I tienen todas los significados definidos en el presente documento.",,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/094-273-479-643-124,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,PENDING
204,PE,A1,PE 20200447 A1,005-999-777-746-003,2020-02-28,2020,PE 2019002479 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,COMPUESTOS DE BIHETEROARILO Y USOS DE LOS MISMOS,"Referido a un compuesto de formula (I-I) o sus sales, en el que R1, R2 y R3 son cada uno independientemente H, F, Cl, Br, I, alquilo C1-6 o haloalquilo C1-6; X1 es N; X2 es N o CH; y A y Cy se selecciona entre el grupo que consiste en pirrolidina, piperidina, azetidina, entre otros. Un compuesto preferido es 5-[2-(3,3-difluoro-1-piperidil)-6-[(1S,4S)-2-oxa-5-azabiciclo[2.2.1]heptan-5-il]pirimidin-4-il]pirimidin-2-amina. Estos compuestos biheteroarilos inhiben la actividad de la doble quinasa de cremallera de leucina (DLK), siendo util para el tratamiento de enfermedades neurodegenerativas.",HOFFMANN LA ROCHE,ESTRADA ANTHONY;;GIBBONS PAUL;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL;;CHEN KEVIN X;;HUESTIS MALCOLM;;DONG LITING;;LYSSIKATOS JOSEPH P,,https://lens.org/005-999-777-746-003,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,PENDING
205,KR,A,KR 20160003241 A,092-878-575-562-120,2016-01-08,2016,KR 20157034239 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"본 발명은 질환(예컨대 신경변성 질환)의 치료를 위한 하기 화학식 I-I의 화합물 및 이의 실시양태 및 염을 제공한다:화학식 I-I의 R, R, R, X, X, A 및 Cy 변수는 모두 본원에 정의된 의미를 갖는다.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/092-878-575-562-120,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08,,0,0,,,,ACTIVE
206,EA,B1,EA 029568 B1,155-986-882-943-689,2018-04-30,2018,EA 201592060 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R, R, R, X, X, A and Cy variable in Formula I-I all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/155-986-882-943-689,Granted Patent,no,6,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
207,MX,A,MX 2015015130 A,101-361-277-206-649,2016-02-18,2016,MX 2015015130 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF.,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1, R 2, R 3, X 1, X 2, A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE,LYSSIKATOS JOSEPH P;;KELLAR TERRY;;ESTRADA ANTHONY;;SHORE DANIEL;;HUESTIS MALCOLM;;SIU MICHAEL;;PATEL SNAHEL;;LIU WEN;;CHEN KEVIN X;;DONG LITING;;GIBBONS PAUL;;MA CHANGYOU;;OLIVERO ALAN,,https://lens.org/101-361-277-206-649,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,PENDING
208,AU,B2,AU 2014/261894 B2,165-543-961-962-554,2018-10-18,2018,AU 2014/261894 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/165-543-961-962-554,Granted Patent,no,2,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
209,CR,A,CR 20200177 A,179-063-732-290-729,2020-06-28,2020,CR 20200177 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1, R 2, R 3, X 1, X 2, A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE,DONG LITING;;MA CHANGYOU;;PATEL SNAHEL;;GIBBONS PAUL;;LIU WEN;;LYSSIKATOS JOSEPH P;;OLIVERO ALAN;;KELLAR TERRY;;CHEN KEVIN X;;HUESTIS MALCOLM;;ESTRADA ANTHONY;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/179-063-732-290-729,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,A61P25/18;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/28;;C07D401/14;;C07D403/14,,0,0,,,,PENDING
210,JP,A,JP 2018035187 A,014-785-483-793-739,2018-03-08,2018,JP 2017200127 A,2017-10-16,US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"PROBLEM TO BE SOLVED: To provide organic compounds useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of Dual Leucine Zipper Kinase useful for treating neurodegeneration diseases and disorders.SOLUTION: The present invention provides a compound of formula (I-I) (R, R, R: H, F, Cl, Br, I, Calkyl or Chaloalkyl. X: N or C-R(R: F, Cl, Br, I and the like). X: N or CH. A: C1alkyl, Chaloalkyl and the like. Cy: C1alkyl, Chaloalkyl and the like).SELECTED DRAWING: None",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ANTHONY ESTRADA;;PAUL GIBBONS;;MALCOLM HUESTIS;;TERRY KELLAR;;LIU WEN;;JOSEPH P LYSSIKATOS;;MA CHANGYOU;;ALAN OLIVERO;;SNAHEL PATEL;;DANIEL SHORE;;SIU MICHAEL,,https://lens.org/014-785-483-793-739,Patent Application,no,8,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D239/48;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/00;;A61L27/36;;A61L27/38;;A61P9/10;;A61P21/00;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/14;;C07D407/14;;C07D413/14;;C07D417/14;;C07D487/04;;C07D487/08;;C07D491/048;;C07D491/08;;C07D491/107;;C07D495/08;;C07D519/00,,0,0,,,,ACTIVE
211,CL,A1,CL 2015003147 A1,034-184-911-731-238,2016-06-17,2016,CL 2015003147 A,2015-10-26,US 201361817966 P,2013-05-01,Compuestos de biheteroarilo y usos de los mismos,"COMPUESTOS DERIVADOS DE BIHETEROARILO NITROGENADOS, MODULADORES DE JNK ; COMPOSICIÓN FARMACEUTICA: Y SU USO PARA UN TRASTORNO NUERODEGENERATIVO, TAL COMO E. ALZHEIMER, E. PARKINSON, ENTRE OTROS.",HOFFMANN LA ROCHE,ESTRADA ANTHONY;;SHORE DANIEL;;CHEN KEVIN X;;DONG LITING;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SIU MAICHAEL,,https://lens.org/034-184-911-731-238,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,PENDING
212,BR,B1,BR 112015027055 B1,115-555-115-388-439,2023-09-26,2023,BR 112015027055 A,2014-04-30,CN 2014076654 W;;US 201361817966 P,2013-05-01,"Bi-heteroarilas, usos das mesmas, e composição farmacêutica","bi-heteroarilas, usos das mesmas, e composição farmacêutica. a presente invenção provê compostos de fórmula i-i e modalidades e sais dos mesmos para o tratamento de doenças (por exemplo, doenças neurodegenerativas). as variáveis r1, r2, r3, x1, x2, a e cy na fórmula i-i todas têm o significado como definido aqui. (i-i)",HOFFMANN LA ROCHE,OLIVERO ALAN;;ESTRADA ANTHONY;;MA CHANGYOU;;SHORE DANIEL;;JOSEPH P LYSSIKATOS;;KEVIN X CHEN;;DONG LITING;;HUESTIS MALCOLM;;SIU MICHAEL;;GIBBONS PAUL;;PATEL SNAHEL;;KELLAR TERRY;;LIU WEN,,https://lens.org/115-555-115-388-439,Granted Patent,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
213,EA,B1,EA 033084 B1,016-391-702-353-540,2019-08-30,2019,EA 201792471 A,2014-04-30,US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R, R, R, X, X, A and Cy variables in Formula I-I all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/016-391-702-353-540,Granted Patent,no,6,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
214,AU,A1,AU 2019/200249 A1,043-227-777-249-435,2019-01-31,2019,AU 2019/200249 A,2019-01-15,AU 2019/200249 A;;AU 2014/261894 A;;US 201361817966 P;;CN 2014076654 W,2013-05-01,Biheteroaryl compounds and uses thereof,"BIHETEROARYL COMPOUNDS AND USES THEREOF The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R', R2 , R3 , X', X2 , 5 A and Cy variable in Formula I-I all have the meaning as defined herein. Cy X2 A Cy X211AFormula I-I",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/043-227-777-249-435,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
215,NZ,A,NZ 712934 A,098-205-516-814-246,2020-10-30,2020,NZ 71293414 A,2014-04-30,CN 2014076654 W;;US 201361817966 P,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides dual leucine zipper kinase (DLK) inhibitor compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g. neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy of Formula (I-I) are as defined herein. In a preferred embodiment X1 is C-R4.",HOFFMANN LA ROCHE,LYSSIKATOS JOSEPH P;;CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/098-205-516-814-246,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/4427;;A61K31/506;;A61K31/535;;A61K31/5377;;A61P25/16;;A61P25/28;;C07D403/14,,0,0,,,,DISCONTINUED
216,JP,A,JP 2020079264 A,114-040-158-240-929,2020-05-28,2020,JP 2020014468 A,2020-01-31,US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"To provide novel compounds for treatment of diseases (e.g., neurodegenerative diseases).SOLUTION: Provided are compounds of a formula I-I and embodiments and salts thereof. (R, Rand Rare each independently H, F, Cl, Br, I, Calkyl or Chaloalkyl; Xis N or C-R; Xis N or CH; A is Calkyl, Chaloalkyl, Cdialkylamino, 3 to 12 membered cycloalkyl, 3 to 12 membered heterocycloalkyl, and 5 to 6 membered heteroaryl; and Cy is Calkyl, Chaloalkyl, 3 to 12 membered cycloalkyl, 3 to 12 membered heterocycloalkyl, and 5 to 6 membered heteroaryl.)SELECTED DRAWING: None",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ANTHONY ESTRADA;;PAUL GIBBONS;;MALCOLM HUESTIS;;TERRY KELLAR;;LIU WEN;;JOSEPH P LYSSIKATOS;;MA CHANGYOU;;ALAN OLIVERO;;SNAHEL PATEL;;DANIEL SHORE;;SIU MICHAEL,,https://lens.org/114-040-158-240-929,Patent Application,no,10,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D213/73;;A61K31/407;;A61K31/438;;A61K31/4985;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/547;;A61K31/55;;A61K31/551;;A61K31/553;;A61K45/00;;A61P25/00;;C07D239/48;;C07D401/14;;C07D403/14;;C07D405/14;;C07D417/14;;C07D451/02;;C07D451/14;;C07D487/04;;C07D487/08;;C07D491/048;;C07D491/08;;C07D491/107;;C07D495/08;;C07D498/08;;C07D519/00,,0,0,,,,PENDING
217,SG,A,SG 10201707002V A,034-105-722-131-622,2017-10-30,2017,SG 10201707002V A,2014-04-30,US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,,HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/034-105-722-131-622,Unknown,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,,,0,0,,,,PENDING
218,BR,A2,BR 112015027055 A2,104-994-042-407-824,2017-07-25,2017,BR 112015027055 A,2014-04-30,CN 2014076654 W;;US 201361817966 P,2013-05-01,compostos de bi-heteroarila e usos dos mesmos,"resumo patente de invenção: ""compostos de bi-heteroarila e usos dos mesmos"". a presente invenção provê compostos de fórmula i-i e modalidades e sais dos mesmos para o tratamento de doenças (por exemplo, doenças neurodegenerativas). as variáveis r1, r2, r3, x1, x2, a e cy na fórmula i-i todas têm o significado como definido aqui. (i-i)",HOFFMANN LA ROCHE,ALAN OLIVERO;;ANTHONY ESTRADA;;CHANGYOU MA;;DANIEL SHORE;;JOSEPH P LYSSIKATOS;;KEVIN X CHEN;;LITING DONG;;MALCOLM HUESTIS;;MICHAEL SIU;;PAUL GIBBONS;;SNAHEL PATEL;;TERRY KELLAR;;WEN LIU,,https://lens.org/104-994-042-407-824,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
219,BR,A8,BR 112015027055 A8,148-642-112-737-739,2020-01-14,2020,BR 112015027055 A,2014-04-30,CN 2014076654 W;;US 201361817966 P,2013-05-01,"bi-heteroarilas, usos das mesmas, e composição farmacêutica","resumo patente de invenção: ""compostos de bi-heteroarila e usos dos mesmos"". a presente invenção provê compostos de fórmula i-i e modalidades e sais dos mesmos para o tratamento de doenças (por exemplo, doenças neurodegenerativas). as variáveis r1, r2, r3, x1, x2, a e cy na fórmula i-i todas têm o significado como definido aqui. (i-i)",HOFFMANN LA ROCHE,ALAN OLIVERO;;ANTHONY ESTRADA;;CHANGYOU MA;;DANIEL SHORE;;JOSEPH P LYSSIKATOS;;KEVIN X CHEN;;LITING DONG;;MALCOLM HUESTIS;;MICHAEL SIU;;PAUL GIBBONS;;SNAHEL PATEL;;TERRY KELLAR;;WEN LIU,,https://lens.org/148-642-112-737-739,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
220,WO,A1,WO 2014/177060 A1,050-172-054-499-949,2014-11-06,2014,CN 2014076654 W,2014-04-30,US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula (I-I) all have the meaning as defined herein.",HOFFMANN LA ROCHE;;GENENTECH INC,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/050-172-054-499-949,Patent Application,yes,6,12,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,1,0,,,See also references of EP 2991978A4,PENDING
221,EA,B1,EA 038235 B1,112-936-157-898-488,2021-07-28,2021,EA 201991064 A,2014-04-30,US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"The invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variables in Formula I-I all have the meaning as defined herein.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/112-936-157-898-488,Granted Patent,no,6,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
222,SG,A,SG 11201509027W A,118-187-135-448-956,2015-12-30,2015,SG 11201509027W A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,,HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/118-187-135-448-956,Unknown,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,PENDING
223,KR,A,KR 20180026806 A,127-920-933-472-171,2018-03-13,2018,KR 20187006149 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,"본 발명은 질환(예컨대 신경변성 질환)의 치료를 위한 하기 화학식 I-I의 화합물 및 이의 실시양태 및 염을 제공한다:화학식 I-I의 R, R, R, X, X, A 및 Cy 변수는 모두 본원에 정의된 의미를 갖는다.",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/127-920-933-472-171,Patent Application,no,4,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D403/14;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08,,0,0,,,,ACTIVE
224,AU,A1,AU 2014/261894 A1,188-452-786-528-259,2015-10-29,2015,AU 2014/261894 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R",HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/188-452-786-528-259,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D401/14;;A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D403/14,,0,0,,,,ACTIVE
225,HK,A1,HK 1219276 A1,156-283-205-616-926,2017-03-31,2017,HK 16107343 A,2016-06-23,CN 2014076654 W;;US 201361817966 P,2013-05-01,BIHETEROARYL COMPOUNDS AND USES THEREOF,,HOFFMANN LA ROCHE,CHEN KEVIN X;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/156-283-205-616-926,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D/;;A61K/;;A61P/,,0,0,,,,PENDING
226,US,B2,US 11129832 B2,026-351-021-300-239,2021-09-28,2021,US 201916666273 A,2019-10-28,US 201916666273 A;;US 201815868301 A;;US 201514927267 A;;CN 2014076654 W;;US 201361817966 P,2013-05-01,Biheteroaryl compounds and uses thereof,"The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.",GENENTECH INC,ESTRADA ANTHONY;;DONG LITING;;CHEN KEVIN X;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;MA CHANGYOU;;LYSSIKATOS JOSEPH P;;OLIVERO ALAN G;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/026-351-021-300-239,Granted Patent,yes,31,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D471/08;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00,,38,35,010-690-954-150-039;;076-377-741-088-482;;032-039-523-018-613;;023-729-114-126-404;;008-602-308-653-120;;143-721-218-362-238;;037-967-415-385-364;;030-714-548-701-324;;023-330-931-990-046;;013-241-509-688-565;;107-938-918-571-163;;061-311-115-443-305;;003-101-293-057-686;;056-904-015-376-38X;;012-503-389-547-67X;;040-169-100-598-068;;069-748-915-814-920;;012-490-727-723-374;;062-988-279-579-971;;038-022-163-471-664;;031-490-531-093-269;;007-339-740-839-088;;055-363-625-771-074;;006-999-952-868-312;;020-435-443-101-790;;043-328-638-198-044;;029-410-094-669-826;;024-024-199-258-17X;;066-431-997-219-126;;015-013-876-900-917;;057-916-704-449-999;;056-157-407-319-601;;016-047-078-541-632;;040-455-991-439-606;;007-324-885-162-969,10.1038/nrd2217;;17330070;;17455299;;10.1002/jnr.21298;;10.1074/jbc.m113.451658;;pmc3745324;;23836896;;10.1111/j.1460-9568.2005.04389.x;;16262628;;10.1101/gad.1592107;;17901218;;pmc2000324;;10.1038/nrd3248;;21031003;;24900266;;10.3410/f.13357116.14726431;;pmc4017971;;10.1021/ml200156t;;10.1523/jneurosci.2132-07.2008;;pmc2896687;;18199767;;14657393;;10.1073/pnas.2336254100;;pmc299947;;22388811;;10.1038/nature10841;;10.3390/ph4081070;;10.1038/39899;;9349820;;10.1074/jbc.271.40.24788;;8798750;;10.1016/j.brainres.2010.01.089;;20138848;;pmc2739046;;19525941;;10.1038/nn.2346;;10.1083/jcb.201103153;;pmc3171129;;21893599;;10.1016/j.brainres.2003.10.029;;14697498;;10.1016/j.exer.2004.11.016;;15862173;;10.1097/nen.0b013e3182419dea;;pmc6674859;;10.1523/jneurosci.2272-06.2006;;17108173;;23979718;;pmc3760612;;10.1083/jcb.201303066;;10.1016/j.bbrc.2009.04.009;;19358824;;10.1016/j.pharmthera.2005.10.006;;16472864;;10.1007/bf01345237;;9871436;;24010121;;10.3389/fonc.2013.00222;;pmc3757457;;10.1021/jm5013984;;25341110;;15519530;;10.1016/j.phrs.2004.05.005;;pmc3383631;;10.1016/j.neuron.2012.04.028;;22726832;;10.1073/pnas.0307453101;;pmc327205;;14704277;;9930727;;10.1046/j.1471-4159.1999.0720557.x;;19022249;;10.1016/j.expneurol.2008.10.008;;10.1111/j.1471-4159.2008.05713.x;;pmc2632584;;19014392;;10.1016/j.drudis.2013.06.015;;23831857;;10.1073/pnas.1211284110;;10.3410/f.717992468.793480123;;23431148;;pmc3593842;;10.1136/pgmj.2009.080473;;21493636,"(Office Action issued in U.S. Appl. No. 15,041,375, dated Aug. 11, 2016).;;Agid et al., “How can drug disvocery for psychiatric disorders be improved” Nature Reviews/Drug Discovery 6:189 ( 2007).;;Akanksha Thakur et al., “c-Jun Phosphorylation in Alzheimer Disease” Journal of Neuroscience Research 85(8):1668-1673 ( 2007).;;Andrew J. Steelman et al., “Galectin-9 Protein Is Up-regulated in Astrocytes by Tumor Necrosis Factor and Promotes Encephalitogenic T-cell Apoptosis*” The Journal of Biological Chemistry 288(33):23776-23787 (Aug. 2013).;;Angela S. Vlug et al., “ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation” European Journal of Neuroscience 22(8):1881-1894 ( 2005).;;Bloom et al., “The requirement for Phr1 in CNS axon tract formation reveals the corticostriatal boundary as a choice point for cortical axons” Genes & Development 21:2593-2606 ( 2007).;;Brinkmann et al., “Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis” Nature Reviews / Drug Discovery 9:883 ( 2010).;;Burger et al., “Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I P13 Kinase Inhibitor for Treating Cancer” ACS Medicinal Chemistry Letters 2:774-779 ( 2011).;;Chen et al., “Antiapoptotic and trophic effects of dominant-negative forms of dual leueine zipper kinase in dopamine neurons of the substantia nigra in vivo” J Neurosci 28(3):672-680 (Jan. 16, 2008).;;Chia-Yi Kuan et al., “A critical role of neural-specific JNK3 for ischemic apoptosis” Proceedings of the National Academy of Sciences of the USA 100(25):15184-15189 (Dec. 2003).;;Cook et al., “Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain” Nature 483:213-218 (2012).;;David Heras-Sandoval et al., “The Phosphatidylinositol 3-Kinase/m Tor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration” Pharmaceuticals 4: 1070-1087 ( 2011).;;Derek D. Yang et al., “Absence of excitotoxicityinduced apoptosis in the hippocampus of mice lacking the Jnk3 gene” Nature 389(6653):865-870 ( 1997).;;Fan et al., “Dual Leucine Zipper-beating Kinase (DLK) Activates p46 SAPK and p38mapk but not ERK2” J. of Biological Chemistry 271(10):24788-24793 ( 1996).;;Gabor G. Kovacs et al., “Distribution of apoptosis-related proteins in sporadic Creutzfeldt-Jakob disease” Brain Research 1323:192-199 ( 2010).;;Gerardo A Morfini et al., “Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin” Nature Neuroscience 12(7):864-781 (Jul. 2009).;;Ghosh, A. et al., “DLK induces developmental neuronal degeneration via selective regulation of propoptotic JNK activity” Journal of Cell Biology 194(5):751-764 ( 2011).;;Gülgün Tezel et al., “Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice” Brain Research 996(2):202-212 ( 2004).;;Hana Levkovitch-Verbin et al., “The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma” Experimental Eye Research 80(5):663-670 ( 2005).;;Hien T. Tran et al., “Inhibition of JNK by a Peptide Inhibitor Reduces Traumatic Brain InjuryYInduced Tauopathy in Transgenic Mice” Journal of Neuropathology and Experimental Neurology 71(2):116-129 (Feb. 2012).;;Hirai et al., “The c-Jun N-Terminal kinase activator dual leucine zipper kinase regulates axon growth and neuronal migration in the developing cerebral cortex” J. of Neuroscience 26(46):11992-12002 ( 2006).;;Huntwork-Rodriguez et al., “JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis” J. of Cell Biology(202):747-763 ( 2013).;;Itoh et al., “Impaired regenerative response of primary sensory neurons in ZPK/DLK gene-trap mice” Biochemical and Biophysical Research Communications 383:258-262 ( 2009).;;Judge et al., “Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment” Pharmacology & Therapeutics 111:224-259 ( 2006).;;Kuster B. Kinase Inhibitors Methods and Protocols “Chapter 1” Humana Press, ( 2012).;;L. D. Loopuijt et al., “The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease” Amino Acids 14:17-23 ( 1998).;;Marelli et al., “Tumor targeting Via integrin ligands” Frontiers in Oncology 3:1-12 ( 2013).;;Patel et al., “Discovery of dual leueine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models” J. of Medicinal Chemistry 58:401-418 ( 2015).;;PCT Written Opinion for PCT/CN2014/076654 dated Jul. 30, 2014.;;S. K. Sonkusare et al., “Dementia of Alzheimer's disease and other neurodegenerative disorders—memantine, a new hope” Pharmacological Research 51:1-17 ( 2005).;;Shin et al., “Dual leueine zipper kinase is required for retrograde injury signaling and axonal regeneration” Neuron 74: 1015-1022 ( 2012).;;Stéphane Hunot et al., “JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease” Proceedings of the National Academy of Sciences of the USA 101(2):665-670 (Jan. 2004).;;Tinmarla F. Oo et al., “Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a Development Model of Induced Apoptotic Death in Neurons of the Substantia Nigra” Journal of Neurochemistry 72(2):557-564 ( 1999).;;V. Pernin et al., “Implication of the JNK pathway in a rat model of Huntington's disease” Experimental Neurology 215(1):191-200 ( 2009).;;Vincent Ries et al., “JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration” Journal of Neurochemistry 107(6):1578-1588 ( 2008).;;Wang et al., “Mathematical modeling in cancer drug discovery” Drug Discovery Today 19:145-150 ( 2014).;;Welsbie et al., “Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death” PNAS 110(10):4045-4050 ( 2013).;;Zakrzewska et al., “Trigeminal neuraligia: the diagnosis and management of this excruciating and poorly understood facial pain” Postgrad Med J. 87:410-416 ( 2011).",ACTIVE
227,EP,A1,EP 4328436 A1,130-322-353-619-091,2024-02-28,2024,EP 23193568 A,2023-08-25,US 202217896773 A;;US 202318224843 A,2022-08-26,PROPORTIONAL RESTRICTION OF FUEL NOZZLE WITH AN AUXILIARY CIRCUIT,"A fuel injector for a turbine engine includes a fuel scheduling valve configured for regulation of fuel flow from a fuel inlet (115), in response to fuel pressure received at the fuel inlet. Primary, secondary and auxiliary fuel circuits (117, 119, 118) receive fuel from the scheduling valve, and an electrically-controlled valve (120) is provided in fluid communication with the auxiliary circuit (118), which electrically-controlled valve (120) is adapted and configured to actively control fuel through the auxiliary circuit (118) in response to a control signal.
",HAMILTON SUNDSTRAND CORP;;COLLINS ENGINE NOZZLES INC,WILLIAMS BRANDON P;;RYON JASON A;;HAUSJAAHABINK TODD;;LOKHANDWALLA MURTUZA;;REUTER CHARLES E;;FERRAROTTI MICHAEL;;GIBBONS KEVIN;;PETERS JESSE C;;ROURKE RUSSELL P JR;;KOKAS JAY W;;VERSAILLES RICHARD E,,https://lens.org/130-322-353-619-091,Patent Application,yes,8,0,2,3,0,F02C7/232;;F02C7/222;;F05D2270/31;;F05D2270/62;;F02C9/34;;F02C9/263;;F02C7/232;;F23R3/28,F02C7/22;;F02C7/232;;F02C9/26;;F02C9/34,,0,0,,,,PENDING
228,MA,A1,MA 48577 A1,059-843-196-265-04X,2021-03-31,2021,MA 48577 A,2014-04-30,US 201361817966 P;;CN 2014076654 W,2013-05-01,Composes biheteroaryle et leurs utilisations,"La présente invention concerne des composés représentés par la formule i-i ainsi que des modes de réalisation et des sels correspondants qui sont destinés au traitement de maladies (notamment, de maladies neurodégénératives). R 1, r 2, r 3, x 1, x 2, a et la variable cy de la formule i-i possèdent tous la signification telle que définie dans la description.",HOFFMANN LA ROCHE,CHEN KEVIN X;;FRANCHI LUIGI;;DONG LITING;;ESTRADA ANTHONY;;GIBBONS PAUL;;HUESTIS MALCOLM;;KELLAR TERRY;;LIU WEN;;LYSSIKATOS JOSEPH P;;MA CHANGYOU;;OLIVERO ALAN;;PATEL SNAHEL;;SHORE DANIEL;;SIU MICHAEL,,https://lens.org/059-843-196-265-04X,Patent Application,no,0,0,73,73,0,A61K31/444;;A61K31/506;;A61P25/00;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/28;;C07D401/14;;C07D403/14;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P3/00;;A61P31/18;;A61P39/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61K31/444;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;A61K31/553;;A61K35/30;;A61K45/06;;A61P3/00;;A61P9/00;;A61P9/10;;A61P21/00;;A61P21/02;;A61P21/04;;A61P25/00;;A61P25/02;;A61P25/04;;A61P25/08;;A61P25/14;;A61P25/16;;A61P25/18;;A61P25/20;;A61P25/28;;A61P27/02;;A61P27/06;;A61P31/18;;A61P39/02;;A61P43/00;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/08;;C07D471/18;;C07D487/08;;C07D487/14;;C07D487/18;;C07D491/08;;C07D495/08;;C07D519/00;;A61K2300/00;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/5386;;A61K31/55;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D451/14;;C07D487/08;;C07D471/08;;A61K45/06;;A61K31/5386;;A61K31/4545;;A61K31/506;;A61K31/5377;;A61K31/55;;A61K35/30;;C07D401/14;;C07D403/04;;C07D403/14;;C07D405/14;;C07D413/14;;C07D471/18;;C07D487/08;;C07D491/08;;C07D495/08;;C07D519/00;;A61K31/553;;C07D417/14;;C07D487/14;;C07D487/18;;A61K31/444,C07D403/14;;C07D401/14,,0,0,,,,PENDING
